Россия, г. Королев.

eburdiyg@gmail.com

8 (903) 781-84-63

  • Главная
  • Use of Angiotensin II type 1 receptor antagonists for the prevention of stroke, diabetes and/or congestive heart failure

Use of Angiotensin II type 1 receptor antagonists for the prevention of stroke, diabetes and/or congestive heart failure

Номер патента: EP1925303A2
Опубликовано: 28-05-2008
Автор(ы): Anders Ljunggren, Badrudin Rangoonwala, Bernward Schoelkens, Gilles Dagenais, Hetzel Gerstein, Norbert Bender, Salim Yusuf
Принадлежит: Sanofi Aventis Deutschland GmbH
Получить PDF файл: Открыть в новом окне

Вам могут быть интересны следующие патенты

Рисунок 1. Взаимосвязь патентов (ближайшие 20).

Pharmaceutical preparations and their application for prevention of stroke, diabetes and/or congestive heart failure

Номер патента: RU2378018C2. Автор: Бернвард ШЕЛКЕНС,Норберт БЕНДЕР,Бадрудин РАНГООНВАЛА,Жилль ДАЖЕНЕ,Хертцель ГЕРШТАЙН,Андерс ЮНГГРЕН,Салим ЮСУФ. Владелец: Авентис Фарма Дойчланд Гмбх. Дата публикации: 2010-01-10.

Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure

Номер патента: US20130317047A1. Автор: Bernward Scholkens,Salim Yusuf,Anders Ljunggren,Hertzel Gerstein,Norbert Bender,Badrudin Rangoonwala,Gilles Dagenais. Владелец: Aventis Pharma Deutschland GmbH. Дата публикации: 2013-11-28.

Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure

Номер патента: CA2382387A1. Автор: Bernward Schoelkens,Salim Yusuf,Anders Ljunggren,Hertzel Gerstein,Norbert Bender,Badrudin Rangoonwala,Gilles Dagenais. Владелец: Gilles Dagenais. Дата публикации: 2001-03-08.

Pharmaceutical formulations containing renin-angiotensin system inhibitors and use thereof in the prevention of stroke, diabetes and/or congestive heart failure

Номер патента: CZ2002644A3. Автор: Bernward Schoelkens,Salim Yusuf,Anders Ljunggren,Hertzel Gerstein,Norbert Bender,Badrudin Rangoonwala,Gilles Dagenais. Владелец: Aventis Pharma Deutschland GmbH. Дата публикации: 2002-05-15.

Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure.

Номер патента: ZA200201471B. Автор: Bernward Schoelkens,Salim Yusuf,Anders Ljunggren,Hertzel Gerstein,Norbert Bender,Badrudin Rangoonwala,Gilles Daganais. Владелец: Aventis Pharma Gmbh. Дата публикации: 2003-05-28.

Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure

Номер патента: BG106319A. Автор: Bernward Schoelkens,Salim Yusuf,Anders Ljunggren,Hertzel Gerstein,Norbert Bender,Badrudin Rangoonwala,Gilles Dagenals. Владелец: Sanofi - Aventis Deutschland GmbH. Дата публикации: 2002-12-29.

Pharmaceutical formulations and their use in the prevention of stroke, diabetes and / or congestive heart failure

Номер патента: JP4843172B2. Автор: ベルンヴアルト・シエルケンス,ノールベルト・ベンダー,バートルーディン・ラングーンワラ,ジレ・ダジェネ,ハーツェル・ガースタイン,アンダーシュ・ユンググレン,セイリム・ユースフ. Владелец: サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング. Дата публикации: 2011-12-21.

Pharmacological formulations used in the prevention of stroke, diabetes and / or congestive heart failure.

Номер патента: TR200202466T2. Автор: GERSTEIN Hertzel,Yusuf Salim,LJUNGGREN Anders,Bender Norbert,Rangoonwala Badrudin,Dagenais Gilles,Schoelkens Bernward. Владелец: Aventis Pharma Deutschland GmbH. Дата публикации: 2002-12-23.

Pharmaceutical formulations and use thereof in prevention of stroke, diabetes and/or congestive heart failure

Номер патента: CN100408093C. Автор: S·尤索夫,B·肖勒肯斯,N·本德,B·兰古恩瓦拉,G·达格奈斯,H·杰斯坦恩,A·勒琼格仁. Владелец: Aventis Pharma Deutschland GmbH. Дата публикации: 2008-08-06.

Pharmacological formulations used to prevent stroke, diabetes and / or congestive heart failure

Номер патента: TR200202464T2. Автор: GERSTEIN Hertzel,LJUNGGREN Anders,Bender Norbert,Rangoonwala Badrudin,Dagenais Gilles,Schoelkens Bernward,Yusuf Sal�M. Владелец: Aventis Pharma Deutschland GmbH. Дата публикации: 2003-01-21.

Pharmaceutical preparations and their using for prophylaxis of stroke, diabetes and/or congestive cardiac insufficiency

Номер патента: RU2272651C2. Автор: Бернвард ШЕЛКЕНС,Норберт БЕНДЕР,Бадрудин РАНГООНВАЛА,Жилль ДАЖЕНЕ,Хертцель ГЕРШТАЙН,Андерс ЮНГГРЕН,Салим ЮСУФ. Владелец: Санофи-Авентис Дойчланд Гмбх. Дата публикации: 2006-03-27.

Mek-inhibitors for the treatment or prevention of coronavirus infections and/or covid-19 cytokine storm

Номер патента: EP4153159A1. Автор: Michael Schindler,Oliver Planz,Stephan Ludwig,Helen Elisa HOFFMANN,Julia KOCH-HEIER. Владелец: Atriva Therapeutics GmbH. Дата публикации: 2023-03-29.

Mek-inhibitors for the treatment or prevention of coronavirus infections and/or covid-19 cytokine storm

Номер патента: CA3178137A1. Автор: Michael Schindler,Oliver Planz,Stephan Ludwig,Helen Elisa HOFFMANN,Julia KOCH-HEIER. Владелец: Atriva Therapeutics GmbH. Дата публикации: 2021-11-25.

MEK-inhibitors for the treatment or prevention of coronavirus infections and/or covid-19 cytokine storm

Номер патента: AU2021277517A1. Автор: Michael Schindler,Oliver Planz,Stephan Ludwig,Helen Elisa HOFFMANN,Julia KOCH-HEIER. Владелец: Atriva Therapeutics GmbH. Дата публикации: 2022-12-08.

USE OF 1,3-DIAZA-DIBENZO[e,h] AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS

Номер патента: EP1684749A1. Автор: Mladen Mercep,Milan Mesic,Dijana Pesic,Renata Rupcic. Владелец: Pliva Istrazivacki Institut doo. Дата публикации: 2006-08-02.

Uses of adenosine a2a receptor antagonists

Номер патента: CA2510655A1. Автор: John C. Hunter,Michael Grzelak,Annamarie Pond,Geoffrey Varty. Владелец: Individual. Дата публикации: 2005-05-19.

Uses of adenosine A2a receptor antagonists

Номер патента: AU2010214749A1. Автор: John C. Hunter,Michael Grzelak,Annamarie Pond,Geoffrey Varty. Владелец: Schering Corp. Дата публикации: 2010-09-23.

Uses of adenosine A2a receptor antagonists

Номер патента: AU2003304527A1. Автор: John C. Hunter,Michael Grzelak,Annamarie Pond,Geoffrey Varty. Владелец: Schering Corp. Дата публикации: 2005-05-26.

Adenosine a2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders

Номер патента: US20090029967A1. Автор: John Hunter,Michael Grzelak,Annamarie Pond,Geoffrey Vaity. Владелец: Schering Corp. Дата публикации: 2009-01-29.

A sortilin antagonist for use in the prevention or treatment of hearing loss

Номер патента: AU2021356121A9. Автор: Anders Nykjaer,Mads Fuglsang KJØLBY,Paul Little,Manuel Cases. Владелец: Insusense Aps. Дата публикации: 2024-10-31.

A sortilin antagonist for use in the prevention or treatment of hearing loss

Номер патента: US20230374143A1. Автор: Anders Nykjaer,Mads Fuglsang KJØLBY,Paul Little,Manuel Cases. Владелец: Insusense Aps. Дата публикации: 2023-11-23.

Indolidone derivatives for the treatment or prevention of fibrotic diseases (vargatef, cryptogenic fibrosing alveolitis)

Номер патента: NZ556681A. Автор: Armin Heckel,Georg Dahmann,Matthias Grauert,Trixi Brandl,John Edward Park,Nveed Chaudhary,Gerald Juergen Roth. Владелец: Boehringer Ingelheim Int. Дата публикации: 2011-01-28.

Indolidone derivatives for the treatment or prevention of fibrotic diseases

Номер патента: AU2005318126B2. Автор: Armin Heckel,Gerald Jürgen Roth,Georg Dahmann,Matthias Grauert,Trixi Brandl,John Edward Park,Nveed Chaudhary. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2011-11-24.

Medicaments for the treatment or prevention of fibrotic diseases

Номер патента: CA2591083C. Автор: Armin Heckel,Georg Dahmann,Matthias Grauert,Trixi Brandl,John Edward Park,Nveed Chaudhary,Gerald Juergen Roth. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2013-10-01.

Medicaments for the treatment or prevention of fibrotic diseases

Номер патента: US20230372297A1. Автор: Armin Heckel,Georg Dahmann,Matthias Grauert,Trixi Brandl,John Edward Park,Nveed Chaudhary,Gerald Juergen Roth. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2023-11-23.

Indolidone derivatives for the treatment or prevention of fibrotic diseases

Номер патента: RS52653B. Автор: Armin Heckel,Gerald Jürgen Roth,Georg Dahmann,Matthias Grauert,Trixi Brandl,John Edward Park,Nveed Chaudhary. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2013-06-28.

Method for the treatment or prevention of lower urinary tract symptoms

Номер патента: US09993442B2. Автор: Risto Santti,Tomi Streng. Владелец: Hormos Medical Ltd. Дата публикации: 2018-06-12.

Method for the treatment or prevention of lower urinary tract symptoms

Номер патента: CA2527396C. Автор: Risto Santti,Tomi Streng. Владелец: Hormos Medical Corp. Дата публикации: 2012-10-16.

Method for the treatment or prevention of lower urinary tract symptoms

Номер патента: EP2258360A3. Автор: Risto Santti,Tomi Streng. Владелец: Hormos Medical Ltd. Дата публикации: 2011-03-23.

Compositions and methods for the treatment and prevention of muscular dystrophy

Номер патента: US11931341B2. Автор: Robert Weiss,Rasna SABHARWAL. Владелец: University of Iowa Research Foundation UIRF. Дата публикации: 2024-03-19.

Use of a standardised dry extract of leaves of buddleja globosa hope, bg-126, for the treatment and prevention of gastrointestinal disorders caused by treatment with nitrofurantoin and other antimicrobials

Номер патента: US20140017344A1. Автор: Maria Eugenia Letelier Munoz,Enrique Antonio Ossandon Salas. Владелец: Individual. Дата публикации: 2014-01-16.

Medicaments for the treatment or prevention of fibrotic diseases

Номер патента: CA2591089C. Автор: Armin Heckel,Thorsten Lehmann-Lintz,Joerg Kley,John Edward Park,Nveed Chaudhary,Gerald Juergen Roth. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2014-02-11.

Method and preparation for the treatment or prevention of anxiety or neurogenesis

Номер патента: RU2606841C2. Автор: Юдит ХОМБЕРГ,Аманда Йоханне КИЛИАН,Ладислаус Мария БРУРСЕН. Владелец: Н.В. Нютрисиа. Дата публикации: 2017-01-10.

Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders

Номер патента: EP1225900A1. Автор: Wolfgang Eisert. Владелец: Boehringer Ingelheim Pharma GmbH and Co KG. Дата публикации: 2002-07-31.

Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders

Номер патента: NZ518525A. Автор: Wolfgang Eisert. Владелец: BOEHRINGER INGELHEIM PHARMA. Дата публикации: 2004-04-30.

V3 antagonists for the treatment or prevention of chronic pain

Номер патента: CA2671891C. Автор: Inga Neumann. Владелец: Merck Sharp and Dohme BV. Дата публикации: 2015-05-26.

Alginate oligomers for the treatment or prevention of microbial overgrowth in the intestinal tract

Номер патента: WO2017060388A1. Автор: Arne Dessen,Philip Rye. Владелец: ALGIPHARMA AS. Дата публикации: 2017-04-13.

Alginate oligomers for the treatment or prevention of microbial overgrowth in the intestinal tract

Номер патента: CA3001047A1. Автор: Arne Dessen,Philip Rye. Владелец: ALGIPHARMA AS. Дата публикации: 2017-04-13.

Products for the treatment and prevention of neurological disorders coursing with a cognition deficit or impairment, and of neurodegenerative diseases

Номер патента: US20170231931A1. Автор: María Del Mar Cuadrado Tejedor,Ana María García Osta,Julen Oyarzabal Santamarina,Maria Obdulia Rabal Gracia. Владелец: FUNDACIÓN PARA LA INVESTIGACIÓN MÈDICA APLICADA. Дата публикации: 2017-08-17.

Use of atii antagonist for the treatment or prevention of metabolic syndrome

Номер патента: EP1613309A1. Автор: Anders Svensson,Anders Ljunggren. Владелец: AstraZeneca AB. Дата публикации: 2006-01-11.

Use of atii antagonist for the treatment or prevention of metabolic syndrome

Номер патента: US20060194856A1. Автор: Anders Ljunggren. Владелец: AstraZeneca AB. Дата публикации: 2006-08-31.

Use of angiontensin II antagonists including losartan, candesartan, cilexetil, irbesartan and candesartan for the treatment or prevention of metabolic syndrome or Syndrome X

Номер патента: NZ542640A. Автор: Anders Svensson,Anders Ljunggren. Владелец: AstraZeneca AB. Дата публикации: 2008-06-30.

Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Номер патента: US09403790B2. Автор: Ping Chen,Ann E. Weber,Tesfaye Biftu. Владелец: Merck Sharp and Dohme LLC. Дата публикации: 2016-08-02.

A pharmaceutical composition for the treatment or prevention of allergic diseases, use thereof, and a method for treatment or prevention of allergic diseases

Номер патента: WO2007108633A1. Автор: Sook-Yeong Jeon,Dong-Ho Nahm. Владелец: Dong-Ho Nahm. Дата публикации: 2007-09-27.

Dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes

Номер патента: WO2013122920A1. Автор: Ann E. Weber,Tesfaye Biftu. Владелец: Merck Sharp & Dohme Corp.. Дата публикации: 2013-08-22.

Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes

Номер патента: WO2010056708A1. Автор: Ping Chen,Jason M. Cox,Ann E. Weber,Tesfaye Biftu. Владелец: Merck Sharp & Dohme Corp.. Дата публикации: 2010-05-20.

Nr2b receptor antagonists for the treatment or prevention of migraines

Номер патента: WO2002100352A3. Автор: Christopher Allen,Ken S Koblan,Timothy Sleeth. Владелец: Timothy Sleeth. Дата публикации: 2003-03-27.

Use of a selective estrogen receptor modulator for the manufacture of a pharmaceutical preparation for use in a method for the treatment or prevention of androgen deficiency

Номер патента: CA2578852A1. Автор: Risto Lammintausta,Taru Blom,Janne Komi. Владелец: Janne Komi. Дата публикации: 2006-03-09.

Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes

Номер патента: NZ592826A. Автор: Ping Chen,Tesfaye Biftu,Jason M Cox,Ann E Weber. Владелец: Merck Sharp & Dohme. Дата публикации: 2012-06-29.

Topically administrable formulation for the control and prevention of animal parasites

Номер патента: US20210059986A1. Автор: Wolfgang Wiehl,Franziska Schmidt,Petra Ohage-Spitzlei. Владелец: Bayer Animal Health GmbH. Дата публикации: 2021-03-04.

Topically administrable formulation for the control and prevention of animal parasites

Номер патента: AU2018329158A8. Автор: Wolfgang Wiehl,Franziska Schmidt,Petra Ohage-Spitzlei. Владелец: Bayer Animal Health GmbH. Дата публикации: 2020-03-12.

Method for the treatment and prevention of cachexia

Номер патента: US20030087942A1. Автор: Louis Muglia. Владелец: Washington University in St Louis WUSTL. Дата публикации: 2003-05-08.

Use of NK-1 receptor antagonists for treating bipolar disorders

Номер патента: US5977104A. Автор: Gregory John Hollingworth,Raymond Baker,Neil Roy Curtis,Jason Matthew Elliott,Timothy Harrison,Philip Stephen Jackson,Janusz Jozef Kulagowski,Nadia Melanie Rupniak,Eileen May Seward,Christopher John Swain,Brian John Williams. Владелец: Merck Sharp and Dohme Ltd. Дата публикации: 1999-11-02.

Use of antioxidants for the treatment of cognitive and behavioural disorders in individuals with fragile x syndrome

Номер патента: US20140148439A1. Автор: María Yolanda De Diego Otero,Lucia María Pérez Costillas,Ignacio Del Arco Herrera. Владелец: Instituto Mediterraneo para el Avance de la Biotecnologia y la Investigacion Sanitaria (Fundacion Imabis). Дата публикации: 2014-05-29.

Use of n-aminoimidazole cytoprotective compounds for treating cell death and/or gsk-3 mediated diseases

Номер патента: US20090149523A1. Автор: Christophe Pannecouque,Wim Robberecht,Miguel Stevens. Владелец: Katholieke Universiteit Leuven. Дата публикации: 2009-06-11.

Use of n-aminoimidazole cytoprotective compounds for treating cell death and/or gsk-3 mediated diseases

Номер патента: WO2007128088A3. Автор: Wim Robberecht,Miguel Stevens,Chrsitophe Pannecouque. Владелец: Chrsitophe Pannecouque. Дата публикации: 2008-02-21.

Use of n-aminoimidazole cytoprotective compounds for treating cell death and/or gsk-3 mediated diseases

Номер патента: EP2015747A2. Автор: Wim Robberecht,Miguel Stevens,Chrsitophe Pannecouque. Владелец: Katholieke Universiteit Leuven. Дата публикации: 2009-01-21.

Use of n-aminoimidazole cytoprotective compounds for treating cell death and/or gsk-3 mediated diseases

Номер патента: WO2007128088A2. Автор: Wim Robberecht,Miguel Stevens,Chrsitophe Pannecouque. Владелец: K.U.LEUVEN RESEARCH AND DEVELOPMENT. Дата публикации: 2007-11-15.

Histamine h3 receptor antagonists/inverse agonists for the treatment of autism spectrum disorder

Номер патента: EP4251148A1. Автор: György István Lévay,Viktor Roman. Владелец: Richter Gedeon Nyrt. Дата публикации: 2023-10-04.

Prevention of migraine recurrence using a 5-HT1B/1D receptor agonist such as eletriptan and pharmaceutical composition thereof

Номер патента: NZ527625A. Автор: Neville Colin Jackson,Stephen Uden. Владелец: Pfizer. Дата публикации: 2005-01-28.

Use of eletriptan for the prevention of migraine recurrence

Номер патента: EP1100499B1. Автор: Neville Colin Jackson,Stephen Uden. Владелец: Pfizer Ltd. Дата публикации: 2004-03-10.

Prevention of migraine recurrence using a 5-HT1B/1D receptor agonist such as eletriptan

Номер патента: NZ508736A. Автор: Neville Colin Jackson,Stephen Uden. Владелец: Pfizer. Дата публикации: 2003-09-26.

Prevention of migraine recurrence

Номер патента: EP1100499A1. Автор: Neville Colin Jackson,Stephen Uden. Владелец: Pfizer Ltd. Дата публикации: 2001-05-23.

Pharmaceutical combination of telmisartan and atorvastatin for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases

Номер патента: NZ541747A. Автор: Michael Mark,Axel Riedel,Josep-Maria Sendra,Stefan Kauschke,Josef M E Leiter. Владелец: Boehringer Ingelheim Int. Дата публикации: 2009-09-25.

1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders

Номер патента: US09737533B2. Автор: Gregor James Macdonald,Daniel Oehlrich,Gary John Tresadern,Andrés Avelino Trabanco-Suárez,José Maria CID-NÚÑEZ,Juan Antonio Vega Ramiro. Владелец: Addex Pharmaceuticals SA. Дата публикации: 2017-08-22.

1, 2, 4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders

Номер патента: MY161325A. Автор: Gregor James Macdonald,Daniel Oehlrich,Gary John Tresadern,Andrés Avelino Trabanco-Suárez,José Maria CID-NÚÑEZ,Ramiro Juan Antonio Vega. Владелец: Addex Pharmaceuticals SA. Дата публикации: 2017-04-14.

Excitatory amino acid receptor antagonists in methods for the use thereof

Номер патента: US5196421A. Автор: Edward C. R. Smith,Charles H. Mitch,Darryle D. Schoepp,Loretta A. McQuaid,Paul L. Ornstein. Владелец: Eli Lilly and Co. Дата публикации: 1993-03-23.

Pharmaceutical formulations for the treatment and prevention of trauma-induced neuropathology and neurodegeneration

Номер патента: US10201569B2. Автор: James Lorne HENRY. Владелец: SAPNA LIFE SCIENCES Corp. Дата публикации: 2019-02-12.

Use of jumonji c demethylase inhibitors for the treatment and prevention of chemotherapy resistance and radioresistance in cancer

Номер патента: US20230255951A1. Автор: John D. Minna,Amit Das,Maithili P. DALVI,Elisabeth D. MARTINEZ,Juan BAYO-FINA. Владелец: University of Texas System. Дата публикации: 2023-08-17.

Use of jumonji c demethylase inhibitors for the treatment and prevention of chemotherapy resistance and radioresistance in cancer

Номер патента: US20190151296A1. Автор: Amit Das,John D Minna,Juan BAYO-FINA,Maithili P DALVI,Elisabeth D MARTINEZ. Владелец: University of Texas System. Дата публикации: 2019-05-23.

Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure

Номер патента: CA3228434A1. Автор: Brandon James Walsh. Владелец: Arena Pharmaceuticals Inc. Дата публикации: 2023-02-16.

Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure

Номер патента: EP4384169A1. Автор: Brandon James Walsh. Владелец: Arena Pharmaceuticals Inc. Дата публикации: 2024-06-19.

Topical ophthalmic formulations for the treatment and prevention of migraine headache

Номер патента: US20180140612A1. Автор: Matthew J. Chapin,Mark B. Abelson. Владелец: ORA Inc. Дата публикации: 2018-05-24.

Use of cyclin-dependent kinase (cdk) inhibitors for the slowdown or prevention of biological aging

Номер патента: US20230293414A1. Автор: Felipe Veloso. Владелец: Hope Permanente LLC. Дата публикации: 2023-09-21.

Quinoline methanol compounds for the treatment and prevention of parasitic infections

Номер патента: WO2008060269A2. Автор: Tiffany N. Heady,Geoffrey S. DOW,Kirsten Smith. Владелец: The United States of America, as Represented by the Secretary of the Army. Дата публикации: 2008-05-22.

Topical Ophthalmic Formulations for the Treatment and Prevention of Migraine Headache

Номер патента: US20170042903A1. Автор: Matthew J. Chapin,Mark B. Abelson. Владелец: ORA Inc. Дата публикации: 2017-02-16.

Quinoline methanol compounds for the treatment and prevention of parasitic infections

Номер патента: WO2008060269A3. Автор: Kirsten Smith,Geoffrey S Dow,Tiffany N Heady. Владелец: Tiffany N Heady. Дата публикации: 2009-01-29.

USE OF 3-AZA-1-OXA-DIBENZO i e,h /i AZULENES FOR TH E MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEAS AND DISORDERS

Номер патента: EP1684766A1. Автор: Mladen Mercep,Milan Mesic,Dijana Pesic,Iva Dzapo. Владелец: Pliva Istrazivacki Institut doo. Дата публикации: 2006-08-02.

Use of 3-aza-1-oxa-dibenzo [e,h] azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders

Номер патента: CA2546591A1. Автор: Mladen Mercep,Milan Mesic,Dijana Pesic,Iva Dzapo. Владелец: Individual. Дата публикации: 2005-06-02.

USE OF 3-AZA-1-OXA-DIBENZO [e,h] AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEAS AND DISORDERS

Номер патента: WO2005049036A1. Автор: Mladen Mercep,Milan Mesic,Dijana Pesic,Iva Dzapo. Владелец: Pliva-Istrazivacki Institut D.O.O.. Дата публикации: 2005-06-02.

Compositions for the treatment and prevention of cancer

Номер патента: WO2024069344A1. Автор: Francisco Rodriguez,Nabil HAJJI. Владелец: Keyzell Holding S.L.. Дата публикации: 2024-04-04.

Histone-acetylation-modulating agents for the treatment and prevention of organ injury

Номер патента: WO2022006133A2. Автор: Zhong Wang,Yuqing E. Chen,Bertram Pitt,Paul C. Tang,Shuo TIAN,Ienglam Lei,Francis Pagani. Владелец: THE REGENTS OF THE UNIVERSITY OF MICHIGAN. Дата публикации: 2022-01-06.

Combination therapy for the treatment or prevention of neurological disorders

Номер патента: WO2024061474A1. Автор: Christiana BJORKLI,Mary HEMLER,Joshua JULIAN,Axel SANDVIG,Ioanna SANDVIG. Владелец: NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (NTNU). Дата публикации: 2024-03-28.

Histone-acetylation-modulating agents for the treatment and prevention of organ injury

Номер патента: US20230241076A1. Автор: Zhong Wang,Yuqing E. Chen,Bertram Pitt,Paul C. Tang,Shuo TIAN,Ienglam Lei,Francis Pagani. Владелец: University of Michigan. Дата публикации: 2023-08-03.

Combination therapy for the treatment or prevention of neurological disorders

Номер патента: US20240115581A1. Автор: Christiana BJORKLI,Mary HEMLER,Joshua JULIAN,Axel SANDVIG,Ioanna SANDVIG. Владелец: Norwegian University of Science and Technology NTNU. Дата публикации: 2024-04-11.

Histone-acetylation-modulating agents for the treatment and prevention of organ injury

Номер патента: WO2022006133A3. Автор: Zhong Wang,Yuqing E. Chen,Bertram Pitt,Paul C. Tang,Shuo TIAN,Ienglam Lei,Francis Pagani. Владелец: THE REGENTS OF THE UNIVERSITY OF MICHIGAN. Дата публикации: 2022-02-10.

Histone-acetylation-modulating agents for the treatment and prevention of organ injury

Номер патента: EP4171219A2. Автор: Zhong Wang,Yuqing E. Chen,Bertram Pitt,Paul C. Tang,Shuo TIAN,Ienglam Lei,Francis Pagani. Владелец: University of Michigan. Дата публикации: 2023-05-03.

Pharmaceutical combinations of an angiotensin receptor antagonist and an NEP inhibitor

Номер патента: NZ594006A. Автор: Paul Allen Sutton,Lili Feng,Mahavir Prashad,Sven Erik Godtfredsen,Piotr Karpinski,Michael J Girgis. Владелец: NOVARTIS AG. Дата публикации: 2012-07-27.

USE OF A COMPOSITION CONTAINING AN ASSOCIATION OF ANGIOTENSIN II AT1 RECEPTOR ANTAGONISTS AND INDOMETHACIN FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF CROONIC GLOMERULONIC PREPARITES

Номер патента: DE69923982D1. Автор: Giuseppe Remuzzi,Remi Brouard. Владелец: Sanofi Aventis France. Дата публикации: 2005-04-07.

Combined use of valsartan and calcium channel blockers for therapeutic purposes

Номер патента: EP1870098A2. Автор: Randy Lee Webb,Marc De Gasparo. Владелец: Novartis Pharma Gmbh. Дата публикации: 2007-12-26.

Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders

Номер патента: US09580438B2. Автор: Mirko Zaja,Johann Leban. Владелец: 4SC Discovery GmbH. Дата публикации: 2017-02-28.

Pharmaceutical composition for treatment or prevention of stress-related disorders

Номер патента: EP4299074A1. Автор: Daisuke Yamada,Akiyoshi Saitoh,Eriko Nakata. Владелец: Nippon Chemiphar Co Ltd. Дата публикации: 2024-01-03.

Pharmaceutical composition for treatment or prevention of stress-related disorders

Номер патента: CA3211977A1. Автор: Daisuke Yamada,Akiyoshi Saitoh,Eriko Nakata. Владелец: Nippon Chemiphar Co Ltd. Дата публикации: 2022-09-01.

Pharmaceutical composition for treatment or prevention of stress-related disorders

Номер патента: AU2022225712A1. Автор: Daisuke Yamada,Akiyoshi Saitoh,Eriko Nakata. Владелец: Nippon Chemiphar Co Ltd. Дата публикации: 2023-09-07.

Pharmaceutical composition for treatment or prevention of stress-related disorders

Номер патента: US20240156796A1. Автор: Daisuke Yamada,Akiyoshi Saitoh,Eriko Nakata. Владелец: Nippon Chemiphar Co Ltd. Дата публикации: 2024-05-16.

Use of carbamate compound for preventing or treating diseases associated with increase in late sodium current

Номер патента: US20200352908A1. Автор: Sun Young PARK. Владелец: SK Biopharmaceuticals Co Ltd. Дата публикации: 2020-11-12.

Use of carbamate compound for preventing or treating diseases associated with increase in late sodium current

Номер патента: EP3711760A1. Автор: Sun Young PARK. Владелец: SK Biopharmaceuticals Co Ltd. Дата публикации: 2020-09-23.

Molecules for the prevention and treatment of neuromuscular disorders

Номер патента: WO2024028324A1. Автор: Benoit Bordignon,Léa LESCOUZÈRES,Pascale BOMONT. Владелец: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE. Дата публикации: 2024-02-08.

Use of iodide compounds for the treatment and prevention of chemotherapy-associated cachexia and cardiotoxicity

Номер патента: IL292688A. Автор: . Владелец: Faraday Pharmaceuticals Inc. Дата публикации: 2022-07-01.

The use of urocanic acid being able to acidify the cell cytoplasm and for preventing or halting cellular proliferation in a person

Номер патента: ZA200602940B. Автор: LEINO Lasse,Laihia Jarmo. Владелец: BIOCIS PHARMA OY. Дата публикации: 2007-07-25.

Use of urocanic acid being able to acidify the cell cytoplasm and for preventing or halting cellular proliferation in a person

Номер патента: US20060189691A1. Автор: Lasse Leino,Jarmo Laihia. Владелец: BIOCIS PHARMA OY. Дата публикации: 2006-08-24.

The use of urocanic acid being able to acidify the cell cytoplasm and for preventing or halting cellular proliferation in a person

Номер патента: EP1691805A1. Автор: Lasse Leino,Jarmo Laihia. Владелец: BIOCIS PHARMA OY. Дата публикации: 2006-08-23.

The use of urocanic acid being able to acidify the cell cytoplasm and for preventing or halting cellular proliferation in a person

Номер патента: CA2544720A1. Автор: Lasse Leino,Jarmo Laihia. Владелец: Individual. Дата публикации: 2005-06-23.

The use of urocanic acid being able to acidify the cell cytoplasm and for preventing or halting cellular proliferation in a person

Номер патента: AU2004296570A1. Автор: Lasse Leino,Jarmo Laihia. Владелец: BIOCIS PHARMA OY. Дата публикации: 2005-06-23.

The use of urocanic acid being able to acidify the cell cytoplasm and for preventing or halting cellular proliferation in a person

Номер патента: WO2005056007A1. Автор: Lasse Leino,Jarmo Laihia. Владелец: BIOCIS PHARMA OY. Дата публикации: 2005-06-23.

Use of guanylate cyclase inhibitors in the treatment of shock

Номер патента: US5298506A. Автор: Joseph Loscalzo,Jonathan Stamler. Владелец: Brigham and Womens Hospital Inc. Дата публикации: 1994-03-29.

Use of an antagonistic compound of the cb receptors, of the cannabinoids, derived from pyrazole, for the preparation of useful medicines for the treatment and prevention of benign prostatic hypertrophy

Номер патента: CL2007001632A1. Автор: Tiziano Croci,Fabio Guagnini,Roberta Avallone. Владелец: Sanofi Aventis. Дата публикации: 2008-01-18.

Method of muscle regeneration or repair comprising administering a range retinoic acid receptor antagonist (rary); method for the induction or stimulation of myogenic differentiation of stem cells; composition comprising mesenchymal stem cells; pharmaceutical composition; kit

Номер патента: CL2013000580A1. Автор: Masahiro Iwamoto,Maurizio Pacifici. Владелец: Univ Jefferson. Дата публикации: 2013-07-12.

Use of Guanylate Cyclase Inhibitors in the Treatment of Shock

Номер патента: CA2135070A1. Автор: Joseph Loscalzo,Jonathan Stamler. Владелец: The Brigham And Women's Hospital. Дата публикации: 1993-11-25.

Compositions and methods for the treatment or prevention of preterm labor

Номер патента: AU2021380039A9. Автор: Jean-Pierre Gotteland. Владелец: Xoma US LLC. Дата публикации: 2024-09-19.

5-nonyloxytryptamine and related intracellular ph acidifiers for the treatment and prevention of cancer

Номер патента: US20140296278A1. Автор: Eli Eliyahu Bar. Владелец: JOHNS HOPKINS UNIVERSITY. Дата публикации: 2014-10-02.

Medicaments for the Treatment or Prevention of Fibrotic Diseases

Номер патента: US20060154939A1. Автор: Armin Heckel,Georg Dahmann,Matthias Grauert,Trixi Brandl,Thorsten Lehmann-Lintz,Joerg Kley,John Park,Nveed Chaudhary,Gerald Roth. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2006-07-13.

Compositions and methods for the treatment or prevention of preterm labor

Номер патента: US20240024294A1. Автор: Jean-Pierre Gotteland. Владелец: Xoma US LLC. Дата публикации: 2024-01-25.

Compositions and methods for the treatment or prevention of preterm labor

Номер патента: EP4243817A1. Автор: Jean-Pierre Gotteland. Владелец: Xoma US LLC. Дата публикации: 2023-09-20.

Pharmaceutical combinations of statins and fibrates for the treatment and prevention of hyperlipidemias and cardiovascular disease

Номер патента: US20230355578A1. Автор: Jorge Alejandro GONZÁLEZ CANUDAS,Sixto Serafin Espinoza Leon,Paola Yazmin Ollervides Rubio,Claudia Delfina FARFÁN SALAZAR. Владелец: Laboratorios Silanes SA de CV. Дата публикации: 2023-11-09.

Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associated conditions

Номер патента: CA2593084C. Автор: Michael A. Zeligs. Владелец: BioResponse LLC. Дата публикации: 2014-03-18.

Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prevention of cerebral degenerative disorders

Номер патента: US5827873A. Автор: Michael Shalmi,Birgitte Hjort Guldhammer,Niels Korsgaard. Владелец: Novo Nordisk AS. Дата публикации: 1998-10-27.

Use of a class of antiviral compounds for production of an agent for the treatment or prevention of a viral infection in the respiratory tract

Номер патента: US20060069153A1. Автор: Thomas Muster,Andreas Grassauer,Elisabeth Gaudernak,Joachim Seipelt,Ernst Kuchler. Владелец: Ratier Figeac SAS. Дата публикации: 2006-03-30.

New therapeutic combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino[2,3-e]indol-8-one and neuroleptics for the treatment or prevention of psychotic disorders

Номер патента: CA2396351C. Автор: Karen Lovell Marquis. Владелец: WYETH LLC. Дата публикации: 2009-11-10.

Compositions for the treatment and prevention of eyelid swelling

Номер патента: EP2015733A2. Автор: Matthew Jonathan Chapin,Mark Barry Abelson,Akimitsu Makino,Keith Jeffrey Lane. Владелец: ACIEX Inc. Дата публикации: 2009-01-21.

1h-cyclopenta[b]benzofuran derivatives for the prevention and treatment of virus diseases

Номер патента: WO2024056619A1. Автор: Krishnaraj Rajalingam. Владелец: KHR Biotec GmbH. Дата публикации: 2024-03-21.

Cobalt porphyrins for the treatment of blood-related disorders

Номер патента: US20170196882A1. Автор: Agata Szade,Krzysztof Szade,Alicja Jozkowicz,Jozef Dulak. Владелец: UNIWERSYTET JAGIELLONSKI. Дата публикации: 2017-07-13.

Use of kappa opioid receptor antagonist-containing compositions for the treatment of dissociative disorders

Номер патента: AU2007236003A1. Автор: Holger Lars Hermann. Владелец: Emodys GmbH. Дата публикации: 2007-10-18.

Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Номер патента: CA2450740C. Автор: Malcolm Maccoss,Emma R. Parmee,Scott D. Edmondson,Michael H. Fisher,Dooseop Kim,Ann E. Weber,Jinyou Xu. Владелец: Merck and Co Inc. Дата публикации: 2006-02-14.

Use of mycobacterium avium paratuberculosis peptides to diagnose type 1 diabetes

Номер патента: US20140271701A1. Автор: Roberto Mallone,Leonardo Antonio Sechi. Владелец: Università Degli Studi Di Sassari. Дата публикации: 2014-09-18.

Carbonic anhydrase 1 (ca1) inhibitors for the treatment or prevention of myeloproliferative disorders and other hematopoietic malignancies, and as biomarker of myeloproliferative disorders and other hematopoietic malignancies

Номер патента: WO2022200613A3. Автор: Shohei Murakami,Daniel Lewandowski,Paul-Henri Romeo,Vilma BARROCA. Владелец: Université Paris Cite. Дата публикации: 2022-11-17.

Carbonic anhydrase 1 (ca1) inhibitors for the treatment or prevention of myeloproliferative disorders and other hematopoietic malignancies, and as biomarker of myeloproliferative disorders and other hematopoietic malignancies

Номер патента: EP4313025A2. Автор: Shohei Murakami,Daniel Lewandowski,Paul-Henri Romeo,Vilma BARROCA. Владелец: Universite Paris Saclay. Дата публикации: 2024-02-07.

Carbonic anhydrase 1 (ca1) inhibitors for the treatment or prevention of myeloproliferative disorders and other hematopoietic malignancies, and as biomarker of myeloproliferative disorders and other hematopoietic malignancies

Номер патента: WO2022200613A2. Автор: Shohei Murakami,Daniel Lewandowski,Paul-Henri Romeo,Vilma BARROCA. Владелец: Université Paris Cite. Дата публикации: 2022-09-29.

Use of bicyclic heterocycles for the treatment and prevention of arterial thrombotic disease

Номер патента: US20020193404A1. Автор: Jean-Marie Stassen,Norbert Hauel,Wolfgang Wienen. Владелец: Individual. Дата публикации: 2002-12-19.

Novel methods and compositions for the treatment or prevention of dysmenorrhoea and menstrual side effects: the use of phospholipase inhibitors

Номер патента: US20040247639A1. Автор: Stephen Taylor,David Fairlie,Ian Shiels. Владелец: Individual. Дата публикации: 2004-12-09.

Novel methods and compositions for the treatment or prevention of dysmenorrhoea and menstrual side effects: the use of phospholipase inhibitors

Номер патента: EP1418902A1. Автор: Stephen Maxwell Taylor,Ian Alexander Shiels,David Paul Fairlie. Владелец: University of Queensland UQ. Дата публикации: 2004-05-19.

Use of oligonucleotides for the treatment and prevention of pain

Номер патента: US20220362279A1. Автор: Alejandro Daniel Montaner,Marcelo Jose Villar,Pablo Rodolfo Brumovsky,Candelaria Leiguarda,Maria Florencia Coronel,Inelia Mailín Lara Casadei,Sandra Sbrascini,Julia Rubione. Владелец: Universidad Austral. Дата публикации: 2022-11-17.

Benzimidazole sulfide derivatives for the treatment or prevention of tuberculosis

Номер патента: EP3250205A1. Автор: Stewart Cole,Jan Lars RYBNIKER. Владелец: Ecole Polytechnique Federale de Lausanne EPFL. Дата публикации: 2017-12-06.

Methods for the treatment and prevention of age-related retinal dysfunction

Номер патента: CA2714530C. Автор: Krzysztof Palczewski,Tadao Maeda,David Saperstein. Владелец: UNIVERSITY OF WASHINGTON. Дата публикации: 2018-09-25.

Methods for the treatment and prevention of age-related retinal dysfunction

Номер патента: CA3018374A1. Автор: Krzysztof Palczewski,Tadao Maeda,David Saperstein. Владелец: UNIVERSITY OF WASHINGTON. Дата публикации: 2009-08-20.

Glucosidase inhibitors for the treatment and prevention of pulmonary infections

Номер патента: US20240016786A1. Автор: Sebastian Mario Marcuccio,David Alexander Vodden Morton,Simon Peter Tucker. Владелец: Covirix Medical Pty Ltd. Дата публикации: 2024-01-18.

Use of phanquinone for the treatment or prevention of memory impairment

Номер патента: US20030055078A1. Автор: Michel Xilinas,Panayotis Gerolymatos. Владелец: PN Gerolymatos SA. Дата публикации: 2003-03-20.

Use of phanquinone for the treatment or prevention of memory impairment

Номер патента: EP1140090A1. Автор: Panayotis Nikolas Gerolymatos,Michel Xilinas. Владелец: PN Gerolymatos SA. Дата публикации: 2001-10-10.

Glucosidase inhibitors for the treatment and prevention of pulmonary infections

Номер патента: AU2021332085A1. Автор: Sebastian Mario Marcuccio,David Alexander Vodden Morton,Simon Peter Tucker. Владелец: Covirix Medical Pty Ltd. Дата публикации: 2022-05-19.

Fluoro substituted omega-carboxyaryl diphenyl urea, combination with anti-cancer agents, pharmaceutical compositions containing them and their use in the manufacture of medicaments for the treatment and prevention of diseases and conditions

Номер патента: IL173256A. Автор: . Владелец: Bayer Pharmaceuticals Corp. Дата публикации: 2011-03-31.

Methods for the treatment and prevention of age-related retinal dysfunction

Номер патента: NZ600498A. Автор: Krzysztof Palczewski,Tadao Maeda,David Saperstein. Владелец: Univ Washington. Дата публикации: 2014-01-31.

Benzimidazole sulfide derivatives for the treatment or prevention of tuberculosis

Номер патента: US20180028517A1. Автор: Stewart Cole,Jan Lars RYBNIKER. Владелец: Ecole Polytechnique Federale de Lausanne EPFL. Дата публикации: 2018-02-01.

Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions

Номер патента: MY142799A. Автор: Stephen Boyer,Jacques Dumas,Bernd Riedl,Scott Wilhelm. Владелец: Bayer HealthCare LLC. Дата публикации: 2010-12-31.

Compositions of cyclooxygenase-2 selective inhibitors and 5-ht1b/1d agonists for the treatment and prevention of migraine

Номер патента: EP1608361A2. Автор: Karen Seibert. Владелец: Pharmacia LLC. Дата публикации: 2005-12-28.

Methods and compounds for the treatment or prevention of hypercytokinemia and severe influenza

Номер патента: US20240277680A1. Автор: Paul Andrew Whittaker,Adrian Huw DAVIES,Pui-Man CHOY,Vinay SAUNDERS,Basma BAHSOUN,Surender VASHIST,Neil Edward TORBETT. Владелец: Poolbeg Pharma UK Ltd. Дата публикации: 2024-08-22.

Modulators of airway basal cells for the treatment or prevention of lung diseases

Номер патента: US12036218B2. Автор: Antje Prasse,Jonas SCHUPP. Владелец: Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eV. Дата публикации: 2024-07-16.

Carbonic anhydrase 1 (ca1) inhibitors for the treatment or prevention of myeloproliferative disorders and other hematopoietic malignancies, and as biomarker of myeloproliferative disorders and other hematopoietic malignancies

Номер патента: US20240180930A1. Автор: Shohei Murakami,Daniel Lewandowski,Paul-Henri Romeo,Vilma BARROCA. Владелец: Universite Paris Saclay. Дата публикации: 2024-06-06.

Quinolylnitrones for the treatment and prevention of a cerebral stroke or ischaemia

Номер патента: WO2020074666A1. Автор: Jose Luis Marco Contelles,Alberto Alcazar Gonzalez,Emma MARTÍNEZ ALONSO,Mourad CHIOUA ASRI. Владелец: Fundación Para La Investigación Biomédica Del Hospital Ramón Y Cajal (Fibiohrc). Дата публикации: 2020-04-16.

Compound for the treatment and prevention of central nervous system disorders

Номер патента: CA3166310A1. Автор: Francisco Javier Garcia-Ladona. Владелец: ABAXYS THERAPEUTICS. Дата публикации: 2021-07-08.

Compositions for the treatment and prevention of infections of the oral cavity

Номер патента: AU2009240294B2. Автор: Paolo Morazzoni,Ezio Bombardelli,Massimo Ronchi,Gabriele Fontana,Antonella Riva,Andrea Giori. Владелец: Indena SpA. Дата публикации: 2014-04-10.

Novel methods for the treatment and prevention of ileus

Номер патента: CA2393141C. Автор: William K. Schmidt,John J. Farrar,Peter J. Schied,Randall L. Carpenter. Владелец: Adolor Corp. Дата публикации: 2013-08-13.

Methods and compounds for the treatment or prevention of hypercytokinemia and severe influenza

Номер патента: US11969412B2. Автор: Paul Andrew Whittaker,Adrian Huw DAVIES,Pui-Man CHOY,Vinay SAUNDERS,Basma BAHSOUN,Surender VASHIST,Neil Edward TORBETT. Владелец: Poolbeg Pharma UK Ltd. Дата публикации: 2024-04-30.

4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and metabolites for the treatment and prevention of diseases and conditions

Номер патента: NZ544920A. Автор: Stephen Boyer,Jacques Dumas,Bernd Riedl,Scott Wilhelm. Владелец: Bayer HealthCare LLC. Дата публикации: 2009-11-27.

Method for the treatment and prevention of arteriosclerosis with nitrophenyl substituted dihydropyridines

Номер патента: US4859688A. Автор: Isamu Yamaguchi,Jiro Hirosumi. Владелец: Fujisawa Pharmaceutical Co Ltd. Дата публикации: 1989-08-22.

New therapeutic combinations for the treatment or prevention of depression

Номер патента: CA2604915A1. Автор: Sharon Rosenzweig-Lipson,Janet Jandura. Владелец: Janet Jandura. Дата публикации: 2006-11-02.

Antimycotic gel for the treatment and prevention of skin mycoses

Номер патента: CA2267160C. Автор: Manfred Bohn,Astrid Markus,Karl Theodor Kraemer. Владелец: Sanofi Aventis Deutschland GmbH. Дата публикации: 2006-10-31.

Methods and compounds for the treatment or prevention of hypercytokinemia and severe influenza

Номер патента: AU2018390132B2. Автор: Paul Andrew Whittaker,Adrian Huw DAVIES,Pui-Man CHOY,Vinay SAUNDERS,Basma BAHSOUN,Surender VASHIST,Neil Edward TORBETT. Владелец: Poolbeg Pharma UK Ltd. Дата публикации: 2024-02-22.

Compound for the treatment and prevention of central nervous system disorders

Номер патента: US20230057133A1. Автор: Francisco Javier Garcia-Ladona. Владелец: ABAXYS THERAPEUTICS. Дата публикации: 2023-02-23.

Compound for the treatment and prevention of central nervous system disorders

Номер патента: AU2020416623A1. Автор: Francisco Javier Garcia-Ladona. Владелец: ABAXYS THERAPEUTICS. Дата публикации: 2022-07-14.

Compound for the treatment and prevention of central nervous system disorders

Номер патента: EP4084793A1. Автор: Francisco Javier Garcia-Ladona. Владелец: ABAXYS THERAPEUTICS. Дата публикации: 2022-11-09.

Compound for the treatment and prevention of central nervous system disorders

Номер патента: WO2021136827A1. Автор: Francisco Javier Garcia-Ladona. Владелец: ABAXYS THERAPEUTICS. Дата публикации: 2021-07-08.

Quinolylnitrones for the treatment and prevention of a cerebral stroke or ischaemia

Номер патента: US20210330662A1. Автор: Jose Luis Marco Contelles,Alberto Alcazar Gonzalez,Juan José MONTOYA,Emma MARTÍNEZ ALONSO,Mourad CHIOUA ASRI. Владелец: Isquaemia Biotech SL. Дата публикации: 2021-10-28.

Quinolylnitrones for the treatment and prevention of a cerebral stroke or ischaemia

Номер патента: EP3863632A1. Автор: Jose Luis Marco Contelles,Alberto Alcazar Gonzalez,Juan José MONTOYA,Emma MARTÍNEZ ALONSO,Mourad CHIOUA ASRI. Владелец: Isquaemia Biotech SL. Дата публикации: 2021-08-18.

Methods and compositions for the treatment and prevention of ocular diseases and conditions

Номер патента: EP3914263A1. Автор: Pedram Hamrah,Arsia JAMALI. Владелец: Tufts Medical Center Inc. Дата публикации: 2021-12-01.

Pharmaceutical combinations comprising (a) the cyclin dependent kinase 4/6 (cdk4/6) inhibitor lee011 (=ribociclib), and (b) the epidermal growth factor receptor (egfr) inhibitor erlotinib, for the treatment or prevention of cancer

Номер патента: EP3340990A1. Автор: Joseph Lehar,Giordano Caponigro,Thomas HORN-SPIROHN. Владелец: NOVARTIS AG. Дата публикации: 2018-07-04.

Pyrimidine-Based Bicycles as Antiviral Agents for the Treatment and Prevention of HIV Infection

Номер патента: AU2024200431A1. Автор: Mikhail Gennadievich Shurygin,Vladimir Nikolaevich Ivanov,Denis Nikolaevich KAZYULKIN,Ekaterina Vladimirovna MANASOVA,Alexander Vitalievich Kurkin. Владелец: Pharmasyntez Joint Stock Co. Дата публикации: 2024-02-08.

Compounds for the treatment and prevention of infections

Номер патента: US09695156B2. Автор: Daniel William Carney,Jason K. Sello,Christian Nelson,Walter Atwood. Владелец: BROWN UNIVERSITY. Дата публикации: 2017-07-04.

2′,3′-dideoxynucleoside analogues for the treatment or prevention of Flaviviridae infections

Номер патента: US7772208B2. Автор: Junxing Shi,Raymond Schinazi,Robert Striker. Владелец: Pharmasset Inc. Дата публикации: 2010-08-10.

Methods and compositions for the treatment or prevention of abnormal bone formation in a soft tissue

Номер патента: US20190231779A1. Автор: Paul B. Yu,Jana Bagarova,Devaveena Dey. Владелец: Brigham and Womens Hospital Inc. Дата публикации: 2019-08-01.

Methods and compositions for the treatment or prevention of abnormal bone formation in a soft tissue

Номер патента: US20180021340A1. Автор: Paul B. Yu,Jana Bagarova,Devaveena Dey. Владелец: Brigham and Womens Hospital Inc. Дата публикации: 2018-01-25.

Use of nk-1 receptor antagonists for treating movement disorders

Номер патента: AU5559498A. Автор: Gregory John Hollingworth,Raymond Baker,Neil Roy Curtis,Jason Matthew Elliott,Timothy Harrison,Philip Stephen Jackson,Janusz Jozef Kulagowski,Nadia Melanie Rupniak,Christopher John Swain,Brian John Williams,Eileen Mary Seward. Владелец: Merck Sharp and Dohme Ltd. Дата публикации: 1998-06-29.

Use of agents that alter the peritumoral environment for the treatment of cancer

Номер патента: US20180071317A1. Автор: Manuel Vicente Salinas Martín,María Carmen Lara Ruiz. Владелец: SERVICIO ANDALUZ DE SALUD. Дата публикации: 2018-03-15.

Use of agents that alter the peritumoral environment for the treatment of cancer

Номер патента: US20200085845A1. Автор: Manuel Vicente Salinas Martín,María Carmen Lara Ruiz. Владелец: SERVICIO ANDALUZ DE SALUD. Дата публикации: 2020-03-19.

Use of NK-1 receptor antogonists for treating substance use disorders

Номер патента: US5919781A. Автор: Gregory John Hollingworth,Raymond Baker,Neil Roy Curtis,Jason Matthew Elliott,Timothy Harrison,Philip Stephen Jackson,Janusz Jozef Kulagowski,Nadia Melanie Rupniak,Christopher John Swain,Brian John Williams,Eileen Mary Seward. Владелец: Merck Sharp and Dohme Ltd. Дата публикации: 1999-07-06.

Use of nk-1 receptor antagonists for treating cognitive disorders

Номер патента: AU5561398A. Автор: Gregory John Hollingworth,Raymond Baker,Neil Roy Curtis,Jason Matthew Elliott,Timothy Harrison,Philip Stephen Jackson,Janusz Jozef Kulagowski,Nadia Melanie Rupniak,Christopher John Swain,Brian John Williams,Eileen Mary Seward. Владелец: Merck Sharp and Dohme Ltd. Дата публикации: 1998-06-29.

Use of NK-1 receptor antagonists for treating mania

Номер патента: US6090819A. Автор: Nadia Melanie Rupniak. Владелец: Merck Sharp and Dohme Ltd. Дата публикации: 2000-07-18.

NK-1 receptor antagonists and eletriptan for the treatment of migraine

Номер патента: EP1095655A2. Автор: Susan Beth Sobolov-Jaynes. Владелец: Pfizer Products Inc. Дата публикации: 2001-05-02.

Nk-1 receptor antagonists and eletriptan for the treatment of migraine

Номер патента: CA2324116A1. Автор: Susan Beth Sobolov-Jaynes. Владелец: Pfizer Products Inc. Дата публикации: 2001-04-25.

Fsh receptor antagonists

Номер патента: CA2849176C. Автор: Cornelis Marius Timmers,Wesley Peter Blackaby,Martin Dekort,Mark ENTHOVEN,Paul Stuart HINCHLIFFE,Christian Bernard Matthijs Poulie,Saskia VERKAIK. Владелец: Merck Sharp and Dohme BV. Дата публикации: 2019-03-19.

Compositions and methods for the prevention and treatment of cancer

Номер патента: CA2796419C. Автор: David G. Hangauer,Michael J. Ciesielski,Robert A. Fenstermaker. Владелец: Athenex Inc. Дата публикации: 2018-11-06.

Non-peptide tachykinin receptor antagonists to treat allergy

Номер патента: US5492927A. Автор: William H. W. Lunn,Bruce D. Gitter. Владелец: Eli Lilly and Co. Дата публикации: 1996-02-20.

Compounds for the prevention and treatment of cardiovascular diseases

Номер патента: CA2676984C. Автор: Henrik Hansen. Владелец: Resverlogix Corp. Дата публикации: 2015-03-17.

Use of a steroid prodrug for the treatment of disease of the posterior segment of the eye

Номер патента: CA2653902C. Автор: Laura Rabinovich-Guilatt,Gregory Lambert. Владелец: Santen SAS. Дата публикации: 2015-03-17.

Compositions for use in treating and/or preventing type 2 diabetes, pre-diabetes, and/or a symptom thereof

Номер патента: WO2024038169A1. Автор: Johan de Faire. Владелец: De Faire Medical AB. Дата публикации: 2024-02-22.

Compositions for use in treating and/or preventing type 2 diabetes, pre-diabetes, and/or a symptom thereof

Номер патента: GB2621976A. Автор: De Faire Johan. Владелец: De Faire Medical AB. Дата публикации: 2024-03-06.

Use of a cox-2 inhibitor and a nk-1 receptor antagonist for treating inflammation

Номер патента: CA2327585A1. Автор: Nadia Melanie Rupniak,Susan Boyce,Raymond George Hill. Владелец: Individual. Дата публикации: 1999-11-25.

Methods of treatment or prevention of acute brain or nerve injuries

Номер патента: US12042482B2. Автор: Maria Maccecchini. Владелец: Annovis Bio Inc. Дата публикации: 2024-07-23.

Gap junction modulators and their use for the treatment of age-related macular degeneration

Номер патента: CA3240515A1. Автор: Ulrik Mouritzen,Bradford YOUNG. Владелец: Breye Therapeutics ApS. Дата публикации: 2023-06-29.

Novel pyrrolidines as glucagon receptor antagonists, compositions, and methods for their use

Номер патента: US20120178789A1. Автор: William J. Greenlee,Andrew W. Stamford,Eric J. Gilbert,Michael W. Miller,Duane Eugene DeMong. Владелец: Individual. Дата публикации: 2012-07-12.

Pharmaceutical products containing a 7-diphenylmethylene- bicycloheptane or 7-diphenylmethylenebicycloheptene derivative, the use of these compounds as medicaments, and new 7-diphenylmethylenebicycloheptanes and 7-diphenylmethylene-bicycloheptenes and processes for the preparation thereof

Номер патента: AU612177B2. Автор: Herbert Siegel,Ernold Granzer. Владелец: Hoechst AG. Дата публикации: 1991-07-04.

Methods of treatment or prevention of acute brain or nerve injuries

Номер патента: WO2017030968A1. Автор: Maria Maccecchini. Владелец: QR PHARMA. Дата публикации: 2017-02-23.

Methods of treatment or prevention of acute brain or nerve injuries

Номер патента: EP3334425A1. Автор: Maria Maccecchini. Владелец: QR Pharma Inc. Дата публикации: 2018-06-20.

Methods of treatment or prevention of acute brain or nerve injuries

Номер патента: CA2994974C. Автор: Maria Maccecchini. Владелец: Annovis Bio Inc. Дата публикации: 2024-04-09.

Methods of treatment or prevention of acute brain or nerve injuries

Номер патента: US20180228771A1. Автор: Maria Maccecchini. Владелец: QR Pharma Inc. Дата публикации: 2018-08-16.

Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders

Номер патента: CA2382580A1. Автор: Walter Elger,Gerd Schubert,Kristof Chwalisz. Владелец: Jenapharm Gmbh & Co. Kg. Дата публикации: 2001-03-08.

Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders

Номер патента: CA2382580C. Автор: Walter Elger,Gerd Schubert,Kristof Chwalisz. Владелец: Bayer Schering Pharma AG. Дата публикации: 2009-05-19.

Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure

Номер патента: CA2493208C. Автор: Brian Guth,Randolph Seidler,Juergen Daemmgen. Владелец: Boehringer Ingelheim Pharma GmbH and Co KG. Дата публикации: 2011-11-01.

Use of 2-thia-dibenzo(e,h) azulenes for the treatment and prevention of central nervous system diseaes and disorders

Номер патента: EP1684702A2. Автор: Boska Hrvacic,Ivana Ozimec Landek,Mladen Mercep,Milan Mesic,Dijana Pesic,Barbara Stanic. Владелец: Pliva Istrazivacki Institut doo. Дата публикации: 2006-08-02.

A method for the treatment or prevention of coronary graft vasospasm

Номер патента: CA2376930C. Автор: Lasse Lehtonen,Julius Papp,Janos Szecsi. Владелец: Orion Oyj. Дата публикации: 2008-07-29.

Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

Номер патента: US12059418B2. Автор: Sanjay A. Desai. Владелец: US Department of Health and Human Services. Дата публикации: 2024-08-13.

Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

Номер патента: US09808458B2. Автор: Sanjay A. Desai. Владелец: US Department of Health and Human Services. Дата публикации: 2017-11-07.

Method and composition for the treatment and prevention of viral infections

Номер патента: AU619174B2. Автор: Anthony Atkinson,Graham Lloyd,Peter M. Sutton. Владелец: Public Health Laboratory Service Board. Дата публикации: 1992-01-23.

Steroidal hormones for the treatment and prevention of wave burst arrhythmia

Номер патента: US11666584B2. Автор: Joe-Elie SALEM,Christian FUNCK-BRENTANO,Anne Bachelot,Xavier Waintraub. Владелец: Assistance Publique Hopitaux de Paris APHP. Дата публикации: 2023-06-06.

Steroidal hormones for the treatment and prevention of wave burst arrhythmia

Номер патента: US20200352960A1. Автор: Joe-Elie SALEM,Christian FUNCK-BRENTANO,Anne Bachelot,Xavier Waintraub. Владелец: Individual. Дата публикации: 2020-11-12.

Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour

Номер патента: EP1032394A1. Автор: Minghua Sun,Jose Halperin,Ying-Duo Gao,Adel M. Moussa,Wayne I. Lencer,Mark Froimowitz,Carlo Brugnara,John J. Clifford,Reem M. Haidar,Falguni M. Kher,Yesh P. Sachdeva,Heather N. Taft,Richard John Lombardy,Seth Alper,Emile M. Bellot, Jr.,Eugne W. Kelleher. Владелец: Childrens Medical Center Corp. Дата публикации: 2000-09-06.

Use of a therapeutic agent with phosphodiesterase-7 inhibitory activity for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance

Номер патента: WO2024038089A1. Автор: Klaus Wirth. Владелец: Mitodicure Gmbh. Дата публикации: 2024-02-22.

Use of substituted benzoxazole and benzofuran compounds for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance

Номер патента: WO2024038090A1. Автор: Klaus Wirth. Владелец: Mitodicure Gmbh. Дата публикации: 2024-02-22.

Use of vitamin d glycosides for the treatment or prevention of osteoporosis

Номер патента: CA2152163A1. Автор: Michael F. Holick. Владелец: Individual. Дата публикации: 1994-07-07.

Method and composition for the treatment and prevention of viral infections

Номер патента: CA1317224C. Автор: Anthony Atkinson,Graham Lloyd,Peter M. Sutton. Владелец: Public Health Laboratory Service Board. Дата публикации: 1993-05-04.

7-substituted sulfonimidoylpurinones for the treatment and prevention of viral infection

Номер патента: RU2751349C2. Автор: ЦЗЯНЬПИН Ван,Бо Чжан,Хунин ЮНЬ,Лу Гао,Чуньгэнь Лян,Сюфан Чжэн,Кунь МЯО. Владелец: Ф. Хоффманн-Ля Рош Аг. Дата публикации: 2021-07-13.

Methods for the treatment and prevention of inflammatory diseases

Номер патента: US09657046B2. Автор: Dale T. Umetsu,Ya-Jen Chang,Rosemarie H. De Kruyff,Petr Illarionov. Владелец: Childrens Medical Center Corp. Дата публикации: 2017-05-23.

Compounds selected from clarithromycin and lexithromycin for the treatment and prevention of viral infections caused by coronaviruses

Номер патента: WO2022002789A1. Автор: Jose María BENLLOCH BAVIERA,María GALVEZ LLOMPART,Jorge GALVEZ ÁLVAREZ,Riccardo ZANNI. Владелец: UNIVERSITAT DE VALENCIA. Дата публикации: 2022-01-06.

Medicament carrier for the treatment and prevention of pathological conditions in the urogenital region

Номер патента: US20170266423A1. Автор: Otto von Stetten,Jean-Jaques BECCIOLINI. Владелец: INURA MEDICAL AG. Дата публикации: 2017-09-21.

Methods for the treatment and prevention of pain using stress-activated protein kinase

Номер патента: CA2447091C. Автор: Robert L. Hudkins,Matthew S. Miller,Lisa D. Aimone. Владелец: Cephalon LLC. Дата публикации: 2012-03-27.

Compositions for the treatment and prevention of cardiovascular diseases

Номер патента: CA2348445C. Автор: Herwig Buchholz,Jerzy D. Meduski. Владелец: Merck Patent GmBH. Дата публикации: 2009-12-15.

Pyridazinones for the treatment or prevention of hypertension

Номер патента: EP4351518A1. Автор: Jo Klaveness,Finn Olav Levy,Anita Wegert,Alessandro Cataliotti,Ruben Leenders,Piotr NIECZYPOR,Lise Román MOLZAU,Henriette ANDRESEN,Zakieh IZAKIAN. Владелец: Universitetet I Oslo. Дата публикации: 2024-04-17.

Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantation

Номер патента: RU2667960C2. Автор: Джованни Монтелеоне,Петер БУКВАЛД,Лука ИНВЕРАРДИ,Антонелло ПИЛЕДЖИ,Камилло Рикорди,Аличе ТОМЕИ. Владелец: Юниверсити Оф Майами. Дата публикации: 2018-09-25.

Use of l-carnitine and its alkanoyl derivatives for the preparation of a medicament useful for the treatment of patients suffering from diabetic and/or dysmetabolic nephropathy

Номер патента: CA2376033C. Автор: Claudio Cavazza,Giovanni Valentini. Владелец: Sigma Tau Industrie Farmaceutiche Riunite SpA. Дата публикации: 2009-04-07.

Use of L carnitine and its alkanoyl dervatives for the preparation of a medicament useful for the treatment of patients suffering from diabetic and/or dysmetabolic nephropathy

Номер патента: US6696492B1. Автор: Claudio Cavazza,Giovanni Valentini. Владелец: Sigma Tau Industrie Farmaceutiche Riunite SpA. Дата публикации: 2004-02-24.

Method for suppressing diabetes and/or hepatic lipids using tormentic acid

Номер патента: US20170105953A1. Автор: Yueh-Hsiung Kuo,Jin-Bin Wu,Hui-Ya Ho,Chun-Ching Shih,Cheng-Hsiu Lin. Владелец: Individual. Дата публикации: 2017-04-20.

Treatment of type 2 diabetes and/or chronic kidney disease with hepatocyte nuclear factor 4 alpha (hnf4a) agonists

Номер патента: WO2024129571A1. Автор: Viktoria Gusarova,Alan Shuldiner,Joshua Backman,Jonas BOVIJN,Moeen Riaz,Gemma Pearson. Владелец: Regeneron Pharmaceuticals, Inc.. Дата публикации: 2024-06-20.

Pharmaceutical composition for the treatment of alzheimer's disease or dementia

Номер патента: US20240165097A1. Автор: Tim TASKER. Владелец: Allergan Pharmaceuticals International Ltd. Дата публикации: 2024-05-23.

Pharmaceutical composition for the treatment of alzheimer's disease or dementia

Номер патента: EP4304591A1. Автор: Tim TASKER. Владелец: Heptares Therapeutics Ltd. Дата публикации: 2024-01-17.

Use of weak acids or their precursors for the treatment of tuberculosis (tb) and drug resistant tb

Номер патента: WO2004062607A3. Автор: Ying Zhang. Владелец: Ying Zhang. Дата публикации: 2005-11-10.

Carbostyril oxytocin receptor antagonists

Номер патента: WO1995019773A1. Автор: Peter D. Williams,Roger M. Freidinger,Douglas J. Pettibone,Joseph M. Pawluczyk. Владелец: Merck & Co., Inc.. Дата публикации: 1995-07-27.

Peripheralization of centrally-acting cannabinoid-1 receptor antagonists by nanoparticles for the treatment metabolic related conditions

Номер патента: WO2023242843A1. Автор: Joseph Tam,Gershon Golomb,Meital NAIM,Shira Hirsch. Владелец: YISSUM Research Development Company of the Hebrew University of Jerusalem LTD.. Дата публикации: 2023-12-21.

Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and -cyanamides for the treatment of diseases

Номер патента: WO2001035936A3. Автор: William Taylor. Владелец: William Taylor. Дата публикации: 2002-03-28.

Use of Collismycin and Derivatives Thereof as Oxidative Stress Inhibitors

Номер патента: US20080275088A1. Автор: Miguel Medina Padilla,Mercedes Alonso Cascón,Ana Martinez Gil,Ana Castro Morera,Esther Garcia Palomero,Paola Usan Egea,Francisco Romero Millan,Rosa Isabel Fernandez Chimeno,Julia Perez Baz,Jorge Sanchez Quesada,Librada María CAÑEDO HERNÁNDEZ,Antonio Medarde Fernandez. Владелец: Instituto Biomar SA. Дата публикации: 2008-11-06.

The use of quaternary pyridinium compounds for vasoprotection and/or hepatoprotection

Номер патента: EP2124946A1. Автор: Stefan CHŁOPICKI,Jan Adamus,Jerzy Gebicki,Andrzej Marcinek. Владелец: Trigendo Sp zoo. Дата публикации: 2009-12-02.

The use of n-methyl pyridinium derivatives for hepatoprotection

Номер патента: EP2124946B1. Автор: Stefan CHŁOPICKI,Jan Adamus,Jerzy Gebicki,Andrzej Marcinek. Владелец: Hependo Sp Zoo. Дата публикации: 2012-05-23.

The use of quaternary pyridinium compounds for vasoprotection and/or hepatoprotection

Номер патента: WO2008104920A1. Автор: Stefan CHŁOPICKI,Jan Adamus,Jerzy Gebicki,Andrzej Marcinek. Владелец: Trigendo Sp. Z O.O.. Дата публикации: 2008-09-04.

Use of quaternary pyridinium salts as vasoprotective agents

Номер патента: US09675601B2. Автор: Stefan CHŁOPICKI,Jerzy Gebicki. Владелец: Pharmena Sa. Дата публикации: 2017-06-13.

4-quinolinemethanol derivatives as purine receptor antagonists (i)

Номер патента: EP1107760A2. Автор: David Reginald Adams,Roger John Gillespie,Simon Edward Ward,Joanne Lerpiniere,Suneel Gaur,Lars Jacob Stray Knutsen. Владелец: Vernalis Research Ltd. Дата публикации: 2001-06-20.

Use of an opioid receptor antagonist for the treatment or prevention of gastrointestinal tract disorders

Номер патента: US20110071163A1. Автор: Richard M. Woodward. Владелец: Adolor Corp. Дата публикации: 2011-03-24.

The use of tizanidine for treating metabolic disorders related to abnormal insulin secretion

Номер патента: WO2003030903A1. Автор: Hazel Judith Bardsley. Владелец: Arachnova Therapeutics Ltd.. Дата публикации: 2003-04-17.

Use of Quaternary Pyridinium Compounds for Vasoprotection and/or Hepatoprotection

Номер патента: US20080221172A1. Автор: Stefan CHŁOPICKI,Jan Adamus,Jerzy Gebicki,Andrzej Marcinek. Владелец: Trigendo Sp zoo. Дата публикации: 2008-09-11.

Use of quaternary pyridinium compounds for vasoprotection and/or hepatoprotection

Номер патента: US7893095B2. Автор: Stefan CHŁOPICKI,Jan Adamus,Jerzy Gebicki,Andrzej Marcinek. Владелец: Trigendo Sp zoo. Дата публикации: 2011-02-22.

Flibanserin for the treatment of urinary incontinence and related diseases

Номер патента: US09763936B2. Автор: Angelo Ceci,Ramiro Castro. Владелец: Sprout Pharmaceuticals Inc. Дата публикации: 2017-09-19.

Use of chiral (1r, 2r)-diaminocyclohexane derivative with taddol substituent

Номер патента: WO2020222665A1. Автор: Tomasz Olszewski,Krzysztof Pyrc,Elżbieta Wojaczyńska,Jakub Iwanejko,Magdalena Pachota,Marcin Sieńczyk,Renata Grzywa. Владелец: Politechnika Wrocławska. Дата публикации: 2020-11-05.

Novel methods and compositions for the treatment or prevention of dysmenorrhoea and menstrual side effects: the use of phospholipase inhibitors

Номер патента: AU2001272210A1. Автор: Stephen Maxwell Taylor,Ian Alexander Shiels,David Paul Fairlie. Владелец: University of Queensland UQ. Дата публикации: 2002-01-30.

Sortilin antagonists for use in the treatment of diabetic retinopathy

Номер патента: US20230144901A1. Автор: Anders Nykjaer,Mads Fuglsang KJØLBY,Paul Little,Andreas JURGEIT. Владелец: Insusense Aps. Дата публикации: 2023-05-11.

Sortilin antagonists for use in the treatment of diabetic retinopathy

Номер патента: EP4121033A1. Автор: Anders Nykjaer,Mads Fuglsang KJØLBY,Paul Little,Andreas JURGEIT. Владелец: Insusense Aps. Дата публикации: 2023-01-25.

Sortilin antagonists for use in the treatment of diabetic retinopathy

Номер патента: AU2021236930A1. Автор: Anders Nykjaer,Mads Fuglsang KJØLBY,Paul Little,Andreas JURGEIT. Владелец: Insusense Aps. Дата публикации: 2022-10-06.

Combination of ferroquine and an artemisinin derivative for the treatment of malaria

Номер патента: MY145581A. Автор: FRAISSE Laurent,TER-MINASSIAN Daniel. Владелец: Sanofi Aventis. Дата публикации: 2012-02-29.

Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases

Номер патента: CA2544332C. Автор: Linda Greensmith,Geoffrey Burnstock,Rudolf Urbanics. Владелец: Orphazyme AS. Дата публикации: 2014-09-23.

Use of 6 amino-quinoline-5, 8 quinones and nucleic acids associated with senescence for the treatment of tumors

Номер патента: WO2004022059A2. Автор: Heiko Hermeking,Dimitri Lodygin. Владелец: MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V.. Дата публикации: 2004-03-18.

Use of phenoxy pyridine derivatives for the treatment of illnesses caused by disorders of the dopamine system

Номер патента: WO1996041629A1. Автор: Claus Riemer,Thierry Godel,Deborah Hartman. Владелец: F. Hoffmann-La Roche AG. Дата публикации: 1996-12-27.

Methods for the selective modulation of ppar

Номер патента: US20070190079A1. Автор: Guy Oshiro,Andrew Shiau,James Malecha,Ayman Kabakibi,Mark Massari,Stewart Noble. Владелец: Kalypsys Inc. Дата публикации: 2007-08-16.

Use of 5-[[4-[2-[5-acetylpyridin-2-yl]ethoxy]benzyl]-1,3-thiazolidine-2,4-dione and its salts

Номер патента: CA3102584A1. Автор: Marc Martinell Pedemonte,Ana Maria Garcia Collazo,Maria Pilar Pizcueta Lalanza,Maria Angeles Perez De La Cruz Moreno,Estefania TRAVER LOPEZ. Владелец: Minoryx Therapeutics SL. Дата публикации: 2019-12-12.

Use of .beta.-lapachone and related naphthoquinones in the treatment of amp-activated protein kinase (ampk) mediated disorders

Номер патента: CA2595564C. Автор: In Geun Jo,Taehwan Kwak,Sang-Ku Yoo,Myunggyu Park. Владелец: KT&G Co Ltd. Дата публикации: 2015-03-31.

The use of quaternary pyridinium salts as vasoprotective agents

Номер патента: CA2547234C. Автор: Stefan CHŁOPICKI,Jerzy Gebicki. Владелец: Pharmena Sa. Дата публикации: 2010-07-20.

5-imino-1,2,4-thiadiazoles derivatives useful for the treatment of neurodegenerative diseases

Номер патента: CA2780695C. Автор: Ana Martinez Gil,Carmen Gil Ayuso-Gontan,Valle Palomo Ruiz,Concepcion Perez Martin,María Isabel Loza García,Daniel Perez Fernandez,Ana Maria Perez Castillo,Maria Isabel Cadavid Torres,Jose Brea Floriani. Владелец: Consejo Superior de Investigaciones Cientificas CSIC. Дата публикации: 2019-08-20.

Therapeutic compositions with imino sugars for the treatment of diseases with accumulation of heparan sulfate

Номер патента: WO2023203004A1. Автор: Luigi Michele PAVONE,Anna ESPOSITO,Annalisa GUARAGNA,Valeria DE PASQUALE,Massimo D'AGOSTINO. Владелец: Dagostino Massimo. Дата публикации: 2023-10-26.

Use of 5-[[4-[2-[5-acetylpyridin-2-yl]ethoxy]benzyl]-1,3-thiazolidine-2,4-dione and its salts

Номер патента: US20240091210A1. Автор: Marc Martinell Pedemonte,Ana Maria Garcia Collazo,Maria Pilar Pizcueta Lalanza,Maria Angeles Perez De La Cruz Moreno,Estefania TRAVER LOPEZ. Владелец: Minoryx Therapeutics SL. Дата публикации: 2024-03-21.

Use of benidipine for the treatment of epilepsy disease

Номер патента: WO2022139753A3. Автор: Mehmet Nuri KOÇAK,Abdulmecit ALBAYRAK,Erdal TEKİN,Muhammet Çeli̇k,Remzi ARSLAN,Zülküf KAYA,Mustafa BAYRAKTAR. Владелец: Atatürk Üni̇versi̇tesi̇ Bi̇li̇msel Araştirma Projeleri̇ Bi̇ri̇mi̇. Дата публикации: 2022-08-18.

Use of benidipine for the treatment of epilepsy disease

Номер патента: WO2022139753A2. Автор: Mehmet Nuri KOÇAK,Abdulmecit ALBAYRAK,Erdal TEKİN,Muhammet Çeli̇k,Remzi ARSLAN,Zülküf KAYA,Mustafa BAYRAKTAR. Владелец: Atatürk Üni̇versi̇tesi̇ Bi̇li̇msel Araştirma Projeleri̇ Bi̇ri̇mi̇. Дата публикации: 2022-06-30.

Adenosine a2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders

Номер патента: EP2001511A1. Автор: John Hunter,Michael Grzelak,Annamarie Pond,Geoffrey Varty. Владелец: Schering Corp. Дата публикации: 2008-12-17.

Adenosine a2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders

Номер патента: CA2623040A1. Автор: John C. Hunter,Michael Grzelak,Annamarie Pond,Geoffrey Varty. Владелец: Geoffrey Varty. Дата публикации: 2007-04-05.

ADENOSINE A2a RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EXTRA-PYRAMIDAL SYNDROME AND OTHER MOVEMENT DISORDERS

Номер патента: EP1940408A1. Автор: John C. Hunter,Michael Grzelak,Annamarie Pond,Geoffrey Varty. Владелец: Schering Corp. Дата публикации: 2008-07-09.

Use of allopurinol for the treatment of hand foot skin reaction

Номер патента: CA2759085A1. Автор: Yolanda Rodemer. Владелец: Nobera Pharma SL. Дата публикации: 2010-11-04.

Use of allopurinol for the treatment of palmar plantar erythrodysesthesia

Номер патента: CA2654270C. Автор: Yolanda Rodemer. Владелец: Nobera Pharma SL. Дата публикации: 2014-05-13.

The use of anti-histaminics for acute reduction of elevated intracranial pressure

Номер патента: CA2690483C. Автор: Joseph Elisabeth Leenaerts,Frans Eduard Janssens,Manuel Jesus Alcazar-Vaca,José Manuel Bartolomé-Nebreda,Francisco Javier FERNÁNDEZ-GADEA,Antonio Gomez-Sanchez,Frank Tegtmeier,Koenraad Arthur Van Rossem,Pedro Martinez-Jimenez,Jozef Leo Henri Van Reempts. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2012-07-24.

Use of 1h-quinazoline- 2, 4 -diones for use in the prevention or treatment photosensitive epilepsy

Номер патента: EP2753331A1. Автор: Donald Johns,Klaus KUCHER,George IMBERT. Владелец: NOVARTIS AG. Дата публикации: 2014-07-16.

Methods for the Prevention and Treatment of Hearing Loss

Номер патента: US20230285418A1. Автор: Jian Zuo,Pezhman Salehi Dermanaki,Marisa Laura Zallocchi,Sarath Vijayakumar. Владелец: Ting Therapeutics LLC. Дата публикации: 2023-09-14.

Methods for the prevention and treatment of hearing loss

Номер патента: US11857551B1. Автор: Jian Zuo,Pezhman Salehi Dermanaki. Владелец: Ting Therapeutics LLC. Дата публикации: 2024-01-02.

Methods for the prevention and treatment of hearing loss

Номер патента: WO2022011325A8. Автор: Jian Zuo,Pezhman Salehi Dermanaki,Marisa Laura Zallocchi,Sarath Vijayakumar. Владелец: Ting Therapeutics LLC. Дата публикации: 2022-03-17.

Method and use of psilocybin in the prevention and treatment of stroke

Номер патента: WO2023212812A1. Автор: Fabio CHIANELLI. Владелец: Revive Therapeutics Ltd. Дата публикации: 2023-11-09.

Method and use of bucillamine in the prevention and treatment of stroke

Номер патента: WO2023184031A1. Автор: Fabio CHIANELLI. Владелец: Revive Therapeutics Ltd. Дата публикации: 2023-10-05.

Method based on bismuth ion for the treatment and prevention of a disease caused by a Shiga toxin

Номер патента: US09468653B2. Автор: Hector Manuel Fernandez. Владелец: SOUBEIRAN CHOBET Srl. Дата публикации: 2016-10-18.

Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor

Номер патента: EP1253926A1. Автор: Siegfried Wurster,Mia Engstrom,Liisa Huovinen,Sari Kalliokoski,Leila Kelanne,Eeva-Liisa Savola. Владелец: Juvanita Pharma Ltd Oy. Дата публикации: 2002-11-06.

Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor

Номер патента: WO2001058454A1. Автор: Siegfried Wurster,Mia Engstrom,Liisa Huovinen,Sari Kalliokoski,Leila Kelanne,Eeva-Liisa Savola. Владелец: Oy Juvantia Pharma Ltd. Дата публикации: 2001-08-16.

Method for obtaining a pharmaceutical composition and a pharmaceutical composition for the treatment and prevention of periodontal diseases

Номер патента: RU2761303C1. Автор: Сергей Игоревич Анисимов. Владелец: Общество с ограниченной ответственностью "Дубна-Биофарм".. Дата публикации: 2021-12-07.

Compositions of cyclooxygenase-2 selective inhibitors and nmda receptor antagonists for the treatment or prevention of neuropathic pain

Номер патента: WO2004039371A3. Автор: Raymond Y Cheung. Владелец: Raymond Y Cheung. Дата публикации: 2004-06-17.

Use of rotigotine for the treatment or prevention of dopaminergic neuron loss

Номер патента: CA2547645C. Автор: Dieter Scheller,Frank Dressen. Владелец: UCB PHARMA GMBH. Дата публикации: 2013-07-16.

Method based on bismuth ion for the treatment and prevention of a disease caused by a shiga toxin

Номер патента: US20140205682A1. Автор: Hector Manuel Fernandez. Владелец: SOUBEIRAN CHOBET Srl. Дата публикации: 2014-07-24.

Method based on bismuth ion for the treatment and prevention of a disease caused by a shiga toxin

Номер патента: US9974806B2. Автор: Hector Manuel Fernandez. Владелец: SOUBEIRAN CHOBET Srl. Дата публикации: 2018-05-22.

Use of 2-hydroxy or 2-acetyloxy-4-trifluoromethylbenzoic acid derivatives as an agent for the treatment and prevention of mild cognitive impairment

Номер патента: WO2003047562A1. Автор: Julian Garcia-Rafanell,Genis Muñoz Orti,Jose Carlos Navas Ramirez,Jose Ignacio Izquierdo Pulido. Владелец: J. Uriach & Cia. S.A.. Дата публикации: 2003-06-12.

Use of 2-hydroxy or 2-acetyloxy-4-trifluoro-methylbenzoic acid derivatives as an agent for the treatment and prevention of mild cognitive impairment

Номер патента: EP1453499A1. Автор: Julian Garcia-Rafanell,Genis Muñoz Orti,Jose Carlos Navas Ramirez,Jose Ignacio Izquierdo Pulido. Владелец: J Uriach y Cia SA. Дата публикации: 2004-09-08.

Use of 2-hydroxy or 2-acetyloxy-4-trifluoromethylbenzoic acid derivatives as an agent for the treatment and prevention of mild cognitive impairment

Номер патента: US20030162756A1. Автор: José Pulido,Jose Ramirez,Julian Garcia-Rafanell,Genis Orti. Владелец: J Uriach y Cia SA. Дата публикации: 2003-08-28.

Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes

Номер патента: CA2646962C. Автор: Ann E. Weber,Tesfaye Biftu. Владелец: Merck Sharp and Dohme LLC. Дата публикации: 2011-06-21.

USE OF N- ( DIBENZ (b, f) OXEPIN-10-YLMETHYL ) N-METHYL-N- PROP- 2 -YNYLAMINE (OMIGAPIL) FOR THE PROPHYLAXIS AND / OR TREATMENT OF CONGENITAL MUSCULAR DYSTROPHY OR MYOPATHY RESULTING FROM COLLAGEN VI DEFICIENCY

Номер патента: EP2004176A1. Автор: Thomas Meier. Владелец: Santhera Pharmaceuticals Schweiz GmbH. Дата публикации: 2008-12-24.

Use of N- ( dibenz (b, f) oxepin-10-ylmethyl ) N-methyl-N- prop- 2 -ynylamine (omigapil) for the prophylaxis and / or treatment of congenital muscular dystrophy or myopathy resulting from collagen VI deficiency

Номер патента: AU2007236161A1. Автор: Thomas Meier. Владелец: Santhera Pharmaceuticals Schweiz GmbH. Дата публикации: 2007-10-18.

Use of n- ( dibenz (b, f) oxepin-10-ylmethyl ) n-methyl-n- prop- 2 -ynylamine (omigapil) for the prophylaxis and / or treatment of congenital muscular dystrophy or myopathy resulting from collagen vi deficiency

Номер патента: CA2648155A1. Автор: Thomas Meier. Владелец: Individual. Дата публикации: 2007-10-18.

USE OF N- ( DIBENZ (b, f) OXEPIN-10-YLMETHYL ) N-METHYL-N- PROP- 2 -YNYLAMINE (OMIGAPIL) FOR THE PROPHYLAXIS AND / OR TREATMENT OF CONGENITAL MUSCULAR DYSTROPHY OR MYOPATHY RESULTING FROM COLLAGEN VI DEFICIENCY

Номер патента: EP2004176B1. Автор: Thomas Meier. Владелец: Santhera Pharmaceuticals Schweiz GmbH. Дата публикации: 2011-10-26.

USE OF N- ( DIBENZ (b, f) OXEPIN-10-YLMETHYL ) N-METHYL-N- PROP- 2 -YNYLAMINE (OMIGAPIL) FOR THE PROPHYLAXIS AND / OR TREATMENT OF CONGENITAL MUSCULAR DYSTROPHY OR MYOPATHY RESULTING FROM COLLAGEN VI DEFICIENCY

Номер патента: WO2007115776A1. Автор: Thomas Meier. Владелец: Santhera Pharmaceuticals (Schweiz) Ag. Дата публикации: 2007-10-18.

Use of N- (dibenz (b, f) oxepin-10-ylmethyl) N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of congenital muscular dystrophy or myopathy resulting from collagen VI deficiency

Номер патента: NZ571129A. Автор: Thomas Meier. Владелец: Santhera Pharmaceuticals Ch. Дата публикации: 2011-01-28.

Use of N- ( dibenz (b, f) oxepin-10-ylmethyl ) N-methyl-N- prop- 2 -ynylamine (omigapil) for the prophylaxis and / or treatment of congenital muscular dystrophy or myopathy resulting from collagen VI deficiency

Номер патента: AU2007236161B2. Автор: Thomas Meier. Владелец: Santhera Pharmaceuticals Schweiz GmbH. Дата публикации: 2009-12-10.

Medicinal composition for the treatment and prevention of the symptoms of heart failure, containing a vasoconstrictor alpha-stimulant agent as active principle

Номер патента: US5116878A. Автор: Laure Cabanes,Alain Lockhart,Simon Weber. Владелец: Universite Paris 5 Rene Descartes. Дата публикации: 1992-05-26.

S-adenosylmethionine and derivatives thereof for the treatment and prevention of alzheimer's disease

Номер патента: EP1326620A1. Автор: Sigfrido Scarpa,Andrea Fuso. Владелец: Universita degli Studi di Roma La Sapienza. Дата публикации: 2003-07-16.

Use of (-)-5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphthol for the treatment of depression

Номер патента: NZ545063A. Автор: Dieter Scheller,Norma Selve,Alexander Breidenbach. Владелец: Sanol Arznei Schwarz Gmbh. Дата публикации: 2009-10-30.

Aminotetralin derivatives as a medicament for the treatment and prevention of myocardial ischemic conditions

Номер патента: US20060229365A1. Автор: Roberta Razzetti,Giuseppe Rossoni. Владелец: Chiesi Farmaceutici SpA. Дата публикации: 2006-10-12.

Pharmaceutical compositions, method, and use of formulation for the treatment and prevention of infections associated with helicobacter pylori in mammals and humans

Номер патента: WO2004089340A1. Автор: José PEDRAZZOLI JUNIOR. Владелец: Cmax Otimizacão De Resultados Sc Ltda. Дата публикации: 2004-10-21.

Casp8ap2 antagonists for use in the prevention or treatment of cancer

Номер патента: US20240002845A1. Автор: Sven Diederichs,Ksenia Myacheva. Владелец: Deutsches Krebsforschungszentrum DKFZ. Дата публикации: 2024-01-04.

Casp8ap2 antagonists for use in the prevention or treatment of cancer

Номер патента: EP4196586A1. Автор: Sven Diederichs,Ksenia Myacheva. Владелец: Deutsches Krebsforschungszentrum DKFZ. Дата публикации: 2023-06-21.

Methods and compositions for the treatment and prevention of lung disease

Номер патента: US20010053758A1. Автор: Roshantha Chandraratna,Donald Massaro,Gloria Massaro. Владелец: Individual. Дата публикации: 2001-12-20.

Use of short chain fatty acids for the treatment and prevention of diseases and disorders

Номер патента: US11759442B2. Автор: Ira C. Spector,Mark A. Feitelson,Alla Arzumanyan. Владелец: Temple University of Commonwealth System of Higher Education. Дата публикации: 2023-09-19.

Methods and compositions for the treatment and prevention of lung disease

Номер патента: US20030078294A1. Автор: Roshantha Chandraratna,Donald Massaro,Gloria Massaro. Владелец: Allergan Sales LLC. Дата публикации: 2003-04-24.

Methods and compositions for the treatment and prevention of lung disease

Номер патента: US6492414B1. Автор: Roshantha A. Chandraratna,Donald Massaro,Gloria Decarlo Massaro. Владелец: Allergan Inc. Дата публикации: 2002-12-10.

Dietary supplement and method for the treatment and prevention of digestive tract ulcers in equines and other animals

Номер патента: NZ543965A. Автор: Peter M J Bedding,Franklin L Pellegrini. Владелец: Freedom Health LLC. Дата публикации: 2010-02-26.

Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes

Номер патента: CA2924682C. Автор: Ivars Kalvins,Maija Dambrova,Helena CIRULE,Edgars Liepins,Elina MAKAROVA,Ilmars Stonans,Ilga MISANE. Владелец: JSC GRINDEKS. Дата публикации: 2018-02-27.

Use of carbohydrates and compositions thereof for the treatment or prevention of diseases caused by imbalanced colon fermentation

Номер патента: CA2499665C. Автор: Juha Apajalahti,Nina Rautonen,Anu Kettunen,Osmo Siikanen. Владелец: Danisco AS. Дата публикации: 2012-02-28.

Use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid for the manufacture of a medicament for the treatment or prevention of restenosis

Номер патента: WO1998029104A3. Автор: Keiji Miyazawa,Juichi Fukuyama,Arao Ujiie,Shuichiro Hamano. Владелец: Kissei Pharmaceutical. Дата публикации: 1998-10-01.

Materials and methods for the treatment or prevention of obesity

Номер патента: NZ525004A. Автор: Hang Shi,Michael B Zemel,Paula Carney. Владелец: Univ Tennessee Res Foundation. Дата публикации: 2007-11-30.

Use of a therapeutic agent with sodium-hydrogen antiporter 1 inhibitory activity for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance

Номер патента: WO2024042160A1. Автор: Klaus Wirth. Владелец: Mitodicure Gmbh. Дата публикации: 2024-02-29.

Use of n-(dibenz (b,f)oxepin-10-ylmethyl)-n-methyl-n-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy

Номер патента: EP1924255A1. Автор: Thomas Meier,Markus A. Ruegg. Владелец: Santhera Pharmaceuticals Schweiz GmbH. Дата публикации: 2008-05-28.

Use of N-(dibenz (B,F)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy

Номер патента: AU2006284140A1. Автор: Thomas Meier,Markus A. Ruegg. Владелец: Santhera Pharmaceuticals Schweiz GmbH. Дата публикации: 2007-03-01.

Use of n-(dibenz (b,f)oxepin-10-ylmethyl)-n-methyl-n-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy

Номер патента: NZ565194A. Автор: Thomas Meier,Markus A Ruegg. Владелец: Santhera Pharmaceuticals Ch. Дата публикации: 2010-04-30.

Use of N-(dibenz (B,F)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy

Номер патента: AU2006284140B2. Автор: Thomas Meier,Markus A. Ruegg. Владелец: Santhera Pharmaceuticals Schweiz GmbH. Дата публикации: 2009-08-20.

Use of n-(dibenz (b,f)oxepin-10-ylmethyl)-n-methyl-n-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy

Номер патента: WO2007022951A1. Автор: Thomas Meier,Markus A. Ruegg. Владелец: Santhera Pharmaceuticals (Schweiz) Ag. Дата публикации: 2007-03-01.

Use of enzyme inhibitors with aminopeptidase n and/or dipeptidylpeptidase iv activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases with seborrhoeic hyperproliferation and altered differentiation states

Номер патента: AU2003214105A1. Автор: Siegfried Ansorge,Klaus Neubert,Robert Vetter,Uwe Lendeckel,Dirk Reinhold,Christos C. Zouboulis,Harald Gollnick,Jürgen FAUST. Владелец: IMTM GMBH. Дата публикации: 2003-09-29.

Use of enzyme inhibitors with aminopeptidase N and/or dipeptidylpeptidase IV activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases with seborrhoeic hyperproliferation and altered differentiation states

Номер патента: AU2003214105A2. Автор: Siegfried Ansorge,Klaus Neubert,Robert Vetter,Uwe Lendeckel,Dirk Reinhold,Christos C. Zouboulis,Harald Gollnick,Jürgen FAUST. Владелец: IMTM GMBH. Дата публикации: 2003-09-29.

Use of valproic acid analog for the treatment and prevention of migraine and affective illness

Номер патента: US20010031789A1. Автор: Emer Leahy,Heinz Nau,Alan O'connell. Владелец: American Biogenetic Sciences Inc. Дата публикации: 2001-10-18.

Composition containing phytic acid, magnesium and polyphenols for the treatment or prevention of renal lithiasis

Номер патента: EP3162376A1. Автор: Antonia Costa Bauza,Felix Grases Freixedas,Rafael Maria PRIETO ALMIRALL,Adrián RODRÍGUEZ RODRÍGUEZ. Владелец: Universitat De Les Illes Balears. Дата публикации: 2017-05-03.

Process for the treatment or prevention of herpes

Номер патента: US5849786A. Автор: Christian-Georges Bidel,Jean Poirson. Владелец: Individual. Дата публикации: 1998-12-15.

Association of faecalibacterium prausnitzii strain cncm i-4573 with pentasa® for the treatment and prevention of gastrointestinal inflammation

Номер патента: ZA202206998B. Автор: Langella Philippe,Sokol Harry,CHATEL JEAN-MARC,CHAIN Florian,Rousseaux Christel,Ruffie Pauline,Martin-Rosique Rebeca. Владелец: Inst Des Sciences Et Industries Du Vivant Et De L’Environnement. Дата публикации: 2024-01-31.

Combinations of carnosine and zinc for the treatment and prevention of viral infections

Номер патента: US20230301959A1. Автор: Deanna J. Nelson. Владелец: Individual. Дата публикации: 2023-09-28.

Pharmaceutical composition for the treatment and prevention of degenerative neurological disorders which comprises, as an active ingredient, a mixed root extract of the tree peony root, the root of dahuric angelica and the root of thorowax or its fraction

Номер патента: RU2668135C1. Автор: Ми Вон СОН,Янг Воонг ЧО,Санг Зин ЧОЙ,Дзин Сеок ДЗЕОНГ,Янгми КИМ,Миунг Соок ОХ,Сеон-Пио ХОНГ,Хай Хуа ЦЗЯН,Эундзин КИМ,Дза Янг РИУ,Сяо Фэй Ду,Дзеонг Соо КИМ,Биоунг Моон КИМ. Владелец: Юниверсити-Индастри Кооперейшн Груп Оф Киунг Хее Юниверсити. Дата публикации: 2018-09-26.

Topical veterinary compositions and methods for the treatment and prevention of infection

Номер патента: EP1651255A1. Автор: Michael D. White,Michael S. Tyndall,John M. Cunningham. Владелец: KO Manufacturing Inc. Дата публикации: 2006-05-03.

Topical veterinary compositions and methods for the treatment and prevention of infection

Номер патента: WO2005016377A1. Автор: Michael D. White,Michael S. Tyndall,John M. Cunningham. Владелец: Ko Manufacturing, Inc.. Дата публикации: 2005-02-24.

A pharmaceutical composition comprising cordycepin for the treatment and prevention of obesity

Номер патента: EP2077851A4. Автор: Sung Won Kim,Su Chan LEE,Si Kwan Kim,Il Woung Kim. Владелец: University Industry Cooperation Corporation of Konkuk University. Дата публикации: 2009-12-16.

Sulfonamides useful for the treatment or prevention of a disease i.e. vascular and coronary heart disease mediated by the alpha-2B-adrenoceptor

Номер патента: NZ520500A. Автор: Siegfried Wurster,Mia Engstrom,Liisa Huovinen,Sari Kalliokoski,Leila Kelanne,Eeva-Liisa Savola. Владелец: Juvantia Pharma Ltd Oy. Дата публикации: 2005-01-28.

Method for the treatmennt or prevention of a disease mediated by the alpha-2B-adrenoceptor

Номер патента: US20020058618A1. Автор: Siegfried Wurster,Mia Engstrom,Liisa Huovinen,Sari Kalliokoski,Leila Kelanne,Eeva-Liisa Savola. Владелец: Juvanita Pharma Ltd Oy. Дата публикации: 2002-05-16.

Nucleoside drugs for the treatment or prevention of coronavirus infection and their uses

Номер патента: US20240252527A9. Автор: Xiaolin Li,Longwu Qi,Nana Du,Shusen Xu. Владелец: Miracure Biotechnology Ltd. Дата публикации: 2024-08-01.

Composition comprising a complex of (+)-catechin and amino acid for the treatment and prevention of cancer

Номер патента: US09844595B2. Автор: Bruno Schoentjes,Paul Niebes,Saïd Rachidi,Julien Estager,Bronislav Henric May. Владелец: VALORE. Дата публикации: 2017-12-19.

Aster glehni extracts, fractions or compounds isolated therefrom for the treatment or prevention of hyperuricemia or gout

Номер патента: US09527879B2. Автор: Jae Yeol Lee,Yong Sup Lee,Chang Bae Jin,Hyoung Ja Kim,Min Jeoung SON,Chang Soo YOOK. Владелец: Korea Advanced Institute of Science and Technology KAIST. Дата публикации: 2016-12-27.

Pharmaceutical compositions for the treatment and prevention of urinary tract infections

Номер патента: CA3188455A1. Автор: Carlo Terruzzi,Fabio Pietro Terruzzi. Владелец: Biofarma SRL. Дата публикации: 2022-02-10.

Pharmaceutical compositions for the treatment and prevention of urinary tract infections

Номер патента: WO2022029578A1. Автор: Carlo Terruzzi,Fabio Pietro Terruzzi. Владелец: GIELLEPI SpA. Дата публикации: 2022-02-10.

Nobiletin compositions and methods for the treatment and prevention of covid-19 and related pathologies

Номер патента: US20230270712A1. Автор: Feng Zhao,Paul Hwang,James ROUFS. Владелец: Cas Properties LLC. Дата публикации: 2023-08-31.

Fosfomycin/tobramycin combinations for the treatment and prevention of ophthalmic, otological and dermatological infections

Номер патента: EP2349278A1. Автор: David Macleod. Владелец: Gilead Sciences Inc. Дата публикации: 2011-08-03.

Nef deleted human immunodeficiency virus for the restoration of T-lymphocyte signaling and activation for the treatment and prevention of human immunodeficiency virus infection

Номер патента: US20090162399A1. Автор: Sateesh Apte. Владелец: Individual. Дата публикации: 2009-06-25.

Unsaturated Hydroxamic Acid Derivatives and Their Use for the Treatment and Prevention of an Ammonia-Associated Disease or Disorder

Номер патента: US20240293344A1. Автор: Jean-Christophe Leroux,Filip Ilievski,Diana EVSTAFEVA. Владелец: Versantis AG. Дата публикации: 2024-09-05.

N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity

Номер патента: WO2002078627A3. Автор: Leonard A Herzenberg,James Andrus,Leonore A Herzenberg,Rosa Stephen C De. Владелец: Bioadvantex Pharma Inc. Дата публикации: 2003-09-18.

Novel substituted arylhexadienoic acids and esters thereof which can be used for the treatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositions comprising them and processes for the preparation of them

Номер патента: ZA200503416B. Автор: BRUNET Michel,Jean-Jacques Zeiller,Bonhomme Yves,Ferrand Gurard. Владелец: Merck Patent GmBH. Дата публикации: 2006-12-27.

Nucleoside drugs for the treatment or prevention of coronavirus infection and their uses

Номер патента: US20230338409A1. Автор: Xiaolin Li,Longwu Qi,Nana Du,Shusen Xu. Владелец: Miracure Biotechnology Ltd. Дата публикации: 2023-10-26.

Compositions and methods for the treatment and prevention of cognitive decline and preservation of neuronal function

Номер патента: SG11202000258TA. Автор: Shawn Nathan WATSON. Владелец: Senescence Life Sciences Pte Ltd. Дата публикации: 2020-02-27.

Composition for the treatment and prevention of urinary tract stones

Номер патента: EP4360640A1. Автор: Sandro Alfieri,Dario Alfieri,Roberto Alfieri. Владелец: Anvest Group Srl. Дата публикации: 2024-05-01.

Synthesis of a novel glucose-conjugated methotrexate and its application for the treatment and prevention of neoplasms

Номер патента: WO2022260545A1. Автор: Andrzej Gamian,Siddarth AGRAWAL,Wiesław Szeja,Jerzy Wiśniewski,Marta WOŹNIAK,Piotr ZIÓLKOWSKI,Sebastian MAKUCH,Gabriela PASTUCH-GAWOŁEK,Monika Krawczyk. Владелец: Uniwersytet Medyczny Im. Piastow Slaskich We Wroclawiu. Дата публикации: 2022-12-15.

Synthesis of a novel glucose-conjugated methotrexate and its application for the treatment and prevention of neoplasms

Номер патента: EP4352072A1. Автор: Andrzej Gamian,Siddarth AGRAWAL,Wiesław Szeja,Jerzy Wiśniewski,Marta WOŹNIAK,Piotr ZIÓLKOWSKI,Sebastian MAKUCH,Gabriela PASTUCH-GAWOŁEK,Monika Krawczyk. Владелец: Uniwersytet Medyczny Im Piastów Slaskich We Wroclawiu. Дата публикации: 2024-04-17.

Pharmaceutical compositions for the treatment and prevention of urinary tract infections

Номер патента: EP4192485A1. Автор: Carlo Terruzzi,Fabio Pietro Terruzzi. Владелец: Biofarma SRL. Дата публикации: 2023-06-14.

Pharmaceutical compositions for the treatment and prevention of urinary tract infections

Номер патента: AU2021321470A1. Автор: Carlo Terruzzi,Fabio Pietro Terruzzi. Владелец: Biofarma SRL. Дата публикации: 2023-03-09.

Pharmaceutical composition for the treatment and prevention of glaucoma

Номер патента: WO2009082124A2. Автор: Taehwan Kwak,Myung-Gyu Park. Владелец: Mazence Inc.. Дата публикации: 2009-07-02.

Method for the treatment or prevention of intrinsically aged skin with retinoids

Номер патента: CA1335651C. Автор: Albert M. Kligman,James A. Mezick,Robert J. Capetola. Владелец: Ortho Pharmaceutical Corp. Дата публикации: 1995-05-23.

Method for the treatment or prevention of intrinsically aged skin with retinoids

Номер патента: MY106263A. Автор: M Kligman Albert,A Mezick James,J Capetola Robert. Владелец: Ortho Pharma Corp. Дата публикации: 1995-04-29.

Polyvinylpyrrolidone as a therapeutically active compound for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens

Номер патента: WO2010054858A3. Автор: Steffen Mergemeier. Владелец: Steffen Mergemeier. Дата публикации: 2010-08-19.

Pharmaceutical composition for the treatment and prevention of hpv

Номер патента: WO2024028914A1. Автор: Roberto BECELLI,Federico DE MARCO,Fabio ALTIERI. Владелец: Np1 Srl. Дата публикации: 2024-02-08.

Compositions and methods for the treatment and prevention of cognitive decline and preservation of neuronal function

Номер патента: AU2018304590B2. Автор: Shawn Nathan WATSON. Владелец: Senescence Life Sciences Pte Ltd. Дата публикации: 2023-09-07.

Compositions and methods for the treatment and prevention of cognitive decline and preservation of neuronal function

Номер патента: EP3655003A1. Автор: Shawn Nathan WATSON. Владелец: Senescence Life Sciences Pte Ltd. Дата публикации: 2020-05-27.

Compositions and methods for the treatment and prevention of cognitive decline and preservation of neuronal function

Номер патента: WO2019016731A1. Автор: Shawn Nathan WATSON. Владелец: Senescence Life Sciences Pte. Ltd.. Дата публикации: 2019-01-24.

Composition for the treatment and prevention of herpes simplex labialis

Номер патента: EP2598132A1. Автор: Costantino Pasquali. Владелец: Pasquali Srl. Дата публикации: 2013-06-05.

Compositions and methods for the treatment and prevention of cognitive decline and preservation of neuronal function

Номер патента: PH12020500147A1. Автор: Shawn Nathan WATSON. Владелец: Senescence Life Sciences Pte Ltd. Дата публикации: 2020-11-09.

Compositions for the treatment and prevention of cancer

Номер патента: EP1520579B1. Автор: Gerhard N. Schrauzer. Владелец: Individual. Дата публикации: 2009-03-25.

Polyvinylpyrrolidone as a therapeutically active compound for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens

Номер патента: EP2376092A2. Автор: Steffen Mergemeier. Владелец: Individual. Дата публикации: 2011-10-19.

Biopolymer compositions for the treatment and prevention of liver disease

Номер патента: US20190000903A1. Автор: Scott P. Noel,William Brian Austin,Alex Greene,John Kirk Shumpert. Владелец: Promend Animal Health Inc. Дата публикации: 2019-01-03.

Modulators of TDP-43 Mediated Toxicity and Methods of Use Thereof for Identifying Agents Having Efficacy for the Treatment and Prevention of Proteinopathies

Номер патента: US20120237499A1. Автор: Aaron D. Gitler,Andrew Elden. Владелец: University of Pennsylvania Penn. Дата публикации: 2012-09-20.

Unsaturated hydroxamic acid derivatives and their use for the treatment and prevention of an ammonia-associated disease or disorder

Номер патента: CA3221837A1. Автор: Jean-Christophe Leroux,Filip Ilievski,Diana EVSTAFEVA. Владелец: Versantis AG. Дата публикации: 2023-01-05.

Unsaturated hydroxamic acid derivatives and their use for the treatment and prevention of an ammonia-associated disease or disorder

Номер патента: EP4362928A1. Автор: Jean-Christophe Leroux,Filip Ilievski,Diana EVSTAFEVA. Владелец: Versantis AG. Дата публикации: 2024-05-08.

Pharmaceutical composition for the treatment and prevention of glaucoma

Номер патента: EP2231146A2. Автор: Taehwan Kwak,Myung-Gyu Park. Владелец: Mazence Inc. Дата публикации: 2010-09-29.

Pharmaceutical composition for the treatment and prevention of hpv

Номер патента: WO2024028914A9. Автор: Roberto BECELLI,Federico DE MARCO,Fabio ALTIERI. Владелец: Np1 Srl. Дата публикации: 2024-06-27.

Use of ghrelin splice variant for treating hypercholesterolemia and/or high cholesterol and/or high cholesterol complication and/or lipemia and/or lipemia complication and/or coronary heart disease and/or weight management and/or diabetes and/or hyperglycemia

Номер патента: CA2647815A1. Автор: Liat Mintz. Владелец: Individual. Дата публикации: 2007-11-08.

Use of ghrelin splice variant for treating hypercholesterolemia and/or high cholesterol and/or high cholesterol complication and/or lipemia and/or lipemia complication and/or coronary heart disease and/or weight management and/or diabetes and/or hyperglycemia

Номер патента: CA2647815C. Автор: Liat Mintz. Владелец: Individual. Дата публикации: 2021-11-23.

Use of 5-chloro-4-[3-[n-[2-(3,4-dimethoxy-phenyl)-ethyl]-n-methylamino]-propylamino]-3-(2h)-pyridazinone as metabolic modulator

Номер патента: WO2004024158A1. Автор: György Lévay,Ildikó NAGYNÉ GYÖNÖS,Gábor SZÉNÁSI,László Gábor HÁRSING,Katalin Ivanicsne Megyeri,Aniko Miklosne Kovacs,Maria Szecseyne Hegedus. Владелец: Egis Gyogyszergyar Rt.. Дата публикации: 2004-03-25.

Use of sodium salt of diethyl ester of 4-oxo-1,4-dihydropyrazolo[5,1-c]-1,2,4-triazine-3,8-dicarboxylic acid, monohydrate as drug for treatment and prevention of late complications of diabetes mellitus

Номер патента: RU2765117C2. Автор: Владимир Иванович Петров,Владимир Леонидович Русинов,Светлана Константиновна Котовская,Ирина Михайловна Сапожникова,Александр Алексеевич Спасов,Алексей Владимирович Смирнов,Валентина Андреевна Бабкова,Юлия Александровна Говорова,Наталия Алексеевна Гурова,Роман Александрович Литвинов,Людмила Владимировна Науменко,Максим Вячеславович Шмидт. Владелец: федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации. Дата публикации: 2022-01-25.

Oxazolidinones for the treatment and/or prophylaxis of heart failure

Номер патента: CA2708418C. Автор: Elisabeth Perzborn,Harald Kallabis,Wolfgang Thielemann,Susanne Roehrig,Lloyd Haskell,Dagmar Kubitza,Theodore Spiro,Jeet Mahal. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2013-11-12.

Agent for treatment and prevention of thrombosis

Номер патента: RU2662308C1. Автор: Феликс Хусаинович Камилов,Александр Владимирович Самородов,Феркат Адельзянович Халиуллин,Юлия Викторовна Шабалина. Владелец: Феркат Адельзянович Халиуллин. Дата публикации: 2018-07-25.

Use of timosaponin BII in the preparation of a medicament or formulation for the prevention and treatment of stroke

Номер патента: JP4987695B2. Автор: マ，バイピン,シュ，クイピン,ツァオ，ヤン,シオン，チェンキ,タン，ダウエイ. Владелец: ツォン グオ レン ミン ジエ ファン ジュン ジュン シ イ シュエ ケ シュエ ユアン ファン シ イ シュエ ヤン ジウ スオ. Дата публикации: 2012-07-25.

Medicament for the enhancement of cognitive function and neuroprotection

Номер патента: EP2049113A2. Автор: Jozsef Barkoczy,Istvan Gacsalyi,Gabor Gigler,Gyula Simig,György Lévay,Hajnalka Kompagne,Gábor SZÉNÁSI,László Gábor HÁRSING,Krisztina Moricz,Szabolcs Kertesz,Marta Agoston. Владелец: Egyt Gyogyszervegyeszeti Gyar. Дата публикации: 2009-04-22.

Medicament for the enhancement of cognitive function and neuroprotection

Номер патента: EP2049113B1. Автор: Jozsef Barkoczy,Istvan Gacsalyi,Gabor Gigler,Gyula Simig,György Lévay,Hajnalka Kompagne,Gábor SZÉNÁSI,László Gábor HÁRSING,Krisztina Moricz,Szabolcs Kertesz,Marta Agoston. Владелец: Egyt Gyogyszervegyeszeti Gyar. Дата публикации: 2010-05-26.

Medicament for the enhancement of cognitive function and neuroprotection

Номер патента: IL196315A0. Автор: . Владелец: Egis Gyogyszergyar Nyilvanosan. Дата публикации: 2009-09-22.

Medicament for the enhancement of cognitive function and neuroprotection

Номер патента: WO2008004013A8. Автор: Jozsef Barkoczy,Istvan Gacsalyi,Gabor Gigler,Gyula Simig,Hajnalka Kompagne,Gábor SZÉNÁSI,László Gábor HÁRSING,Krisztina Moricz,Szabolcs Kertesz,Gyoergy Levay,Marta Agoston. Владелец: Marta Agoston. Дата публикации: 2009-07-02.

Medicament for the enhancement of cognitive function and neuroprotection

Номер патента: IL196315A. Автор: . Владелец: Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag. Дата публикации: 2014-09-30.

Medicament for the enhancement of cognitive function and neuroprotection

Номер патента: AU2007270910A1. Автор: Jozsef Barkoczy,Istvan Gacsalyi,Gabor Gigler,Gyula Simig,György Lévay,Hajnalka Kompagne,Gábor SZÉNÁSI,László Gábor HÁRSING,Krisztina Moricz,Szabolcs Kertesz,Marta Agoston. Владелец: Egyt Gyogyszervegyeszeti Gyar. Дата публикации: 2008-01-10.

Preparation and uses of obeticholic acid

Номер патента: US09732116B2. Автор: Ralf Gross,Emma Sharp,Alex Eberlin,Andre Steiner,Heidi Waenerlund Poulsen,Emilie JOLIBOIS,Melissa REWOLINSKI,Fiona DUBAS-FISHER. Владелец: Intercept Pharmaceuticals Inc. Дата публикации: 2017-08-15.

Agent for the treatment of alopecia

Номер патента: US09480728B2. Автор: Kyoko Endo. Владелец: IGISU CO Ltd. Дата публикации: 2016-11-01.

Preparation and uses of obeticholic acid

Номер патента: US09982008B2. Автор: Ralf Gross,Emma Sharp,Alex Eberlin,Andre Steiner,Heidi Waenerlund Poulsen,Emilie JOLIBOIS,Melissa REWOLINSKI,Fiona DUBAS-FISHER. Владелец: Intercept Pharmaceuticals Inc. Дата публикации: 2018-05-29.

Mammalian metabolites of a tachykinin receptor antagonist

Номер патента: US6727244B2. Автор: Shuet-Hing Lee Chiu,Su-er Wu Huskey. Владелец: Merck and Co Inc. Дата публикации: 2004-04-27.

Use of a chiral 2-azabicycloalkane derivative with dansyl substituent as vp24 protease inhibitor to inhibit the replication of hsv-1 virus

Номер патента: WO2020222666A1. Автор: Krzysztof Pyrc,Elżbieta Wojaczyńska,Magdalena Pachota,Marcin Sieńczyk,Renata Grzywa,Dominika Iwan. Владелец: Politechnika Wrocławska. Дата публикации: 2020-11-05.

Use of a Specific Cyclic Amine Derivative or the Pharmaceutically Acceptable Salts Thereof for the Treatment or Prevention of Heart Failure

Номер патента: US20130317008A1. Автор: DAEMMGEN Juergen,SEIDLER Randolph,GUTH Brian. Владелец: Boehringer Ingelheim Pharma GmbH & Co. KG. Дата публикации: 2013-11-28.

Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure

Номер патента: EP1362590A1. Автор: designation of the inventor has not yet been filed The. Владелец: Boehringer Ingelheim Pharma GmbH and Co KG. Дата публикации: 2003-11-19.

Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure

Номер патента: PT1534296E. Автор: Brian Guth,Randolph Seidler,Juergen Daemmgen. Владелец: Boehringer Ingelheim Vetmed. Дата публикации: 2011-08-18.

Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure

Номер патента: AU2003254554B2. Автор: Brian Guth,Randolph Seidler,Juergen Daemmgen. Владелец: BOEHRINGER INGELHEIM PHARMA. Дата публикации: 2009-01-29.

Use of cilobradine or its pharmaceutically acceptable salts for the treatment or prevention of heart failure

Номер патента: DK1534296T3. Автор: Brian Guth,Randolph Seidler,Juergen Daemmgen. Владелец: Boehringer Ingelheim Vetmed. Дата публикации: 2011-08-15.

Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure

Номер патента: CN1671392A. Автор: 布赖恩·古思,伦道夫·塞德勒,于尔根·戴姆根. Владелец: Boehringer Ingelheim Pharma GmbH and Co KG. Дата публикации: 2005-09-21.

Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure

Номер патента: EP1362590A8. Автор: Brian Guth Dr.,Randolf Seidler Dr.,Jürgen DÄMMGEN Dr.. Владелец: Boehringer Ingelheim Pharma GmbH and Co KG. Дата публикации: 2004-02-25.

Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure

Номер патента: WO2004011006A1. Автор: Brian Guth,Randolph Seidler,Juergen Daemmgen. Владелец: Boehringer Ingelheim Pharma GmbH & Co. KG. Дата публикации: 2004-02-05.

Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure

Номер патента: AU2003254554B8. Автор: Brian Guth,Randolph Seidler,Juergen Daemmgen. Владелец: Boehringer Ingelheim Pharma GmbH and Co KG. Дата публикации: 2009-02-26.

Drug delivery system for the delivery of antiviral agents and contraceptives

Номер патента: WO2021225869A8. Автор: Stephanie Elizabeth Barrett,Ryan S. Teller,Seth P. Forster,Athanas Koynov,Morgan B. GILES. Владелец: Merck Sharp & Dohme LLC. Дата публикации: 2022-08-11.

Drug delivery system for the delivery of antiviral agents and contraceptives

Номер патента: AU2021268584A1. Автор: Stephanie Elizabeth Barrett,Ryan S. Teller,Seth P. Forster,Athanas Koynov,Morgan B. GILES. Владелец: Merck Sharp and Dohme LLC. Дата публикации: 2022-12-01.

Use of the corticoliberin-urocortin system in the treatment of inflammatory diseases

Номер патента: WO2004047866A2. Автор: Andrew N. Margioris,Achille Gravanis. Владелец: Bionature E.A. Limited. Дата публикации: 2004-06-10.

Use of cilobradine or its pharmaceutically acceptable salts for the treatment or prevention of heart failure

Номер патента: DK1362590T3. Автор: Brian Guth Dr,Randolf Seidler Dr,Juergen Daemmgen Dr. Владелец: BOEHRINGER INGELHEIM PHARMA. Дата публикации: 2004-03-29.

Use of cilobradine or pharmaceutically acceptable salts for the treatment or prevention of heart failure

Номер патента: DE60200160T2. Автор: Brian Guth Dr.,Randolf Seidler Dr.,Jürgen DÄMMGEN Dr.. Владелец: Boehringer Ingelheim Pharma GmbH and Co KG. Дата публикации: 2004-11-04.

Tailored liposomes for the treatment of bacterial infections

Номер патента: CA2875470C. Автор: Eduard Babiychuk,Annette Draeger. Владелец: UNIVERSITAET BERN. Дата публикации: 2021-01-12.

USE OF AN ESTROGEN DERIVATIVE FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT AND/OR PREVENTION OF PSYCHIATRIC DISEASES AND FOR THE TREATMENT AND PREVENTION OF SAID DISEASES

Номер патента: US20130172306A1. Автор: Puskas Laszlo,Ozsvari Bela,Hajszan Tibor,Nagy Lajos Istvan. Владелец: . Дата публикации: 2013-07-04.

Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof

Номер патента: EP2351756A4. Автор: Oleg Dmitrievich Mitkin,Alexander Vasilievich Ivashchenko,Nikolay Filippovich Savchuk,Yan Lavrovsky,Madina Georgievna Kadieva. Владелец: Alla Chem LLC. Дата публикации: 2013-01-02.

Use of an estrogen derivative for the manufacture of pharmaceutical compositions useful for the treatment and/or prevention of psychiatric diseases and for the treatment and prevention of said diseases

Номер патента: WO2011161484A1. Автор: Lajos Istvan Nagy,Laszlo Puskas,Tibor HAJSZÁN,Béla ÓZSVÁRI. Владелец: Ubichem Kutató Korlátolt Felelősségű Társaság. Дата публикации: 2011-12-29.

Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof

Номер патента: US20110178078A1. Автор: Oleg Dmitrievich Mitkin,Andrey Alexandrovich Ivashchenko,Alexander Vasilievich Ivashchenko,Nikolay Filippovich Savchuk,Yan Lavrovsky,Madina Georgievna Kadieva. Владелец: Madina Georgievna Kadieva. Дата публикации: 2011-07-21.

Pharmaceutical compositions for preventing platelet loss containing a thromboxane a2 receptor antagonist and method for the preparation thereof

Номер патента: IL89256A0. Автор: . Владелец: Squibb & Sons Inc. Дата публикации: 1989-09-10.

Use of OB-101 to treat ocular inflammation

Номер патента: US5194434A. Автор: George C. Y. Chiou. Владелец: TEXAS A&M UNIVERSITY SYSTEM. Дата публикации: 1993-03-16.

Use of therapeutic peptides for the treatment and prevention of cancer

Номер патента: CA2714939A1. Автор: Joyce A. Schroeder. Владелец: ARIZONA BIOMEDICAL RESEARCH COMMISSION. Дата публикации: 2009-08-27.

Use of inhibitors of the activity or function of pi3k

Номер патента: CA2857302C. Автор: Nigel Graham Cooke,Frédéric ZECRI,Alexander Baxter Smith,Christina Hebach,Pascal Furet,Frank Stowasser,Christoph Kalis,Frederic Stauffer,Nicolas Soldermann,Ian Lewis,Anette Von Matt,Nicola Tufilli,Klemens Högenauer,Romain Wolf,Gregory HOLLINGWORTH,Ross Strang,Paulo Antonio FERNANDES GOMES DOS SANTOS. Владелец: NOVARTIS AG. Дата публикации: 2020-08-25.

Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof

Номер патента: WO2010041983A1. Автор: Александр Васильевич Иващенко,Николай Филиппович Савчук,Андрей Александрович Иващенко,Олег Дмитриевич Митькин,Мадина Георгиевна Кадиева,Ян Лавровский. Владелец: Алла Хем, Ллс. Дата публикации: 2010-04-15.

Use of meloxicam for the treatment of respiratory diseases in pigs

Номер патента: CA2554040C. Автор: Ioannis Papatsas,Ingo Ulrich Lang. Владелец: BOEHRINGER INGELHEIM VETMEDICA GMBH. Дата публикации: 2014-08-05.

Anti-tigit antibodies and uses of the same

Номер патента: WO2023215719A1. Автор: Nigel Pelham Clinton Walker,Juan Carlos Jaen,Matthew J. Walters,Kelsey Sivick GAUTHIER,Paul G. FOSTER,Lisa C. SEITZ. Владелец: Arcus Biosciences, Inc.. Дата публикации: 2023-11-09.

Preparation and uses of obeticholic acid

Номер патента: US20230340010A1. Автор: Ralf Gross,Emma Sharp,Alex Eberlin,Andre Steiner,Heidi Waenerlund Poulsen,Emilie JOLIBOIS,Melissa REWOLINSKI,Fiona DUBAS-FISHER. Владелец: Sigma Aldrich Co Ltd. Дата публикации: 2023-10-26.

Use of nucleoside analogs as anti-koi herpes virus molecules

Номер патента: WO2010012840A1. Автор: JOHAN Neyts,Alain Vanderplasschen,Bérénice COSTES. Владелец: KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D. Дата публикации: 2010-02-04.

Use of angiotensin I derivative as an agent for the treatment and prevention of infarction-related cardiac injuries and disorders

Номер патента: US20030017989A1. Автор: Meng Sim. Владелец: NATIONAL UNIVERSITY OF SINGAPORE. Дата публикации: 2003-01-23.

The use of angiotensin i derivative as an agent for the treatment and prevention of infarction-related cardiac injuries and disorders

Номер патента: EP1406648A1. Автор: Meng Kwoon Sim. Владелец: NATIONAL UNIVERSITY OF SINGAPORE. Дата публикации: 2004-04-14.

Use of activin products for preventing and treating diabetes and/or metabolic syndrome

Номер патента: WO2006108651A3. Автор: Rainer Mussmann,Tri Nguyen. Владелец: Tri Nguyen. Дата публикации: 2007-06-28.

Use of des-Aspartate-angiotensin I as an agent for the treatment and prevention of glomerulosclerosis and renal failure

Номер патента: US7553928B2. Автор: Meng Kwoon Sim,Chorh Chuan Tan. Владелец: NATIONAL UNIVERSITY OF SINGAPORE. Дата публикации: 2009-06-30.

Use of oligonucleotides for the treatment and prevention of pain

Номер патента: US20200155592A1. Автор: Alejandro Daniel Montaner,Marcelo Jose Villar,Pablo Rodolfo Brumovsky,Candelaria Leiguarda,Maria Florencia Coronel,Inelia Mailín Lara Casadei,Sandra Sbrascini. Владелец: Universidad Austral. Дата публикации: 2020-05-21.

Use of a compound, pharmaceutical composition, and therapeutic method for the treatment or prevention of convulsions

Номер патента: US10933113B2. Автор: Ricardo Amaral Remer,Andrea Sterman Heimann. Владелец: Proteimax Biotecnologia Ltd. Дата публикации: 2021-03-02.

Use of long-acting recombinant human soluble tumor necrosis factor ? receptor in manufacture of a medicament for the treatment and/or prophylaxis of hepatic failure

Номер патента: MY157842A. Автор: Li Hai. Владелец: Li Hai. Дата публикации: 2016-07-29.

Use of MP52 or MP121 for the treatment and prevention of diseases of the nervous system

Номер патента: US20030220248A1. Автор: Jens Pohl,Gertrud Hotten,Rolf Bechtold,Michael Paulista,Klaus Unsicker. Владелец: Individual. Дата публикации: 2003-11-27.

Use of MP52 or MP121 for the treatment and prevention of diseases of the nervous system

Номер патента: US7632808B2. Автор: Jens Pohl,Gertrud Hotten,Rolf Bechtold,Michael Paulista,Klaus Unsicker. Владелец: Biopharm Gesellschaft zur biotechnologischen Entwicklung von Pharmaka mbH. Дата публикации: 2009-12-15.

Compositions and methods for the treatment or prevention of heart failure

Номер патента: US11760987B2. Автор: H. Kirk Hammond,Mei Hua Gao,Ngai Chin LAI. Владелец: US Department of Veterans Affairs VA. Дата публикации: 2023-09-19.

Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual

Номер патента: AU1788892A. Автор: Karsten Buschard. Владелец: Individual. Дата публикации: 1992-12-21.

Interferon-associated antigen binding proteins for use for the treatment or prevention of respiratory syncytial virus infection

Номер патента: WO2024126293A1. Автор: Antoine Alam,Xavier MARNIQUET,Pascal Bernard JALAGUIER,Kara Lynn CARTER. Владелец: EVOTEC INTERNATIONAL GMBH. Дата публикации: 2024-06-20.

Interferon-associated antigen binding proteins for use for the treatment or prevention of parainfluenza virus infection

Номер патента: WO2024126294A1. Автор: Antoine Alam,Xavier MARNIQUET,Pascal Bernard JALAGUIER,Kara Lynn CARTER. Владелец: EVOTEC INTERNATIONAL GMBH. Дата публикации: 2024-06-20.

Use of the protein uk114 or of fragments thereof for the treatment and prevention of the endotoxic shock

Номер патента: EP1377308A1. Автор: Alberto Bartorelli,Alberto Panerai,Ferdinando Nicoletti. Владелец: Zetesis SpA. Дата публикации: 2004-01-07.

Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases

Номер патента: US09732140B2. Автор: Alexander Steinkasserer,Matthias Lechmann,Elisabeth Zinser. Владелец: Merix Bioscience Inc. Дата публикации: 2017-08-15.

Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor

Номер патента: CA2432978A1. Автор: Roger A. Sabbadini. Владелец: Individual. Дата публикации: 2002-07-04.

Composition for the treatment and prevention of a disorder correlated with haematic cholesterol and /or hematic glycemia

Номер патента: EP3037098A1. Автор: Mario Martelli,Alessandro Bergamaschi. Владелец: Individual. Дата публикации: 2016-06-29.

Composition and method for the treatment and prevention of enteric bacterial infections

Номер патента: US20140112938A1. Автор: Gottfried Lichti,Grant Thomas Rawlin,Roy Michael Robins-Browne. Владелец: Immuron Ltd. Дата публикации: 2014-04-24.

Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection

Номер патента: NZ619761A. Автор: David Apelian,Thomas H King. Владелец: Globeimmune Inc. Дата публикации: 2015-08-28.

Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Номер патента: US20240262896A1. Автор: Adam S. Grossman,James Mond. Владелец: ADMA Biomanufacturing LLC. Дата публикации: 2024-08-08.

Use of leptin for the treatment or prevention of parkinson's disease

Номер патента: WO2008115880A3. Автор: Wei Zhang,Xin-Yun Lu. Владелец: The Board of Regents of the University of Texas System. Дата публикации: 2009-09-11.

Synthetic antimicrobial peptides and their applications for the treatment and prevention of musculoskeletal infections

Номер патента: WO2018133887A1. Автор: Vaclav Cerovsky,Ondřej Nešuta,Pavel MELICHERCIK. Владелец: Fakultni Nemocnice V Motole. Дата публикации: 2018-07-26.

Synthetic antimicrobial peptides and their applications for the treatment and prevention of musculoskeletal infections

Номер патента: EP3570868A1. Автор: Vaclav Cerovsky,Ondřej Nešuta,Pavel MELICHERCIK. Владелец: Fakultni Nemocnice V Motole. Дата публикации: 2019-11-27.

Use of il-17d for the treatment and prevention of cancers

Номер патента: US20140086868A1. Автор: Jack BUI. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2014-03-27.

Cd40l-specific tn3-derived scaffolds for the treatment and prevention of sjögren's syndrome

Номер патента: WO2024152001A1. Автор: Michael Smith,Ilias Alevizos,William A. REES,Claire L. EMSON,Tuyet-Hang T. PHAM. Владелец: Viela Bio, Inc.. Дата публикации: 2024-07-18.

Combination of nitroprusside and a sulfide salt as an hno-releasing therapeutic for the treatment or prevention of cardiovascular diseases

Номер патента: US20150374749A1. Автор: Ivana Ivanovic-Burmazovic,Milos Filipovic. Владелец: Friedrich Alexander Univeritaet Erlangen Nuernberg FAU. Дата публикации: 2015-12-31.

Combination of nitroprusside and a sulfide salt as an hno-releasing therapeutic for the treatment or prevention of cardiovascular diseases

Номер патента: WO2014122074A1. Автор: Ivana Ivanovic-Burmazovic,Milos Filipovic. Владелец: Friedrich-Alexander-Universität Erlangen-Nürnberg. Дата публикации: 2014-08-14.

Cd40l-specific tn3-derived scaffolds for the treatment and prevention of sjogren's syndrome

Номер патента: EP4408455A1. Автор: Jorn DRAPPA,Ilias Alevizos,Gabor Illei,William Rees,Liangwei Wang. Владелец: Viela Bio Inc. Дата публикации: 2024-08-07.

Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection

Номер патента: US20090220535A1. Автор: Robert L. Garcea,Renee Finnen. Владелец: University of Colorado. Дата публикации: 2009-09-03.

Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection

Номер патента: WO2004062584A3. Автор: Robert L Garcea. Владелец: Robert L Garcea. Дата публикации: 2004-11-04.

Ophthalmic formulation for the treatment and prevention of pterygium

Номер патента: WO2010128486A3. Автор: Marco Ciancaglini,Stefano Sebastiani,Roberta Di Pietro. Владелец: Roberta Di Pietro. Дата публикации: 2011-01-13.

Ophthalmic formulation for the treatment and prevention of pterygium

Номер патента: WO2010128486A2. Автор: Marco Ciancaglini,Stefano Sebastiani,Roberta Di Pietro. Владелец: Roberta Di Pietro. Дата публикации: 2010-11-11.

Cd40l-specific tn3-derived scaffolds for the treatment and prevention of sjogren's syndrome

Номер патента: WO2024226217A1. Автор: Yan Xin,Ilias Alevizos,Liangwei Wang,Gabor G. ILLEI,William A. REES,Donna MURRAY,Kenneth R. DER. Владелец: Viela Bio, Inc.. Дата публикации: 2024-10-31.

Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection

Номер патента: US20170182153A1. Автор: David Apelian,Thomas H. King. Владелец: Globeimmune Inc. Дата публикации: 2017-06-29.

Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection

Номер патента: EP2720716A1. Автор: David Apelian,Thomas H. King. Владелец: Globeimmune Inc. Дата публикации: 2014-04-23.

Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection

Номер патента: US20140193362A1. Автор: Thomas H. King,David Apellan. Владелец: Globeimmune Inc. Дата публикации: 2014-07-10.

Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection

Номер патента: US09987352B2. Автор: David Apelian,Thomas H. King. Владелец: Globeimmune Inc. Дата публикации: 2018-06-05.

Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection

Номер патента: US09579377B2. Автор: David Apelian,Thomas H. King. Владелец: Globeimmune Inc. Дата публикации: 2017-02-28.

Methods and pharmaceutical compositions for the treatment and prevention of hcv infections

Номер патента: WO2012107589A1. Автор: Hicham BOUHLAL,Christele OSSART,Flora CARTIER. Владелец: Centre Hospitalier Universitaire D'amiens. Дата публикации: 2012-08-16.

Methods and compositions for the treatment and prevention of type 1 diabetes

Номер патента: WO2022076385A1. Автор: Mary S. MORRIS,Richard DI PAOLO. Владелец: Dr. Mary Morris & Associates, Llc. Дата публикации: 2022-04-14.

Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Номер патента: CA2998067C. Автор: Adam S. Grossman,James Mond. Владелец: ADMA Biomanufacturing LLC. Дата публикации: 2024-03-19.

Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Номер патента: US11897943B2. Автор: Adam S. Grossman,James Mond. Владелец: ADMA Biomanufacturing LLC. Дата публикации: 2024-02-13.

Methods and compositions for the treatment and prevention of type 1 diabetes

Номер патента: US20240041986A1. Автор: Mary S. MORRIS,Richard J. DiPaolo. Владелец: Dr Mary Morris & Associates LLC. Дата публикации: 2024-02-08.

Use of a compound, pharmaceutical composition, and therapeutic method for the treatment or prevention of convulsions

Номер патента: US20190321438A1. Автор: Ricardo Amaral Remer,Andrea Sterman Heimann. Владелец: PROTEIMAX BIOTECNOLOGIA LTDA. Дата публикации: 2019-10-24.

Method for the treatment and prevention of overweight in mammals

Номер патента: US20030175368A1. Автор: George Verlaan,Rene Raggers. Владелец: Nutricia NV. Дата публикации: 2003-09-18.

Compositions and methods for the treatment or prevention of neurodegenerative disorders

Номер патента: US20240066098A1. Автор: Jin-Sung Park,Carolyn M. Sue,Brianada KOENTJORO. Владелец: Northern Sydney Local Health District. Дата публикации: 2024-02-29.

Edible foam product for the treatment or prevention of obesity

Номер патента: EP2081451A1. Автор: Simeon Dobrev Stoyanov,Andrew Richard Cox,Petrus Wilhelmus Nicolaas De Groot,Sergey Michailovich Melnikov. Владелец: Unilever NV. Дата публикации: 2009-07-29.

Compositions and methods for the treatment or prevention of autoimmune disorders

Номер патента: WO2000078360A1. Автор: Matthias G. Von Herrath. Владелец: The Scripps Research Institute. Дата публикации: 2000-12-28.

Compositions and methods for the treatment or prevention of autoimmune disorders

Номер патента: EP1194172A1. Автор: Matthias G. Von Herrath. Владелец: Scripps Research Institute. Дата публикации: 2002-04-10.

Use of a monoclonal antibody specific for a red blood cell to inhibit the reticuloendothelial system for the treatment of thrombocytopenia

Номер патента: CA2467781C. Автор: Alan H. Lazarus,John Freedman,Seng Song,Andrew R. Crow. Владелец: CANADIAN BLOOD SERVICES. Дата публикации: 2014-09-23.

Nutritional supplement for the treatment and prevention of excessive intestinal permeability

Номер патента: CA2242114C. Автор: Linsey McLean. Владелец: Individual. Дата публикации: 2008-10-07.

Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases

Номер патента: CA2847795C. Автор: Alexander Steinkasserer,Matthias Lechmann,Elisabeth Zinser. Владелец: Merix Bioscience Inc. Дата публикации: 2018-05-01.

Novel peroxide derivatives, their process of preparation and their use in human medicine and in cosmetics for the treatment or prevention of acne

Номер патента: CA2782948C. Автор: Jean-Claude Pascal,Nicolas Rodeville,Claire Bouix-Peter. Владелец: Galderma Research and Development SNC. Дата публикации: 2015-02-10.

Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases

Номер патента: CA2507373C. Автор: Alexander Steinkasserer,Matthias Lechmann,Elisabeth Zinser. Владелец: Merix Bioscience Inc. Дата публикации: 2014-06-10.

Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces

Номер патента: CA2747611C. Автор: Joan M. Fallon,Matthew Heil,James J. Fallon. Владелец: Galenagen LLC. Дата публикации: 2019-09-17.

Improved products and methods for the remineralization and prevention of demineralization of teeth

Номер патента: CA2261804C. Автор: Norman Usen,Anthony E. Winston. Владелец: Enamelon Inc. Дата публикации: 2003-12-16.

Cd40l-specific tn3-derived scaffolds for the treatment and prevention of sjogren's syndrome

Номер патента: CA3230926A1. Автор: Jorn DRAPPA,Ilias Alevizos,Gabor Illei,William Rees,Liangwei Wang. Владелец: Viela Bio Inc. Дата публикации: 2023-04-06.

Composition comprising pasteurized akkermansia for the treatment or prevention of ibs-related anxiety

Номер патента: AU2022330944A1. Автор: Patrice Cani,Amandine BROCHOT. Владелец: Akkermansia Co. Дата публикации: 2024-01-25.

Use of halogen compounds for the treatment and prevention of tissue injury and post-intensive care syndrome

Номер патента: WO2019237065A1. Автор: Mark B. Roth,Akiko Iwata,Stephen A. Hill,Michael L. MORRISON,John W. LANGSTON,Michael Andrew INSKO. Владелец: Faraday Pharmaceuticals, Inc.. Дата публикации: 2019-12-12.

Composition and method for the treatment or prevention of spinal disorders iii

Номер патента: WO2011022753A1. Автор: Ashish Diwan,Divya Diwan. Владелец: Cellixe Pty Ltd. Дата публикации: 2011-03-03.

Feed composition for the treatment or prevention of enteritis in fish

Номер патента: EP2427200A2. Автор: Odd Helge ROMARHEIM,Margareth Overland,Liv Torunn Mydland,Anders Skrede,Thor Landsverk. Владелец: BIOPROTEIN AS. Дата публикации: 2012-03-14.

Use of halogen compounds for the treatment and prevention of tissue injury and post-intensive care syndrome

Номер патента: AU2019282820A1. Автор: Mark B. Roth,Akiko Iwata,Stephen A. Hill,Michael L. MORRISON,John W. LANGSTON,Michael Andrew INSKO. Владелец: Faraday Pharmaceuticals Inc. Дата публикации: 2021-01-21.

Composition comprising pasteurized akkermansia for the treatment or prevention of ibs-related anxiety

Номер патента: CA3224825A1. Автор: Patrice Cani,Amandine BROCHOT. Владелец: Individual. Дата публикации: 2023-02-23.

Novel cholic acid derivatives for the treatment and prevention of autoimmune diseases and uses thereof

Номер патента: WO2023148764A1. Автор: Poonam Singla,Amit Awasthi,Shailendra ASTHANA,Rajdeep DALAL,Deepak SALUNKE,Upasna MADAN,Srikant SADHU,Aarzoo KAMBOJ. Владелец: Panjab University. Дата публикации: 2023-08-10.

Composition comprising pasteurized akkermansia for the treatment or prevention of ibs-related anxiety

Номер патента: EP4387636A1. Автор: Patrice Cani,Amandine BROCHOT. Владелец: Akkermansia Co. Дата публикации: 2024-06-26.

Interferon-associated antigen binding proteins for use for the treatment or prevention of influenza virus infection

Номер патента: WO2024126289A1. Автор: Antoine Alam,Xavier MARNIQUET,Pascal Bernard JALAGUIER,Kara Lynn CARTER. Владелец: EVOTEC INTERNATIONAL GMBH. Дата публикации: 2024-06-20.

Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease

Номер патента: US7291454B2. Автор: Jack R Wands,Suzanne De La Monte. Владелец: General Hospital Corp. Дата публикации: 2007-11-06.

Chemical igf-i formulation for the treatment and prevention of neurodegenerative diseases

Номер патента: CA2477593C. Автор: Eva Maria Carro Diaz,Cristina Lopez Lopez,Ignacio Torres Aleman,Juan Jose Torrado Duran,Santiago Torrado Duran,Celia Carrascosa Martinez. Владелец: Consejo Superior de Investigaciones Cientificas CSIC. Дата публикации: 2012-05-15.

Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death

Номер патента: CA2399093A1. Автор: Gordon B. Mills,Eckard Weber,Douglas R. Green. Владелец: Individual. Дата публикации: 2001-04-19.

Methods for treatment and prevention of vascular disease

Номер патента: US20180185444A1. Автор: Gemma Alexandra Figtree. Владелец: Individual. Дата публикации: 2018-07-05.

Insp163 polypeptides and polynucleotides for the treatment or prevention of lung cancer

Номер патента: EP1879611B1. Автор: Christine Power,Melanie Yorke-Smith. Владелец: MERCK SERONO SA. Дата публикации: 2011-10-26.

Compositions and methods for the treatment and prevention of neoplastic disorders

Номер патента: WO2010093263A8. Автор: Annette Lasham,Glen Reid. Владелец: Solirna Biosciences Limited. Дата публикации: 2010-09-30.

Methods for treatment and prevention of vascular disease

Номер патента: EP3188744A1. Автор: Gemma Alexandra Figtree. Владелец: Individual. Дата публикации: 2017-07-12.

Use of halogen compounds for the treatment and prevention of tissue injury and post-intensive care syndrome

Номер патента: EP3801565A1. Автор: Mark B. Roth,Akiko Iwata,Stephen A. Hill,Michael L. MORRISON,John W. LANGSTON,Michael Andrew INSKO. Владелец: Faraday Pharmaceuticals Inc. Дата публикации: 2021-04-14.

Use of halogen compounds for the treatment and prevention of tissue injury and post-intensive care syndrome

Номер патента: CA3102792A1. Автор: Mark B. Roth,Akiko Iwata,Stephen A. Hill,Michael L. MORRISON,John W. LANGSTON,Michael Andrew INSKO. Владелец: Faraday Pharmaceuticals Inc. Дата публикации: 2019-12-12.

Methods for treatment and prevention of vascular disease

Номер патента: WO2016033643A1. Автор: Gemma Alexandra Figtree. Владелец: Gemma Alexandra Figtree. Дата публикации: 2016-03-10.

Insp163 polypeptides for the treatment or prevention of cancer and arthritis

Номер патента: CA2603671A1. Автор: Christine Power,Melanie Yorke-Smith. Владелец: Individual. Дата публикации: 2006-11-02.

Insp163 polypeptides for the treatment or prevention of cancer and arthritis

Номер патента: WO2006114387A3. Автор: Christine Power,Melanie Yorke-Smith. Владелец: Melanie Yorke-Smith. Дата публикации: 2007-05-10.

Insp163 polypeptides for the treatment or prevention of cancer and arthritis

Номер патента: EP1879611A2. Автор: Christine Power,Melanie Yorke-Smith. Владелец: Laboratoires Serono SA. Дата публикации: 2008-01-23.

Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection

Номер патента: CA2838950C. Автор: David Apelian,Thomas H. King. Владелец: Globeimmune Inc. Дата публикации: 2020-10-27.

Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions

Номер патента: US20120040911A1. Автор: Andrew M. Blumenfeld. Владелец: Individual. Дата публикации: 2012-02-16.

Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions

Номер патента: US20120245096A1. Автор: Andrew M. Blumenfeld. Владелец: Allergan Inc. Дата публикации: 2012-09-27.

Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions

Номер патента: CA2596366A1. Автор: Andrew M. Blumenfeld. Владелец: Individual. Дата публикации: 2006-08-10.

Compounds, compositions and methods for the treatment or prevention of hair loss

Номер патента: GB2595502A. Автор: Chopra Sunil. Владелец: Individual. Дата публикации: 2021-12-01.

Faecalibacterium prausnitzii strain cncm i-4573 for the treatment and prevention of clostridioides difficile infection

Номер патента: WO2024133596A1. Автор: Philippe Langella,Jean-Marc CHATEL,Harry SOKOL,Pauline RUFFIE,Benjamin HADIDA,Séverine PECHINE,Camille CAMPIDELLI,Claire JANOIR. Владелец: Exeliom Biosciences. Дата публикации: 2024-06-27.

Oral administration of lactobacillus for the treatment and prevention of urogenital infection

Номер патента: EP1137423A2. Автор: Gregor Reid,Andrew W. Bruce. Владелец: Urex Biotech Inc. Дата публикации: 2001-10-04.

Oral administration of lactobacillus for the treatment and prevention of urogenital infection

Номер патента: WO2000035465A3. Автор: Gregor Reid,ANDREW W BRUCE. Владелец: Urex Biotech Inc. Дата публикации: 2000-12-28.

Methods and compositions for the treatment or prevention of parkinson's disease

Номер патента: WO2016138392A1. Автор: Ole Isacson. Владелец: The McLean Hospital Corporation. Дата публикации: 2016-09-01.

Production of recombinant protein pap 31 for the diagnosis and prevention of Bartonella bacilliformis infection

Номер патента: US7201902B2. Автор: Jesus Gonzalez,Wei-Mei Ching,Laura Hendrix. Владелец: US Department of Navy. Дата публикации: 2007-04-10.

Composition and method for manufacturing nasal spray solution for the treatment and prevention of covid-19

Номер патента: WO2023101616A1. Автор: Praneet OPANASOPIT,Prasopchai PATROJANASOPHON,Kwanputtha ARUNPRASERT,Porawan AUMKLAD. Владелец: Silpakorn University. Дата публикации: 2023-06-08.

Water-soluble antiviral product containing cyperus articulatus, for the treatment and prevention of acquired immunodeficiency syndrome (aids) and the variants thereof

Номер патента: US20120009289A1. Автор: Erick Vidjin' Agnih Gbodossou. Владелец: Individual. Дата публикации: 2012-01-12.

Water-soluble antiviral product containing aframomum melegueta, for the treatment and prevention of acquired immunodeficiency syndrome (aids)

Номер патента: US20120052140A1. Автор: Erick Vidjin' Agnih Gbodossou. Владелец: Individual. Дата публикации: 2012-03-01.

Inhibitor of integrin for the treatment or prevention of tumours

Номер патента: EP2917241A1. Автор: Mauro Biffoni,Ruggero De Maria Marchiano,Tobias Longin HAAS,Lucia RICCI VITIANI. Владелец: Istituti Fisioterapici Ospitalieri IFO. Дата публикации: 2015-09-16.

Compositions and methods for the treatment and prevention of coccidiosis infection

Номер патента: WO2023220275A1. Автор: Andrea Marie BINNEBOSE,Gretel GOMEZ-JIMENEZ,Victor Leonard Joseph NSEREKO WANTATE,Kevin Townsend WATTS. Владелец: CAN TECHNOLOGIES, INC.. Дата публикации: 2023-11-16.

Production of recombinant protein pap 31 for the diagnosis and prevention of bartonella bacilliformis infection

Номер патента: WO2007040546A3. Автор: Jesus Gonzales,Wei-Mei Ching,Laura Hendrix. Владелец: Us Navy. Дата публикации: 2008-09-25.

Production of recombinant protein pap 31 for the diagnosis and prevention of bartonella bacilliformis infection

Номер патента: WO2007040546A2. Автор: Jesus Gonzales,Wei-Mei Ching,Laura Hendrix. Владелец: The United States of America as represented by the Secretary of the Navy. Дата публикации: 2007-04-12.

Production of recombinant protein pap 31 for the diagnosis and prevention of Bartonella bacilliformis infection

Номер патента: US20060067945A1. Автор: Jesus Gonzalez,Wei-Mei Ching,Laura Hendrix. Владелец: US Department of Navy. Дата публикации: 2006-03-30.

Methods of using pigment epithelium derived factor (pedf) for the treatment and prevention of agent-induced gonadal or uterine toxicity

Номер патента: EP3125924A1. Автор: Dana Chuderland,Ruth Shalgi,Hadas BAR-JOSEPH,Keren GOLDBERG,Irit BEN-AHARON,Salomon M. STEMMER. Владелец: Ramot at Tel Aviv University Ltd. Дата публикации: 2017-02-08.

Methods of using pigment epithelium derived factor (pedf) for the treatment and prevention of agent-induced gonadal or uterine toxicity

Номер патента: US20170202916A1. Автор: Dana Chuderland,Ruth Shalgi,Hadas BAR-JOSEPH,Keren GOLDBERG,Irit BEN-AHARON,Salomon M. STEMMER. Владелец: Ramot at Tel Aviv University Ltd. Дата публикации: 2017-07-20.

Bacteriophage-encoded antibacterial enzyme for the treatment and prevention of gingivitis and root surface caries

Номер патента: WO2004058088A3. Автор: Ming Guo,Allan L Delisle,Gerard J Barcak. Владелец: Gerard J Barcak. Дата публикации: 2006-10-12.

Method for the treatment or prevention of osteoarthritis

Номер патента: AU2017249631B2. Автор: Tim Johannes Maria Welting,Marjolein Maria Johanna CARON. Владелец: UNIVERSITEIT MAASTRICHT. Дата публикации: 2024-08-22.

Compositions of aluminum fluoride and methods of use thereof for the treatment and prevention of actinic keratosis and sun-induced damages

Номер патента: US09649336B2. Автор: Avi Dascalu. Владелец: Individual. Дата публикации: 2017-05-16.

Nucleocapsid-specific antibodies and methods for the treatment and prevention of sars-cov-2 infection therewith

Номер патента: US20240218056A1. Автор: VIII Pablo Penaloza-MacMaster. Владелец: Northwestern University. Дата публикации: 2024-07-04.

Compositions and methods for the treatment or prevention of tuberculosis

Номер патента: US20190151429A1. Автор: Zhimin Guo,Thomas H. King,Ian M. Orme. Владелец: Globeimmune Inc. Дата публикации: 2019-05-23.

Vaccine compositions and methods for the treatment and prevention of urinary tract infections

Номер патента: US20240226260A9. Автор: Soman Abraham,Jianxuan Wu. Владелец: Duke University. Дата публикации: 2024-07-11.

Composition comprising pasteurized akkermansia muciniphila for the treatment or prevention of gut contractility disorders, in particular duodenal contraction amplitude disorder

Номер патента: WO2023020831A1. Автор: Patrice Cani,Amandine BROCHOT. Владелец: The Akkermansia Company. Дата публикации: 2023-02-23.

Compositions and methods for the treatment and prevention of radiation dermatitis

Номер патента: EP3349719A1. Автор: June Jacobs. Владелец: June Jacobs Laboratories Llc. Дата публикации: 2018-07-25.

Biopolymer compositions for the treatment and prevention of gastric ulcers

Номер патента: US20230330156A1. Автор: Scott P. Noel,William Brian Austin,Alex Greene,John Kirk Shumpert. Владелец: Sidr LLC. Дата публикации: 2023-10-19.

Compositions and methods for the treatment or prevention of oxalate-related disorders

Номер патента: EP3468572A1. Автор: Anna Sjögren,Elisabeth LINDNER,Maria Akerman,Orla MCCALLION. Владелец: OXTHERA INTELLECTUAL PROPERTY AB. Дата публикации: 2019-04-17.

Compositions and methods for the treatment or prevention of oxalate-related disorders

Номер патента: US20190125807A1. Автор: Anna Sjögren,Elisabeth LINDNER,Maria Akerman,Orla MCCALLION. Владелец: OXTHERA INTELLECTUAL PROPERTY AB. Дата публикации: 2019-05-02.

Methods for the treatment and prevention of asbestos-related diseases

Номер патента: EP3223828A1. Автор: Anthony George,Jason RAVASINI. Владелец: UNIVERSITY OF TECHNOLOGY SYDNEY. Дата публикации: 2017-10-04.

Methods for the Treatment and Prevention of Asbestos-Related Diseases

Номер патента: US20170258829A1. Автор: Anthony George,Jason RAVASINI. Владелец: Technology Sydney (abn 77 257 686 961) Of Po Box 123, University of. Дата публикации: 2017-09-14.

Methods for the treatment and prevention of asbestos-related diseases

Номер патента: WO2016081993A1. Автор: Anthony George,Jason RAVASINI. Владелец: UNIVERSITY OF TECHNOLOGY, SYDNEY. Дата публикации: 2016-06-02.

Methods for the treatment and prevention of asbestos-related diseases

Номер патента: AU2015354399B2. Автор: Anthony George,Jason RAVASINI. Владелец: Bio Latem Tech Pty Ltd. Дата публикации: 2020-05-14.

Formulations comprising heparan sulfate for the treatment and prevention of viral infections caused by orthocoronaviridae

Номер патента: EP4431103A1. Автор: Celestino Ronchi,Federica Ronchi. Владелец: Zona Swiss Sa. Дата публикации: 2024-09-18.

Composition comprising pasteurized akkermansia muciniphila for the treatment or prevention of gut contractility disorders, in particular duodenal contraction amplitude disorder

Номер патента: US20240350560A1. Автор: Patrice Cani,Amandine BROCHOT. Владелец: Akkermansia Co. Дата публикации: 2024-10-24.

Compositions and methods for the treatment or prevention of hepatitis B virus infection

Номер патента: US09943591B2. Автор: David Apelian,Zhimin Guo,Claire Coeshott,Thomas H. King. Владелец: Globeimmune Inc. Дата публикации: 2018-04-17.

Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM

Номер патента: US09913903B2. Автор: David A. Ross,Thomas Barnett. Владелец: Grifols Worldwide Operations Ltd. Дата публикации: 2018-03-13.

Compositions and methods for the treatment and prevention of Ebp pilus-related diseases

Номер патента: US09839682B2. Автор: Scott J. Hultgren,Michael G. Caparon,Jerome Pinkner,Ana L. Flores-Mireles. Владелец: Washington University in St Louis WUSTL. Дата публикации: 2017-12-12.

Compositions and methods for the treatment or prevention of human immunodeficiency virus infection

Номер патента: US09782473B2. Автор: David Apelian,Thomas H. King. Владелец: Globeimmune Inc. Дата публикации: 2017-10-10.

Compositions and methods for the treatment or prevention of hepatitis B virus infection

Номер патента: US09428556B2. Автор: David Apelian,Zhimin Guo,Claire Coeshott,Thomas H. King. Владелец: Globeimmune Inc. Дата публикации: 2016-08-30.

Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus

Номер патента: WO2017031404A1. Автор: Luis MARTINEZ-SOBRIDO,Aitor NOGALES-GONZALEZ,Colin PARRISH. Владелец: CORNELL UNIVERSITY. Дата публикации: 2017-02-23.

Peptid, obtained from hsp70, a pharmaceutical composition for the treatment or prevention of cancer, containing such peptid, immune response inductor and method for obtaining antigen-presenting path

Номер патента: RU2684911C2. Автор: Кодзи ТАМАДА,Томоя МИЯКАВА,Масааки ОКА,Сёити ХАДЗАМИ,Кейко УДАКА. Владелец: Ситлимик Инк.. Дата публикации: 2019-04-16.

Method of producing biogenic stimulator for the treatment and prevention of diseases of farm animals

Номер патента: RU2648466C1. Автор: Людмила Ивановна Василенко,Алла Егоровна Куцова,Андрей Васильевич Гребенщиков,Артем Игоревич Голубев. Владелец: Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный университет инженерных технологий" (ФГБОУ ВО "ВГУИТ"). Дата публикации: 2018-03-26.

Water-soluble remedy for the treatment and prevention of hoof necrobacteriosis

Номер патента: RU2769227C1. Автор: Ирина Евгеньевна Грачева,Светлана Владимировна Барышева,Виктория Николаевна Корчагова,Станислав Александрович Фомин,Родион Степанович Лищук. Владелец: Общество с ограниченной ответственностью "КОР4". Дата публикации: 2022-03-29.

Methods and compositions for the treatment and prevention of intermittent claudication or alzheimer's disease

Номер патента: WO2003094909A2. Автор: Eyal S. Ron. Владелец: Enos Pharmaceuticals, Inc.. Дата публикации: 2003-11-20.

Np1 activity regulating elements which can be used in the production of drugs for the treatment or prevention of human neurodegenerative diseases, resulting drugs and use thereof

Номер патента: EP2224002A1. Автор: Ramón TRULLAS OLIVA,Marta Enguita Martinez,Mº Alba ABAD FERNANDEZ. Владелец: Consejo Superior de Investigaciones Cientificas CSIC. Дата публикации: 2010-09-01.

Peptide derivatives for the treatment and prevention of asthma and the like

Номер патента: CA1335662C. Автор: Masakuni Okuhara,Tohru Kino,Satoshi Okada,Motoaki Nishikawa,Masami Ezaki,Sumio Kiyoto,Shigehiro Takase,Nobuharu Shigematsu. Владелец: Fujisawa Pharmaceutical Co Ltd. Дата публикации: 1995-05-23.

Bacteriophage-encoded enzymes for the treatment and prevention of dental caries and periodontal diseases

Номер патента: US20040234461A1. Автор: Allan Delisle. Владелец: Individual. Дата публикации: 2004-11-25.

Natural formulation for the treatment and prevention of depression, containing st john's wort and derivatives of dihydro- and tetrahydrofolic acid

Номер патента: CA2348693C. Автор: Herwig Buchholz,Jerzy Meduski,Angela Dudda. Владелец: Merck Patent GmBH. Дата публикации: 2008-07-15.

Process and composition for the remineralization and prevention of demineralization of animal teeth including humans

Номер патента: US4397837A. Автор: Helmut Raaf,Helmut Harth,Helmar R. Wagner. Владелец: Blendax Werke R Schneider and Co GmbH. Дата публикации: 1983-08-09.

Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus

Номер патента: AU2016308917A1. Автор: Luis MARTINEZ-SOBRIDO,Aitor NOGALES-GONZALEZ,Colin PARRISH. Владелец: CORNELL UNIVERSITY. Дата публикации: 2018-03-15.

Feed additive compositions comprising microbial fermentate for the treatment and prevention of pathogen associated disease

Номер патента: WO2023220288A1. Автор: Rachel BALDER,Andrea Marie BINNEBOSE,Gretel GOMEZ-JIMENEZ,Victor Leonard Joseph NSEREKO WANTATE,Kevin Townsend WATTS. Владелец: CAN TECHNOLOGIES, INC.. Дата публикации: 2023-11-16.

Compositions and methods for the treatment and prevention of clostridium associated disease

Номер патента: WO2023220272A1. Автор: Adam T. ZARTH,Andrea Marie BINNEBOSE,Gretel GOMEZ-JIMENEZ,Victor Leonard Joseph NSEREKO WANTATE,Kevin Townsend WATTS. Владелец: CAN TECHNOLOGIES, INC.. Дата публикации: 2023-11-16.

Faecalibacterium prausnitzii strain cncm 1-4573 for the treatment and prevention of gastrointestinal inflammation

Номер патента: SG11201806361PA. Автор: Philippe Langella,Florian CHAIN,Harry SOKOL,Humaran Luis Bermudez,Rosique Rebeca Martin. Владелец: Univ Sorbonne. Дата публикации: 2018-08-30.

Method for the treatment or prevention of osteoarthritis

Номер патента: US11872264B2. Автор: Tim Johannes Maria Welting,Marjolein Maria Johanna CARON. Владелец: Chondropeptix BV. Дата публикации: 2024-01-16.

Lachnospiraceae spp and ruminococcus lactaris strains for the treatment and prevention of alzheimer's disease and aging

Номер патента: WO2023222924A1. Автор: Christiane Bouchier,Damien REI,Dominique CLERMONT,Gérald TOUAK. Владелец: INSTITUT PASTEUR. Дата публикации: 2023-11-23.

Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative deseases

Номер патента: EP1648503A2. Автор: Joseph S. Beckman,Pedro Alzari,Luis Hector Barbeito,Alvaro G. Dept. of Phys. & Biophysics ESTEVEZ,Mariana Inst. Inv. Biologicas Clemente E. PEHAR,Maria Patricia Departamento de Histologia CASSINA. Владелец: Instituto De Investigaciones Biologicas Clemente Estable (iibce). Дата публикации: 2006-04-26.

CMI sequences as an early marker for the future development of cancer, atherosclerosis, diabetes and diseases of the CNS and as a target for the treatment and prevention of these diseases

Номер патента: AU2020210852A1. Автор: Harald Zur Hausen,Ethel-Michele De Villiers-Zur Hausen,Karin Gunst,Timo Bund. Владелец: Deutsches Krebsforschungszentrum DKFZ. Дата публикации: 2021-07-08.

Cmi sequences as an early marker for the future development of cancer, atherosclerosis, diabetes and diseases of the cns and as a target for the treatment and prevention of these diseases

Номер патента: EP3914735A1. Автор: Harald Zur Hausen,Ethel-Michele De Villiers-Zur Hausen,Karin Gunst,Timo Bund. Владелец: Deutsches Krebsforschungszentrum DKFZ. Дата публикации: 2021-12-01.

Cmi sequences as an early marker for the future development of cancer, atherosclerosis, diabetes and diseases of the cns and as a target for the treatment and prevention of these diseases

Номер патента: CA3124032A1. Автор: Harald Zur Hausen,Ethel-Michele De Villiers-Zur Hausen,Karin Gunst,Timo Bund. Владелец: Deutsches Krebsforschungszentrum DKFZ. Дата публикации: 2020-07-30.

Cmi sequences as an early marker for the future development of cancer, atherosclerosis, diabetes and diseases of the cns and as a target for the treatment and prevention of these diseases

Номер патента: WO2020152334A9. Автор: Harald Zur Hausen,Ethel-Michele De Villiers-Zur Hausen,Karin Gunst,Timo Bund. Владелец: Deutsches Krebsforschungszentrum Stiftung des offentlichen Rechts. Дата публикации: 2021-10-14.

Compounds, compositions and methods for the treatment or prevention of hair loss

Номер патента: EP4157310A1. Автор: Sunil Chopra. Владелец: Individual. Дата публикации: 2023-04-05.

Anti-ergotypic t cells for the treatment or prevention of autoimmune diseases and methods of use thereof

Номер патента: WO1990014068A3. Автор: Irun Robert Cohen,Ansgar W Lohse. Владелец: Ansgar W Lohse. Дата публикации: 1991-02-07.

Myelin oligodendrocyte glycoprotein-specific peptide for the treatment or prevention of multiple sclerosis

Номер патента: US20230312670A1. Автор: David J. Baylink,Xiaolei Tang. Владелец: LOMA LINDA UNIVERSITY. Дата публикации: 2023-10-05.

Compositions and methods for the treatment and prevention of campylobacter infection

Номер патента: WO2023220279A1. Автор: Andrea Marie BINNEBOSE,Gretel GOMEZ-JIMENEZ,Victor Leonard Joseph NSEREKO WANTATE,Kevin Townsend WATTS. Владелец: CAN TECHNOLOGIES, INC.. Дата публикации: 2023-11-16.

Agent and method for the treatment and prevention of tse and method for the production of said agent

Номер патента: US20060281676A1. Автор: Detlev Riesner,Dieter Willbold,Carsten Korth,Michael Wolff,Jorg Smolinski,Karen Hanel. Владелец: FORSCHUNGSZENTRUM JUELICH GMBH. Дата публикации: 2006-12-14.

Methods for the treatment and prevention of infection using anti-selectin agents

Номер патента: WO2006083322A3. Автор: Robert F Bargatze,Mark A Jutila,Aiyappa Palecanda,Pati M Glee. Владелец: Pati M Glee. Дата публикации: 2007-01-11.

Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions

Номер патента: EP1846018A1. Автор: Andrew M. Blumenfeld. Владелец: Allergan Inc. Дата публикации: 2007-10-24.

Method for the treatment or prevention of osteoarthritis.

Номер патента: AU2017249629B2. Автор: Tim Johannes Maria Welting,Marjolein Maria Johanna CARON. Владелец: UNIVERSITEIT MAASTRICHT. Дата публикации: 2024-05-16.

Methods and compositions for the treatment or prevention of parkinson's disease

Номер патента: EP3261446A1. Автор: Ole Isacson. Владелец: Mclean Hospital Corp. Дата публикации: 2018-01-03.

Methods and compounds for the treatment or prevention of severe influenza

Номер патента: EP3478322A1. Автор: Paul Andrew Whittaker,Neil Edward TORBETT. Владелец: hVivo Services Ltd. Дата публикации: 2019-05-08.

Bacteriophage-encoded antibacterial enzyme for the treatment and prevention of gingivitis and root surface caries

Номер патента: WO2004058088A8. Автор: Ming Guo,Allan L Delisle,Gerard J Barcak. Владелец: Gerard J Barcak. Дата публикации: 2007-02-01.

Inhibitor of integrin for the treatment or prevention of tumours

Номер патента: US20150315276A1. Автор: Mauro Biffoni,Ruggero De Maria Marchiano,Tobias Longin HAAS,Lucia RICCI VITIANI. Владелец: Istituti Fisioterapici Ospitalieri IFO. Дата публикации: 2015-11-05.

Methods for the treatment and prevention of infection using anti-selectin agents

Номер патента: EP1784221A2. Автор: Pati M. Glee,Robert F. Bargatze,Aiyappa Palecanda,Mark A. Montana State University JUTILA. Владелец: Ligocyte Pharmaceuticals Inc. Дата публикации: 2007-05-16.

Faecalibacterium prausnitzii strain cncm i-4573 for the treatment and prevention of clostridioides difficile infection

Номер патента: EP4389134A1. Автор: Philippe Langella,Jean-Marc CHATEL,Harry SOKOL,Pauline RUFFIE,Benjamin HADIDA,Séverine PECHINE,Camille CAMPIDELLI,Claire JANOIR. Владелец: Exeliom Biosciences. Дата публикации: 2024-06-26.

Method for the treatment or prevention of pain or excessive neuronal activity or epilepsy

Номер патента: EP3519576A1. Автор: Gregory Weir,David Laurence Harvey BENNETT,John Mansfield DAWES. Владелец: Oxford University Innovation Ltd. Дата публикации: 2019-08-07.

Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders

Номер патента: US7491390B2. Автор: Che-Leung Law,Alan F. Wahl,Julie McEarchern. Владелец: Seattle Genetics Inc. Дата публикации: 2009-02-17.

Anti-cd70 antibody and its use for the treatment and prevention of cancer and immune disorders

Номер патента: CA2583208C. Автор: Che-Leung Law,Alan F. Wahl,Julie McEarchern. Владелец: Seattle Genetics Inc. Дата публикации: 2015-08-25.

Halogenated pyrimidine 3-oxide derivatives, their use for the treatment and prevention of hair loss and for stimulating its regrowth

Номер патента: US5132106A. Автор: Alex Junino,Jacqueline Dumats,Michel Hocquaux,Remy Tuloup,Quintino Gaetani. Владелец: LOreal SA. Дата публикации: 1992-07-21.

Carbamoyl phosphate synthatase-1 for the treatment and prevention of internal tissue injury

Номер патента: US20220160846A1. Автор: Min-jung PARK,Bishr Omary. Владелец: University of Michigan. Дата публикации: 2022-05-26.

METHOD FOR THE TREATMENT OR PREVENTION OF INFECTION-RELATED IMMUNE CONDITIONS USING A COMPOSITION COMPRISING IgM

Номер патента: US20230077855A1. Автор: David A. Ross,Thomas Barnett. Владелец: Grifols Worldwide Operations Ltd. Дата публикации: 2023-03-16.

Gut-selective sequestering agents for the treatment and prevention of autism and related disorders

Номер патента: CA3095724C. Автор: David H. Donabedian,Anthony Stewart CAMPBELL. Владелец: Axial Therapeutics Inc. Дата публикации: 2023-04-18.

METHODS, COMPOSITIONS, AND FOOD ADDITIVES COMBINING A F4/F18 VACCINE AND β-MANNANASE AND/OR A PROBIOTIC FOR THE TREATMENT AND PREVENTION OF ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC) IN PIGS

Номер патента: WO2023172440A1. Автор: Pedro Sanchez URIBE. Владелец: Elanco US Inc.. Дата публикации: 2023-09-14.

Compositions and methods for the treatment and prevention of Ebp pilus-related diseases

Номер патента: US10449242B2. Автор: Scott J. Hultgren,Michael G. Caparon,Jerome Pinkner,Ana L. Flores-Mireles. Владелец: Washington University in St Louis WUSTL. Дата публикации: 2019-10-22.

Vanadyl sulfate compositions and methods of use therefor for the treatment and prevention of aging-related diseases and cancer

Номер патента: WO2023225268A1. Автор: Jing Chen. Владелец: The University of Chicago. Дата публикации: 2023-11-23.

Gut-selective sequestering agents for the treatment and prevention of autism and related disorders

Номер патента: US20230364135A1. Автор: David H. Donabedian,Anthony Stewart CAMPBELL. Владелец: Axial Biotherapeutics Inc. Дата публикации: 2023-11-16.

Rab3b for the treatment and prevention of parkinson's disease

Номер патента: WO2009140649A8. Автор: Ole Isacson,Chee Yeun Chung. Владелец: Mclean Hosptial. Дата публикации: 2010-03-18.

Methods and compositions for the treatment and prevention of staphylococcus aureus infections

Номер патента: EP1037650A1. Автор: Susan C. Wright,James W. Larrick,Naomi Balaban. Владелец: Panorama Research Inc. Дата публикации: 2000-09-27.

Combination of inhaled antibodies and immunomodulatory agents for the treatment or prevention of respiratory infections

Номер патента: US20230372416A1. Автор: Muriel Thomas,Thomas SECHER,Nathalie HEUZE-VOURC'H. Владелец: Universite de Tours. Дата публикации: 2023-11-23.

Faecalibacterium prausnitzii strain cncm 1-4573 for the treatment and prevention of gastrointestinal inflammation

Номер патента: US20190030089A1. Автор: Philippe Langella,Florian CHAIN,Harry SOKOL,Luis Bermudez Humaran,Rebeca Martin Rosique. Владелец: Assistance Publique Hopitaux de Paris APHP. Дата публикации: 2019-01-31.

Faecalibacterium prausnitzii strain cncm i-4573 for the treatment and prevention of gastrointestinal inflammation

Номер патента: NZ744528A. Автор: Philippe Langella,Florian CHAIN,Harry SOKOL,Humaran Luis Bermudez,Rosique Rebeca Martin. Владелец: Univ Sorbonne. Дата публикации: 2020-02-28.

COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF Ebp PILUS-RELATED DISEASES

Номер патента: US20160074498A1. Автор: Scott J. Hultgren,Michael G. Caparon,Jerome Pinkner,Ana L. Flores-Mireles. Владелец: Washington University in St Louis WUSTL. Дата публикации: 2016-03-17.

COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF Ebp PILUS-RELATED DISEASES

Номер патента: US20180055923A1. Автор: Scott J. Hultgren,Michael G. Caparon,Jerome Pinkner,Ana L. Flores-Mireles. Владелец: Washington University in St Louis WUSTL. Дата публикации: 2018-03-01.

Compositions and methods for the treatment or prevention of tuberculosis

Номер патента: US20160213767A1. Автор: Zhimin Guo,Thomas H. King,Ian M. Orme. Владелец: Globeimmune Inc. Дата публикации: 2016-07-28.

Vaccine compositions and methods for the treatment and prevention of urinary tract infections

Номер патента: US20240131135A1. Автор: Soman Abraham,Jianxuan Wu. Владелец: Duke University. Дата публикации: 2024-04-25.

Composition comprising pasteurized akkermansia muciniphila for the treatment or prevention of gut contractility disorders, in particular duodenal contraction amplitude disorder

Номер патента: EP4387637A1. Автор: Patrice Cani,Amandine BROCHOT. Владелец: Akkermansia Co. Дата публикации: 2024-06-26.

Use of serrulatan diterpenes in medicine

Номер патента: RU2762568C2. Автор: Колин Чарльз ДЬЮК,Руджи Киокаджи ДЬЮК,Ван Хоан ТРАН. Владелец: Кайнан Дьюк АйПи, ЭлЭлСи. Дата публикации: 2021-12-21.

Compositions and methods of use of phorbal esters for the treatment of stroke

Номер патента: US09550722B2. Автор: Zheng Tao Han,Hung-Fong Chen. Владелец: Biosuccess Biotech Co Ltd. Дата публикации: 2017-01-24.

Use of cyanoglucosides and pharmaceutical formulations thereof in the treatment of diabetes

Номер патента: WO2018000057A1. Автор: Wagner Vilegas,Emerson Ferreira Queiroz,Luiz Leonardo Saldanha,Anne Ligia Dokkedal Bosqueiro,Jose Roberto Bosqueiro,Nathalia Aparecida De Paula Camaforte Henriques,Priscilla Maria Ponce Vareda,Laurence MARCOURT,Jean-Luc WOLFENDER. Владелец: Universidade Estadual Paulista Julio De Mesquita Filho. Дата публикации: 2018-01-04.

Uses of compositions containing a roasted extract and xanthohumol

Номер патента: US09782362B2. Автор: Werner Back,Sascha Wunderlich,Achim Zuercher. Владелец: Ta-Xan Ag. Дата публикации: 2017-10-10.

Use of olfactory receptor or13a1 antagonists in the treatment of lymphomas

Номер патента: WO2023169996A1. Автор: Francesco Bertoni,Andrea Cavalli,Giulio Sartori,Luciano CASCIONE,Milos MATKOVIC. Владелец: Fondazione Per L'istituto Di Ricerca In Biomedicina (Irb). Дата публикации: 2023-09-14.

Compositions and methods of use of phorbol esters for the treatment of stroke

Номер патента: CA2862301C. Автор: Zheng Tao Han,Hung-Fong Chen. Владелец: Biosuccess Biotech Co Ltd. Дата публикации: 2020-10-20.

Compositions and methods of use of phorbol esters for the treatment of stroke

Номер патента: US20170087112A1. Автор: Zheng Tao Han,Hung-Fong Chen. Владелец: Biosuccess Biotech Co Ltd. Дата публикации: 2017-03-30.

Compositions And Methods Of Use Of Phorbol Esters For the Treatment Of Stroke

Номер патента: US20150071908A1. Автор: Zheng Tao Han,Hung-Fong Chen. Владелец: Biosuccess Biotech Co Ltd. Дата публикации: 2015-03-12.

Compositions And Methods Of Use Of Phorbol Esters For the Treatment Of Stroke

Номер патента: US20160237020A9. Автор: Zheng Tao Han,Hung-Fong Chen. Владелец: Biosuccess Biotech Co Ltd. Дата публикации: 2016-08-18.

Compositions And Methods Of Use Of Phorbol Esters For Treatment of Stroke

Номер патента: US20200207697A1. Автор: Richard L. Chang. Владелец: Individual. Дата публикации: 2020-07-02.

Compositions and methods of use of Phorbol Esters for treatment of stroke

Номер патента: US20150376109A1. Автор: Richard L. Chang. Владелец: Individual. Дата публикации: 2015-12-31.

Compositions And Methods Of Use Of Phorbol Esters For Treatment of Stroke

Номер патента: US20150197478A1. Автор: Richard L. Chang. Владелец: Individual. Дата публикации: 2015-07-16.

Methods, compositions and modes of delivery for the treatment of emphysema using 13-cis-retinoic acid

Номер патента: US20020049252A1. Автор: Paula Belloni. Владелец: Syntex USA LLC. Дата публикации: 2002-04-25.

Use of antagonists of cxcl13 or cxcr5 for treating wounds or fibrotic diseases

Номер патента: EP2018179A1. Автор: Neil French,Mark William James Ferguson,Sharon O'kane,Nicholas Occleston,Darren Hodgson. Владелец: Renovo Ltd. Дата публикации: 2009-01-28.

Use of an LTB4 antagonist for the treatment or prevention of diseases caused by increased expression of mucin genes

Номер патента: US6576669B2. Автор: Birgit Jung,Ralf Anderskewitz,Franz Birke,Hans Michael Jennewein,Christopher J. Montague Meade. Владелец: Boehringer Ingelheim Pharma GmbH and Co KG. Дата публикации: 2003-06-10.

Polymers obtained by the reaction of a phenolic compound and a carbonyl compound for use in the treatment or prevention of a condition associated with one or more protease(s)

Номер патента: WO2023051925A1. Автор: Ulrich Mrowietz,Günther SCHERR. Владелец: Christian-Albrechts-Universität zu Kiel. Дата публикации: 2023-04-06.

Polymers obtained by the reaction of a phenolic compound and a carbonyl compound for use in the treatment or prevention of a condition associated with one or more protease(s)

Номер патента: WO2023052520A1. Автор: Günter Scherr,Ulrich Mrowietz. Владелец: Christian-Albrechts-Universität zu Kiel. Дата публикации: 2023-04-06.

Use of an LTB4 antagonist for the treatment or prevention of diseases caused by increased expression of mucin genes

Номер патента: US20020137792A1. Автор: Birgit Jung,Christopher Meade,Ralf Anderskewitz,Franz Birke,Hans Jennewein. Владелец: Individual. Дата публикации: 2002-09-26.

Pharmaceutical compositions and therapeutic applications for the use of a novel vitamin B12 derivative, N-acetyl-L-cysteinylcobalamin

Номер патента: US20080076733A1. Автор: John Williams,Nicola Brasch,Catherine Birch. Владелец: University of Chester. Дата публикации: 2008-03-27.

Drug for the prevention and treatment of vaginitis in cows

Номер патента: RU2751876C1. Автор: Анна Борисовна Шиповская,Наталья Олеговна Гегель,Виталий Николаевич Харламов,Заур Юрьевич Хапцев,Роман Владимирович Радионов. Владелец: Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский национальный исследовательский государственный университет имени Н.Г. Чернышевского". Дата публикации: 2021-07-19.

Use of (r)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs

Номер патента: CA2432432C. Автор: Francesco Colotta,Riccardo Bertini,Roberto Novellini. Владелец: Dompe PhaRMa SpA. Дата публикации: 2008-03-25.

Use of cyanoglucosides and pharmaceutical formulations thereof in the treatment of diabetes

Номер патента: US20190160085A1. Автор: Wagner Vilegas,Emerson Ferreira Queiroz,Luiz Leonardo Saldanha,Anne Ligia Dokkedal Bosqueiro,Jose Roberto Bosqueiro,Nathalia Aparecida De Paula Camaforte Henriques,Priscilla Maria Ponce Vareda,Laurence MARCOURT,Jean-Luc WOLFENDER. Владелец: Universidade Estadual Paulista Julio de Mesquita Filho UNESP. Дата публикации: 2019-05-30.

Use of bacterioruberins and glycosyl derivatives thereof to prevent and treat diseases involving dysregulated protein aggregation, such as neurodegenerative diseases

Номер патента: CA3202415A1. Автор: Jean-Noel Thorel,Miroslav Radman. Владелец: Naos Institute of Life Science SAS. Дата публикации: 2022-06-23.

Use of parabulin for targeting protozoan tubulin for the inhibition of protozoan replication

Номер патента: US20230364041A1. Автор: Ashwani Sharma,Michel Steinmetz,Natacha Gaillard. Владелец: Scherrer Paul Institut. Дата публикации: 2023-11-16.

Polymers obtained by the reaction of a phenolic compound and a carbonyl compound for use in the treatment or prevention of a condition associated with one or more protease(s)

Номер патента: EP4408440A1. Автор: Günter Scherr,Ulrich Mrowietz. Владелец: Christian Albrechts Universitaet Kiel. Дата публикации: 2024-08-07.

Use of parabulin for targeting protozoan tubulin for the inhibition of protozoan replication

Номер патента: EP4225287A1. Автор: Ashwani Sharma,Michael Steinmetz,Natacha OLIERIC. Владелец: Scherrer Paul Institut. Дата публикации: 2023-08-16.

Use of parabulin for targeting protozoan tubulin for the inhibition of protozoan replication

Номер патента: WO2022073759A1. Автор: Ashwani Sharma,Natacha OLIERIC. Владелец: PAUL SCHERRER INSTITUT. Дата публикации: 2022-04-14.

Use of parabulin for targeting protozoan tubulin for the inhibition of protozoan replication

Номер патента: EP3981396A1. Автор: Ashwani Sharma,Natacha OLIERIC. Владелец: Scherrer Paul Institut. Дата публикации: 2022-04-13.

Uses of hibiscus, in particular pharmaceutical uses

Номер патента: US09492489B2. Автор: Yohan Rolland,Charles Duval. Владелец: Naturex SA. Дата публикации: 2016-11-15.

Sulfonamides for the prevention of diabetes

Номер патента: CA2776021C. Автор: Marcello Allegretti,Luisa Daffonchio,Lorenzo Piemonti. Владелец: Dompe Farmaceutici SpA. Дата публикации: 2017-08-01.

Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration

Номер патента: EP1200100A1. Автор: Goran Piljac,Tamara Stipcevic,Tihana Piljac,Jasenka Piljac,Tatjana Dujmic. Владелец: Paradigm Biomedical Inc. Дата публикации: 2002-05-02.

Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration

Номер патента: EP1200100A4. Автор: Goran Piljac,Tamara Stipcevic,Tihana Piljac,Jasenka Piljac,Tatjana Dujmic. Владелец: Individual. Дата публикации: 2004-05-19.

Formulations for topic mucosal and/or oral systemic administrations containing a mixture based on lactoferrin, more effective in iron uptake, for the prevention and treatment of various pathologies

Номер патента: EP4216989A1. Автор: Piera Valenti,Rosalba Paesano. Владелец: Microbo Srl. Дата публикации: 2023-08-02.

Use of 8-prenylflavanones for anti-angiogenesis therapy and for fibrinolytic therapy

Номер патента: WO2003094910A1. Автор: Wolf-Dieter Schleuning,Michael Pepper. Владелец: Schering Aktiengesellschaft. Дата публикации: 2003-11-20.

Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases

Номер патента: EP1392327A2. Автор: Ognjen Culic,Vesna Erakovic,Michael Parnham. Владелец: Pliva Farmaceutika dd. Дата публикации: 2004-03-03.

Compositions comprising selenium and use of same for the treatment and prevention of disease or conditions associated with mitochondrial dysfunction

Номер патента: US09833486B2. Автор: Ronan Power,Zi-Jian LAN,Alexandros Yiannikouris,Stefan Kwiatkowski,Casey Egan,Rijin Xiao,Jackson Colleen LEWIS. Владелец: Alltech Corp. Дата публикации: 2017-12-05.

Uses of compositions containing a roasted extract and xanthohumol

Номер патента: CA2880108C. Автор: Werner Back,Achim ZÜRCHER,Sascha Wunderlich. Владелец: Ta-Xan Ag. Дата публикации: 2021-05-18.

Uses of compositions containing a roasted extract and xanthohumol

Номер патента: EP2877167A1. Автор: Werner Back,Achim ZÜRCHER,Sascha Wunderlich. Владелец: TA XAN AG. Дата публикации: 2015-06-03.

Use of3-amino chromans or thiocromans for the treatment of prostate cancer

Номер патента: WO2005039560A1. Автор: Per-Anders Abrahamsson. Владелец: AstraZeneca AB. Дата публикации: 2005-05-06.

Use of oligosaccharides in the prevention and treatment of the aging of tissues

Номер патента: AU699585B2. Автор: Ladislas Robert,Alexandre Robert,Elemer Moczar. Владелец: ROC SA. Дата публикации: 1998-12-10.

Stat3 inhibition for treatment and prevention of human coronavirus infection

Номер патента: US20230192786A1. Автор: Richard Gabriel,Hector J. Gomez. Владелец: Glg Pharma Llc. Дата публикации: 2023-06-22.

Use of aica riboside compounds for the treatment and prevention of tissue damage due to decreased blood flow

Номер патента: WO1993006833A1. Автор: Harry Edward Gruber,Kevin Michael Mullane,Paul Kevin Laikind. Владелец: Gensia Pharmaceuticals, Inc.. Дата публикации: 1993-04-15.

Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II

Номер патента: US09603823B2. Автор: Samuel T. Henderson. Владелец: Accera Inc. Дата публикации: 2017-03-28.

Use of polyunsaturated fatty acids and flavonoids, as active agent for simultaneous, sequential or separate use for the preparation of a composition for the prevention and/or treatment of headache

Номер патента: FR2912918A1. Автор: Denis Marin,Jean Christophe Anton,Serge Sonie. Владелец: Persee Medica SAS. Дата публикации: 2008-08-29.

USE OF 5-METHYL-1,3-BENZEDIOL OR ITS DERIVATIVES IN THE PRODUCTION OF MEDICINE AND FUNCTIONAL FOOD FOR THE TREATMENT OR PREVENTION OF DEPRESSION

Номер патента: RU2010106275A. Автор: Линь СЮЙ,Цзюнь ЛУ,Цзюнь ЧЖОУ,Юн Шэнь,Цзицзюнь ЧЭНЬ,Жунжун МАО,Мэн ТЯНЬ,Цисинь ЧЖОУ,Сюемэй ЧЖАН,Чжиюн ЦЗЯН,Айсюе ЦЗО,Цзицзюнь ЧЭНЬ (CN),Линь СЮЙ (CN),Цзюнь ЧЖОУ (CN),Цзюнь ЛУ (CN),Жунжун МАО (CN),Мэн ТЯНЬ (CN),Цисинь ЧЖОУ (CN),Сюемэй ЧЖАН (CN),Юн ШЭНЬ (CN),Чжиюн ЦЗЯН (CN),Айсюе ЦЗО (CN). Владелец: Куньмин Цзинбяо Биосайнсиз Р & Д Ко., Лтд. (Cn). Дата публикации: 2011-09-10.

Use of natamycin for the control and prevention of poultry aspergillosis

Номер патента: WO1993000911A1. Автор: Bruce Dexter King. Владелец: Conagra, Inc.. Дата публикации: 1993-01-21.

Dosage forms and therapeutic uses of l-4-chlorokynurenine

Номер патента: AU2022221382B2. Автор: Allen E. CATO,Jack S. HICKLIN,Ralph H Snodgrass. Владелец: Vistagen Therapeutics Inc. Дата публикации: 2024-09-19.

Formulations for topic mucosal and/or oral systemic administrations containing a mixture based on lactoferrin, more effective in iron uptake, for the prevention and treatment of various pathologies

Номер патента: WO2022064357A1. Автор: Piera Valenti,Rosalba Paesano. Владелец: Microbo S.R.L.. Дата публикации: 2022-03-31.

Use of carotenoid of microbial origin that affects composition of intestinal microorganisms

Номер патента: RU2759600C2. Автор: Сэм ПОССЕМИРС,Синди ДЁЙСБЮРГ,Ирис ПИНЕЙРО,Селин БОЛКА,Питер ВАН ДЕН АББЕЛЕ,Массимо МАРЦОРАТИ. Владелец: Майкробиал Рисерч Менеджмент Хелс НВ. Дата публикации: 2021-11-16.

Use of cannabinoids in combination with an anti-psychotic medicament

Номер патента: CA2708921C. Автор: Kenji Maeda,Geoffrey Guy,Tetsuro Kikuchi,Philip Robson,Colin Stott. Владелец: Otsuka Pharmaceutical Co Ltd. Дата публикации: 2018-03-20.

Monosaccharide-based compounds for the treatment of proliferative and inflammatory dermatological diseases

Номер патента: WO2012097052A3. Автор: Waldemar Priebe. Владелец: Intertech Bio, Llc. Дата публикации: 2012-09-07.

Use of natamycin for the control and prevention of poultry aspergillosis

Номер патента: AU2338192A. Автор: Bruce Dexter King. Владелец: EI Du Pont de Nemours and Co. Дата публикации: 1993-02-11.

Use of 2-hydroxy or 2-acetyloxy-4-trifluoromethylbenzoic acid derivatives as an agent for the treatment and prevention of mild cognitive impairment

Номер патента: AU2002352228A1. Автор: Julian Garcia-Rafanell,Genis Muñoz Orti,Jose Carlos Navas Ramirez,Jose Ignacio Izquierdo Pulido. Владелец: J Uriach y Cia SA. Дата публикации: 2003-06-17.

Pharmaceutical compositions, method, and use of formulation for the treatment and prevention of infections associated with helicobacter pylori in mammals and humans

Номер патента: AU2003287797A1. Автор: José PEDRAZZOLI JUNIOR. Владелец: CMAX OTIMIZACAO DE RESULTADOS. Дата публикации: 2004-11-01.

Use of sulfonamide compounds for the treatment of diabetes and/or obesity

Номер патента: WO2005044250A1. Автор: Samantha Louise Budd Haeberlein,Linda Karen Buckett. Владелец: AstraZeneca UK Limited. Дата публикации: 2005-05-19.

Use of sulfamate derivatives for treating impulse control disorders

Номер патента: CA2364949A1. Автор: Susan L. Mcelroy. Владелец: Susan L. Mcelroy. Дата публикации: 2000-08-31.

Halo Derivatives of 9-Deoxo-9a-Aza-9a-Homerythromycin A, Method for its Production, Pharmaceutical Compositions Containing the Same and Their Use for Treatment or Prevention of Bacterial Infections

Номер патента: GEP20032928B. Автор: Zorica Marusic-Istuk,Stjepan Mutak,Gabrijela Kobrehel,Nedjelko Kujundzic,Natasha Marsic. Владелец: Pliva Farmaceutska Ind Dionicko Drustvo. Дата публикации: 2003-03-25.

Nutritional or therapeutic compositions comprising lcpufa for the treatment of anandamide-mediated ailments

Номер патента: CA2386362C. Автор: Alvin Berger,Gayle Crozier. Владелец: SOCIETE DES PRODUITS NESTLE SA. Дата публикации: 2012-08-14.

Use of lactic acid bacteria to treat or prevent eczema

Номер патента: MY177636A. Автор: Angela Marie Rowan,Julian Crane,Kristin Lee Wickens,Thorsten Villiers Stanley,Edwin Arthur Mitchell,Peter Nigel Black,Gerald William Tannock,Penelope Francis Fitzharris. Владелец: Univ Of Otago. Дата публикации: 2020-09-23.

Uses of agrp-melanocortin receptor binding modulating compounds

Номер патента: EP1125579A2. Автор: Andrew Gordon Swick,John Richard Neville Hadcock. Владелец: Pfizer Products Inc. Дата публикации: 2001-08-22.

Galactosylceramide, glucosylceramide, lactosylceramide and its specific catcher for use in the prevention or treatment of prediabetes, diabetes and / or related complications

Номер патента: JP2001527046A. Автор: フレッドマン，パム,ブシャルド，カルステン. Владелец: エイプラス サイエンス インベスト アーベー. Дата публикации: 2001-12-25.

Compounds and Dosage Regimen for Use in the Prevention or Treatment of Chronic Inflammatory and/or Autoimmune Diseases

Номер патента: US20240100005A1. Автор: Daniel Vitt,Andreas Muhler,Manfred Groppel,Hella KOHLHOF. Владелец: Immunic AG. Дата публикации: 2024-03-28.

Compounds and dosage regimen for use in the prevention or treatment of chronic inflammatory and/or autoimmune diseases

Номер патента: US11877995B2. Автор: Daniel Vitt,Andreas Muhler,Manfred Groppel,Hella KOHLHOF. Владелец: Immunic AG. Дата публикации: 2024-01-23.

Sulphated disaccharides for the treatment of neurodegenerative and/or neurovascular diseases

Номер патента: EP2519242A1. Автор: Josep Escaich Ferrer,Ramon Ruhi Roura,Carlos Raul Alaez Verson,Josep Verges Milano,Javier Egea Maiquez,Manuela Garcia Lopez,Antonio Garcia Garcia,Eulàlia MONTELL BONAVENTURA,Pilar Negredo Madrigal,Silvia Lorrio Gonzalez. Владелец: Bioiberica SA. Дата публикации: 2012-11-07.

Sulphated disaccharides for the treatment of neurodegenerative and/or neurovascular diseases

Номер патента: US20120309707A1. Автор: Josep Escaich Ferrer,Ramon Ruhi Roura,Carlos Raul Alaez Verson,Josep Verges Milano,Javier Egea Maiquez,Manuela Garcia Lopez,Antonio Garcia Garcia,Eulàlia MONTELL BONAVENTURA,Pilar Negredo Madrigal,Silvia Lorrio Gonzalez. Владелец: Bioiberica SA. Дата публикации: 2012-12-06.

Sulphated disaccharides for the treatment of neurodegenerative and/or neurovascular diseases

Номер патента: WO2011080203A1. Автор: Josep Escaich Ferrer,Ramon Ruhi Roura,Carlos Raul Alaez Verson,Josep Verges Milano,Javier Egea Maiquez,Manuela Garcia Lopez,Antonio Garcia Garcia,Eulàlia MONTELL BONAVENTURA,Pilar Negredo Madrigal,Silvia Lorrio Gonzalez. Владелец: BIOIBERICA, S.A.. Дата публикации: 2011-07-07.

Sulphated disaccharides for the treatment of neurodegenerative and/or neurovascular diseases

Номер патента: US8785416B2. Автор: Josep Escaich Ferrer,Ramon Ruhi Roura,Carlos Raul Alaez Verson,Josep Verges Milano,Javier Egea Maiquez,Manuela Garcia Lopez,Antonio Garcia Garcia,Eulàlia MONTELL BONAVENTURA,Pilar Negredo Madrigal,Silvia Lorrio Gonzalez. Владелец: Bioiberica SA. Дата публикации: 2014-07-22.

Compositions of cyclooxygenase-2 selective inhibitors and nmda receptor antagonists for the treatment or prevention of neuropathic pain

Номер патента: AU2003277440A1. Автор: Raymond Y. Cheung. Владелец: Pharmacia LLC. Дата публикации: 2004-05-25.

Erucamide compounds for the treatment and prevention to disturbances of the secretory system

Номер патента: EP1408944A1. Автор: Anders Hamberger,Gunnar Stenhagen. Владелец: Individual. Дата публикации: 2004-04-21.

Use of olfactory receptor or13a1 ligands in the treatment of lymphomas

Номер патента: EP4241766A1. Автор: Francesco Bertoni,Andrea Cavalli,Giulio Sartori,Luciano CASCIONE,Milos MATKOVIC. Владелец: Fondazione Per L'istituto Oncologico Di Ricerca Ior. Дата публикации: 2023-09-13.

Compositions and methods for treating diabetes and/or obesity

Номер патента: EP2804614A1. Автор: Mark Andrew Paulik,Rebecca Jane HODGE. Владелец: GlaxoSmithKline Intellectual Property No 2 Ltd. Дата публикации: 2014-11-26.

Use of lipoic acid for treating or preventing degenerative joint conditions, osteoarthritis, cartilage damage, and related disorders in companion animals

Номер патента: US8952052B2. Автор: Nolan Zebulon Frantz. Владелец: Hills Pet Nutrition Inc. Дата публикации: 2015-02-10.

Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes

Номер патента: CA2924682A1. Автор: Ivars Kalvins,Maija Dambrova,Helena CIRULE,Edgars Liepins,Elina MAKAROVA,Ilmars Stonans,Ilga MISANE. Владелец: JSC GRINDEKS. Дата публикации: 2015-04-02.

Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes

Номер патента: JO3333B1. Автор: Kalvins Ivars,Dambrova Maija,Liepins Edgars,Misane Ilga,MAKAROVA Elina,Cirule Helena. Владелец: Grindeks Jsc. Дата публикации: 2019-03-13.

Use of bucillamine in the treatment of infectious diseases

Номер патента: CA3172170A1. Автор: Michael Frank,Fabio Andrea CHIANELLI. Владелец: Individual. Дата публикации: 2021-09-23.

Use of vitamin k for weight maintenance and weight control

Номер патента: NZ613264A. Автор: Cees Vermeer. Владелец: Vitak Bv. Дата публикации: 2015-05-29.

Use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid for the treatment of restenosis associated with coronary intervention

Номер патента: CA2106172C. Автор: Hideo Tamai,Kinzo Ueda,Yung-Sheng Hsu. Владелец: Kissei Pharmaceutical Co Ltd. Дата публикации: 2001-01-02.

Use of lipoic acid for treating or preventing degenerative joint conditions, osteoarthritis, cartilage damage, and related disorders in companion animals

Номер патента: CA2750140C. Автор: Nolan Zebulon Frantz. Владелец: Hills Pet Nutrition Inc. Дата публикации: 2015-10-06.

Use of erss-selective ligands for regulating fertility and compounds useful therefore

Номер патента: EP1365768A2. Автор: Dirk Kosemund,Olaf Peters,Hiroshi Yamanouchi,Christa Hegele-Hartung,Gerd Mueller,Gerd Schubert,Karl-Heinrich Fritzemeier,Ingo Tornus. Владелец: Schering AG. Дата публикации: 2003-12-03.

Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes

Номер патента: CN105530929A. Автор: 伊瓦尔斯·卡尔温斯,马尧伊·达姆布罗瓦,海伦娜·奇鲁尔,埃德加斯·利平斯,叶琳娜·马卡罗娃,伊尔马斯·斯托南斯,伊尔加·米萨内. Владелец: JSC GRINDEKS. Дата публикации: 2016-04-27.

Ophthalmic formulations for the treatment of inflammation

Номер патента: CA2658361C. Автор: Per Gjorstrup,C. Eric Schwartz. Владелец: Resolvyx Pharmaceuticals Inc. Дата публикации: 2013-04-23.

Use of zeaxanthin for the treatment of diseases of the peripheral retina

Номер патента: EP1853239A1. Автор: Regina Goralczyk,Wolfgang Schalch. Владелец: DSM IP ASSETS BV. Дата публикации: 2007-11-14.

Ferric maltol compositions for use in the treatment or prevention of cancer and tumours

Номер патента: CA3019478C. Автор: Jonathan Joseph Powell,Dora I.A. Pereira. Владелец: Shield TX UK Ltd. Дата публикации: 2024-02-13.

Use of proteasome inhibitors in the treatment of coronavirus infections

Номер патента: US20240115588A1. Автор: Peter Hnik,Kishor M. Wasan,Chris GALLIANO,Supratik Mukhopadhyay,Michal Brylinski,Adam Bess,Frej Knut Gosta Berglind,Stephania CORMIER,Allan ADER,Nicholas GRIGGS,Janet GOULD,Tiffany CHO,Julia ABRAMOV. Владелец: Skymount Medical Us Lnc. Дата публикации: 2024-04-11.

Use of ERβ-selective ligands for regulating fertility and compounds useful therefor

Номер патента: US6794409B2. Автор: Dirk Kosemund,Olaf Peters,Hiroshi Yamanouchi,Christa Hegele-Hartung,Sven Ring,Gerd Mueller,Gerd Schubert,Karl-Heinrich Fritzemeier,Ingo Tornus. Владелец: Schering AG. Дата публикации: 2004-09-21.

Tricyclic heteroaromatic compounds as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes

Номер патента: US20100056550A1. Автор: Jason M. Cox,Hong Dong. Владелец: Individual. Дата публикации: 2010-03-04.

Methods involving the use of capG as a diagnostic marker and methods for the identification of capG modulators for the treatment and prevention of osteoporosis and related disease states

Номер патента: US20030017502A1. Автор: C. McAtee. Владелец: Bristol Myers Squibb Co. Дата публикации: 2003-01-23.

Methods involving the use of capg as a diagnostic marker and methods for the identification of capg modulators for the treatment and prevention of osteoporosis and related disease states

Номер патента: EP1368487A1. Автор: C. Patrick Mcatee. Владелец: Bristol Myers Squibb Co. Дата публикации: 2003-12-10.

Methods involving the use of capg as a diagnostic marker and methods for the identification of capg modulators for the treatment and prevention of osteoporosis and related disease states

Номер патента: WO2002074982A1. Автор: C. Patrick Mcatee. Владелец: BRISTOL-MYERS SQUIBB COMPANY. Дата публикации: 2002-09-26.

Method for the treatment and prevention of corneal transplant rejection

Номер патента: RU2770287C1. Автор: Александр Валерьевич Романов,Сергей Владимирович Кравченко,Сергей Николаевич Сахнов,Виктория Владимировна Мясникова,Ирина Валентиновна Черкасова. Владелец: федеральное государственное автономное учреждение "Национальный медицинский исследовательский центр "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации. Дата публикации: 2022-04-15.

Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Номер патента: EP1562925B1. Автор: Anthony Mastracchio,Scott D. Edmondson,Vincent J. Colandrea,Robert J. Mathvink,Ann E. Weber,Jinyou Xu. Владелец: Merck and Co Inc. Дата публикации: 2007-01-03.

Method for the treatment and prevention of back pain by isometric biofeedback training of patients after endoprosthesis of joints of lower limbs

Номер патента: RU2758631C1. Автор: Елена Арнольдовна Турова,Ирэна Владимировна Погонченкова,Марина Анатольевна Рассулова,Максим Сергеевич Филиппов,Дмитрий Алексеевич Сомов,Марина Ростиславовна Макарова,Анна Владимировна Шевцова. Владелец: Государственное автономное учреждение здравоохранения "Московский научно-практический центр медицинской реабилитации, восстановительной и спортивной медицины" Департамента здравоохранения города Москвы. Дата публикации: 2021-11-01.

Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes

Номер патента: CA2587800C. Автор: Anthony Mastracchio,Jason M. Cox,Scott D. Edmondson. Владелец: Merck Sharp and Dohme LLC. Дата публикации: 2012-06-12.

Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes

Номер патента: CA2570807C. Автор: Suresh Singh,Ying-Duo Gao,Ann E. Weber,Tesfaye Biftu,Danqing Dennis Feng. Владелец: Merck Sharp and Dohme LLC. Дата публикации: 2011-12-06.

Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Номер патента: CA2504735C. Автор: Anthony Mastracchio,Scott D. Edmondson,Vincent J. Colandrea,Robert J. Mathvink,Ann E. Weber,Jinyou Xu. Владелец: Merck and Co Inc. Дата публикации: 2009-06-23.

Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes

Номер патента: CA2619111C. Автор: Anthony Mastracchio,Jason M. Cox,Scott D. Edmondson. Владелец: Individual. Дата публикации: 2013-04-09.

Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes

Номер патента: CA2593264C. Автор: Giovanna Scapin,Ying-Duo Gao,Ann E. Weber,Wallace T. Ashton,Charles G. Caldwell,Hong Dong. Владелец: Individual. Дата публикации: 2012-09-25.

Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Номер патента: EP1635818A4. Автор: Scott D Edmondson,Anthony Mastracchio,Emma R Parmee. Владелец: Merck and Co Inc. Дата публикации: 2008-07-02.

Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Номер патента: CA2527806A1. Автор: Emma R. Parmee,Anthony Mastracchio,Scott D. Edmondson. Владелец: Scott D. Edmondson. Дата публикации: 2004-12-29.

3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Номер патента: WO2004064778A2. Автор: Robert J. Mathvink,Ann E. Weber,Hyun O. Ok,Wallace T. Ashton,Charles G. Caldwell,Leah Bitalac Reigle. Владелец: Merck & Co. Inc.. Дата публикации: 2004-08-05.

Interferon-associated antigen binding proteins for use for the treatment or prevention of hepatitis delta virus infection

Номер патента: WO2024213635A1. Автор: Antoine Alam,Xavier MARNIQUET,Pascal Bernard JALAGUIER,Kara Lynn CARTER. Владелец: EVOTEC INTERNATIONAL GMBH. Дата публикации: 2024-10-17.

Elastic bandage that can be used, in particular, for the treatment and prevention of vein diseases

Номер патента: US09913755B2. Автор: Serge Lecomte,Jean-Marc Henri Maurice Pernot. Владелец: URGO RECHERCHE INNOVATION ET DEVELOPPEMENT. Дата публикации: 2018-03-13.

Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto

Номер патента: US11987588B2. Автор: Young-Jun Shin,Brett Ullman,Quyen-Quyen Thuy Do,Thuy-Anh Tran,Bryan Aubrey Kramer. Владелец: Arena Pharmaceuticals Inc. Дата публикации: 2024-05-21.

Interferon-associated antigen binding proteins for use for the treatment or prevention of coronavirus infection

Номер патента: CA3220925A1. Автор: Kara Carter,Antoine Alam,Gregory Kevin Jean-Rene Neveu,Marion Rachel France DAJON,Xavier MARNIQUET. Владелец: EVOTEC INTERNATIONAL GMBH. Дата публикации: 2022-12-15.

Interferon-associated antigen binding proteins for use for the treatment or prevention of coronavirus infection

Номер патента: EP4351732A1. Автор: Kara Carter,Antoine Alam,Gregory Kevin Jean-Rene Neveu,Marion Rachel France DAJON,Xavier MARNIQUET. Владелец: EVOTEC INTERNATIONAL GMBH. Дата публикации: 2024-04-17.

Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity

Номер патента: WO2004054967A1. Автор: Maurizio Botta,Fabio Giannessi,Maria Ornella Tinti,Emanuela Tassoni,Pompeo Pessotto,Federico Corelli. Владелец: Sigma Tau Industrie Farmaceutiche Riunite S.P.A.. Дата публикации: 2004-07-01.

Wearable apparatus for the treatment or prevention of osteopenia and osteoporosis

Номер патента: US12016790B2. Автор: Daniel R. BURNETT,Jose Gutierrez,Shane Mangrum,Evan S. Luxon,Marcie HAMILTON,Alex YEE,Timothy TIGNER. Владелец: Bone Health Technologies Inc. Дата публикации: 2024-06-25.

Wearable apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis

Номер патента: US20220087844A1. Автор: Daniel R. BURNETT,Jose Gutierrez,Shane Mangrum,Evan S. Luxon,Marcie HAMILTON,Alex YEE,Timothy TIGNER. Владелец: TheraNova LLC. Дата публикации: 2022-03-24.

Wearable apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis

Номер патента: US20190133801A1. Автор: Daniel R. BURNETT,Jose Gutierrez,Shane Mangrum,Evan S. Luxon,Marcie HAMILTON,Alex YEE,Timothy TIGNER. Владелец: TheraNova LLC. Дата публикации: 2019-05-09.

Apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis

Номер патента: WO2024191855A2. Автор: Derek Hillstrom,Jeanette Numbers,Michael Jaasma,Chandlyr Jackson,Nari SHIN,Veda VULIGONDA,Laura YECIES,Catherine Jameson,Scott NOH,Sydney LANG,Hannah KMETZ,Abby MCMONIGAL. Владелец: Bone Health Technologies, Inc.. Дата публикации: 2024-09-19.

Self-adhesive elastic bandage that can be used, in particular, for the treatment and prevention of diseases of the veins

Номер патента: US09913754B2. Автор: Serge Lecomte,Jean-Marc Henri Maurice Pernot. Владелец: URGO RECHERCHE INNOVATION ET DEVELOPPEMENT. Дата публикации: 2018-03-13.

Compounds useful for the treatment and prevention of pain and screening methods therefor

Номер патента: US20060217370A1. Автор: Nicholas Kelly,Leila Malik,Ethan Burstein. Владелец: Acadia Pharmaceuticals Inc. Дата публикации: 2006-09-28.

Compositions and methods for the treatment and prevention of coinfection with eimeria and clostridium

Номер патента: WO2023220281A1. Автор: Adam T. ZARTH,Andrea Marie BINNEBOSE,Gretel GOMEZ-JIMENEZ,Victor Leonard Joseph NSEREKO WANTATE,Kevin Townsend WATTS. Владелец: CAN TECHNOLOGIES, INC.. Дата публикации: 2023-11-16.

Systems and methods for the treatment and prevention of female pelvic dysfunction

Номер патента: US20230364398A1. Автор: Mark Juravic. Владелец: Materna Medical. Дата публикации: 2023-11-16.

Wearable apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis

Номер патента: US20240024142A1. Автор: Daniel R. BURNETT,Shane Mangrum,Evan S. Luxon,Marcie HAMILTON,Alex YEE,Timothy TIGNER. Владелец: Bone Health Technologies Inc. Дата публикации: 2024-01-25.

Wearable apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis

Номер патента: US20210052407A1. Автор: Daniel R. BURNETT,Jose Gutierrez,Shane Mangrum,Evan S. Luxon,Marcie HAMILTON,Alex YEE,Timothy TIGNER. Владелец: TheraNova LLC. Дата публикации: 2021-02-25.

Wearable apparatus for the treatment or prevention of osteopenia and osteoporosis

Номер патента: US11806262B2. Автор: Daniel R. BURNETT,Jose Gutierrez,Shane Mangrum,Evan S. Luxon,Marcie HAMILTON,Alex YEE,Timothy TIGNER. Владелец: Bone Health Technologies Inc. Дата публикации: 2023-11-07.

Device for the regeneration and prevention of degeneration of the cartilaginous tissue and subchrondral bone and the proliferation of chondrocytes by means of a pulsed electromagnetic field

Номер патента: EP2019719A1. Автор: Ruggero Cadossi,Stefania Setti. Владелец: IGEA SpA. Дата публикации: 2009-02-04.

Device for the regeneration and prevention of degeneration of the cartilaginous tissue and subchrondral bone and the proliferation of chondrocytes by means of a pulsed electromagnetic field

Номер патента: AU2007251711A1. Автор: Ruggero Cadossi,Stefania Setti. Владелец: IGEA SpA. Дата публикации: 2007-11-22.

Alpha-4 integrin mediated cell adhesion inhibitors for the treatment or prevention of inflammatory diseases

Номер патента: WO2005075438A1. Автор: Jason Witherington,Robert William Ward. Владелец: Tanabe Seiyaku Co., Ltd.. Дата публикации: 2005-08-18.

Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation

Номер патента: CA2310748C. Автор: Minghua Sun,Jose Halperin,Ying-Duo Gao,Adel M. Moussa,Carlo Brugnara,Emile M. Bellott, Jr.,John J. Clifford,Reem M. Haidar,Eugene W. Kelleher,Yesh P. Sachdeva,Heather N. Taft,Rudolf Fluckiger,Richard John Lombardy,Michael H. Zeldin. Владелец: Nuchem Pharmaceuticals Inc. Дата публикации: 2008-07-22.

Apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis

Номер патента: AU2020371656A1. Автор: Daniel R. BURNETT,Alexander Vergara,Nikhil VISWANATHAN. Владелец: Bone Health Technologies Inc. Дата публикации: 2022-04-21.

Apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis

Номер патента: WO2021081189A1. Автор: Daniel R. BURNETT,Alexander Vergara,Nikhil VISWANATHAN. Владелец: Bone Health Technologies, Inc.. Дата публикации: 2021-04-29.

Apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis

Номер патента: CA3152914A1. Автор: Daniel R. BURNETT,Alexander Vergara,Nikhil VISWANATHAN. Владелец: Bone Health Technologies Inc. Дата публикации: 2021-04-29.

Methods and compositions for the treatment and prevention of smooth muscle cell proliferation

Номер патента: US20020182587A1. Автор: Sivaram Pillarisetti. Владелец: Reddy US Therapeutics Inc. Дата публикации: 2002-12-05.

Apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis

Номер патента: EP4025171A1. Автор: Daniel R. BURNETT,Alexander Vergara,Nikhil VISWANATHAN. Владелец: Bone Health Tech Inc. Дата публикации: 2022-07-13.

Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation

Номер патента: AU2448399A. Автор: Minghua Sun,Jose Halperin,Ying-Duo Gao,Adel M. Moussa,Carlo Brugnara,John J. Clifford,Reem M. Haidar,Eugene W. Kelleher,Heather N. Taft,Rudolf Fluckiger,Richard John Lombardy,Emile M. Bellott Jr.,Yesh P Sachdeva. Владелец: Nuchem Pharmaceuticals Inc. Дата публикации: 1999-06-15.

Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation

Номер патента: EP1047411A4. Автор: Minghua Sun,Jose Halperin,Ying-Duo Gao,Adel M Moussa,Carlo Brugnara,Rudolf Fluckiger,Richard John Lombardy,Yesh P Sachdeva,John J Clifford,Reem M Haidar,Eugene W Kelleher,Heather N Taft,Emile M Bellott Jr. Владелец: Nuchem Pharmaceuticals Inc. Дата публикации: 2000-12-06.

Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation

Номер патента: EP1047411A1. Автор: Minghua Sun,Jose Halperin,Ying-Duo Gao,Adel M. Moussa,Carlo Brugnara,Emile M. Bellott, Jr.,John J. Clifford,Reem M. Haidar,Eugene W. Kelleher,Yesh P. Sachdeva,Heather N. Taft,Rudolf Fluckiger,Richard John Lombardy. Владелец: Nuchem Pharmaceuticals Inc. Дата публикации: 2000-11-02.

Pharmaceutical combination of angiotensin ii antagonists and ace inhibitors

Номер патента: WO2002015891A2. Автор: Axel Riedel,Peter Bohm,Wolf Thomas Meinicke. Владелец: Boehringer Ingelheim Pharma GmbH & Co. KG. Дата публикации: 2002-02-28.

Modulators of cytokine mediated signalling pathways and integrin alphavbeta3 receptor antagonists for combination therapy

Номер патента: US20120003229A1. Автор: Wilfried Hornberger,Hervé Geneste. Владелец: Individual. Дата публикации: 2012-01-05.

Novel use of the kinases rsk4 and pak5

Номер патента: EP1802979A2. Автор: Jürgen BORLAK,Monika Niehof. Владелец: Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eV. Дата публикации: 2007-07-04.

New use of somatostatin

Номер патента: WO1990012589A1. Автор: Manuel Rodriguez Puyol,Diego Rodriguez Puyol. Владелец: Holmes, Michael, John. Дата публикации: 1990-11-01.

Use of collagen hydrolysate to lower the viscosity of a composition comprising guar gum

Номер патента: EP1515741B1. Автор: Michael Beer,Nicolas Auriou. Владелец: Nestec SA. Дата публикации: 2011-03-23.

Use of ghrelin splice variant for treating high cholesterol levels or high plasma glucose levels and releated diseases

Номер патента: EP2021365A2. Автор: Liat Mintz. Владелец: Individual. Дата публикации: 2009-02-11.

Use of ghrelin splice variant for treating high cholesterol levels or high plasma glucose levels and releated diseases

Номер патента: WO2007126792A3. Автор: Liat Mintz. Владелец: Liat Mintz. Дата публикации: 2008-05-15.

Use of ghrelin splice variant for treating high cholesterol levels or high plasma glucose levels and releated diseases

Номер патента: WO2007126792A2. Автор: Liat Mintz. Владелец: Liat Mintz. Дата публикации: 2007-11-08.

Use of antibodies to tweak for the treatment of stroke

Номер патента: EP1721157B1. Автор: Armin Schneider,Gerhard Vogt,Moritz Rossner,Markus Schwaninger,C. Linda Burkly. Владелец: Sygnis Bioscience GmbH and Co KG. Дата публикации: 2011-04-06.

Class iii slrp for the treatment of cancer

Номер патента: WO2006043031A3. Автор: Paul N Bishop,Rachel L Cowen. Владелец: Rachel L Cowen. Дата публикации: 2006-07-06.

Class iii slrp for the treatment of cancer

Номер патента: WO2006043031A2. Автор: Paul N. Bishop,Rachel L. Cowen. Владелец: THE UNIVERSITY OF MANCHESTER. Дата публикации: 2006-04-27.

Class iii slrp for the treatment of cancer

Номер патента: EP1809314A2. Автор: Paul N. The University of Manchester BISHOP,Rachel L. The University of Manchester COWEN. Владелец: University of Manchester. Дата публикации: 2007-07-25.

Class iii slrp for the treatment of cancer

Номер патента: CA2626774A1. Автор: Paul N. Bishop,Rachel L. Cowen. Владелец: Individual. Дата публикации: 2006-04-27.

Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseases

Номер патента: US20230346825A1. Автор: István PUSKÁS,Abdula Kurkayev. Владелец: Cyclolab Cyclodextrin Research and Development Laboratory Ltd. Дата публикации: 2023-11-02.

Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseases

Номер патента: US20220096528A1. Автор: Lajos Szente,István PUSKÁS,Tamas SOHAJDA. Владелец: Cyclolab Cyclodextrin Research and Development Laboratory Ltd. Дата публикации: 2022-03-31.

Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseases

Номер патента: EP4221722A1. Автор: István PUSKÁS,Abdula Kurkayev. Владелец: Cyclolab Cyclodextrin Research and Development Laboratory Ltd. Дата публикации: 2023-08-09.

Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseases

Номер патента: WO2022070092A1. Автор: Lajos Szente,István PUSKÁS,Tamas SOHAJDA. Владелец: CYCLOLAB CYCLODEXTRIN RESEARCH AND DEVELOPMENT LABORATORY LTD.. Дата публикации: 2022-04-07.

Use of vegf antagonist for treating retinopathy of prematurity

Номер патента: RU2676303C2. Автор: Сергей АКСЕНОВ,Габриэла БУРЬЯН. Владелец: НОВАРТИС АГ. Дата публикации: 2018-12-27.

Use of angiotensin in the treatment of cancer metastasis

Номер патента: EP1104305B1. Автор: Gavin Paul Division of Biom. Sciences VINSON,John Richard Division of Biom. Science PUDDEFOOT,Miles Gordon Division of Biom. Sciences BERRY. Владелец: QUEEN MARY AND WESTFILED COLLEGE UNIVERSITY OF LONDON. Дата публикации: 2005-03-23.

Modulators of cytokine mediated signalling pathways and integrin .alpha.v.beta.3 receptor antagonists for combination therapy

Номер патента: CA2386230C. Автор: Wilfried Hornberger,Hervé Geneste. Владелец: Abbott GmbH and Co KG. Дата публикации: 2009-05-05.

Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy

Номер патента: AU7912600A. Автор: Wilfried Hornberger,Andreas Kling,Wilhelm Amberg. Владелец: BASF SE. Дата публикации: 2001-05-10.

Faecalibacterium prausnitzii and desulfovibrio piger for use in treatment or prevention of diabetes and intestinal diseases

Номер патента: RU2754367C2. Автор: Мухаммад-Танвир КХАН,Фредрик БЕКХЕД. Владелец: Метабоген Аб. Дата публикации: 2021-09-01.

Short chain peptidomimetics based orally active glp-1 agonist and glucagon receptor antagonist

Номер патента: WO2011048614A3. Автор: Pankaj R. Patel,Mukul R. Jain,Rajesh Bahekar. Владелец: CADILA HEALTHCARE LIMITED. Дата публикации: 2011-07-07.

New pharmaceutical compositions comprising glucagon-like peptide-1 receptor agonists

Номер патента: WO2024127019A1. Автор: David Westberg,Anders Johansson,Erik Lindahl,Marten Rooth,Joel HELLRUP,Polla ROUF,Oliver HEDGE. Владелец: NANEXA AB. Дата публикации: 2024-06-20.

Liquid defibrotide composition for treatment and prevention of venous occlusive disease

Номер патента: RU2766143C2. Автор: Теренцио ИНЬОНИ,Виджей КУМАР,Кхалид ИСЛАМ. Владелец: Джентиум С.Р.Л.. Дата публикации: 2022-02-08.

Complex of myelin lipids of central and peripheral nervous system of animals for treatment and prevention of neurodegenerative demyelinating disorders and methods for its application

Номер патента: RU2761617C2. Автор: Жаудат Гафурович Умеров,Эмма Жаудатовна Соболева,Надия Жаудатовна Умерова. Владелец: Надия Жаудатовна Умерова. Дата публикации: 2021-12-13.

Method and remedy for treatment and prevention of benign prostatic hyperplasia

Номер патента: RU2764850C1. Автор: Дмитрий Евгеньевич Лукин,Владимир Григорьевич Беспалов. Владелец: Миронова Людмила Владимировна. Дата публикации: 2022-01-21.

Novel use of the kinases RSK4 and PAK5

Номер патента: WO2006008126B1. Автор: Borlak Juergen,Monika Niehof. Владелец: Ten Forschung E V Fraunhoffer. Дата публикации: 2006-05-26.

Novel use of the kinases rsk4 and pak5

Номер патента: WO2006008126A2. Автор: Borlak Jürgen,Monika Niehof. Владелец: FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V.. Дата публикации: 2006-01-26.

Novel Use of the Kinases Rsk4 and Pak5

Номер патента: US20080138328A1. Автор: Borlak Jürgen,Monica Niehof. Владелец: Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eV. Дата публикации: 2008-06-12.

Novel use of the kinases rsk4 and pak5

Номер патента: WO2006008126A3. Автор: Borlak Juergen,Monika Niehof. Владелец: Monika Niehof. Дата публикации: 2006-03-30.

Use of ghrelin splice variant for treating hypercholesterolemia and/or high cholesterol and/or high cholesterol complication and/or lipemia complication and/or coronary heart disease and/or weight management and/or diabetes and/or hyperglycemia

Номер патента: IL194177A0. Автор: . Владелец: Liat Mintz. Дата публикации: 2011-08-01.

Receptor antagonists for treating metastatic cancer

Номер патента: RU2455026C2. Автор: Ник ЛОИЗОС,Джим ХЬЮБЕР. Владелец: Имклоун Элэлси. Дата публикации: 2012-07-10.

Use of extracellular vesicles in combination with tissue plasminogen activator and/or thrombectomy to treat stroke

Номер патента: US20220000932A1. Автор: LI ZHANG,Michael Chopp,Zhenggang Zhang,Benjamin Buller. Владелец: HENRY FORD HEALTH SYSTEM. Дата публикации: 2022-01-06.

Methods for the treatment of heart failure

Номер патента: US9533041B2. Автор: Frédéric JAISSER. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2017-01-03.

Use of tweak modulators and inhibitors for the treatment of neurological conditions

Номер патента: EP1721157A1. Автор: Armin Schneider,Moritz Rossner,Markus Schwaninger,Gerhart Vogt. Владелец: Axaron Bioscience AG. Дата публикации: 2006-11-15.

Use of tweak modulators and inhibitors for the treatment of neurological conditions

Номер патента: IL177285A0. Автор: . Владелец: Axaron Bioscience AG. Дата публикации: 2006-12-10.

Use of tweak modulators and inhibitors for the treatment of neurological conditions

Номер патента: CA2558770A1. Автор: Armin Schneider,Gerhard Vogt,Moritz Rossner,Markus Schwaninger. Владелец: Individual. Дата публикации: 2005-09-01.

Use of tweak modulators and inhibitors for the treatment of neurological conditions

Номер патента: AU2005214843A1. Автор: Armin Schneider,Moritz Rossner,Markus Schwaninger,Gerhart Vogt. Владелец: Axaron Bioscience AG. Дата публикации: 2005-09-01.

Use of metal astringents for the treatment and prevention of hairy heel warts

Номер патента: WO2009053934A3. Автор: Joseph P. Morelli,Jeffrey R. Fernandes. Владелец: Ecolab Inc.. Дата публикации: 2009-10-15.

Use of metal astringents for the treatment and prevention of hairy heel warts

Номер патента: EP2207557A2. Автор: Petra Vogt,Edward L.C. Verkaar,Joseph P. Morelli,Jeffrey R. Fernandes. Владелец: Ecolab Inc. Дата публикации: 2010-07-21.

Use of hematopoietic stem cells in preparation of formulation for treating viral diseases

Номер патента: US20220339197A1. Автор: Bin Wang,Zhijun Wu,Haixia Liu,Xianfeng Ding,Haiyan LIANG,Qingyan ZOU,Shiyue LI,Shaoyin DU,Shaobin DUAN. Владелец: Gz Cedicine Biotech Co Ltd. Дата публикации: 2022-10-27.

Methods and compositions for the treatment of cancer and infectious disease using alpha(2) macroglobulin-antigenic molecule complexes

Номер патента: US09566348B2. Автор: Robert J. Binder,Pramod K. Srivastava. Владелец: University of Connecticut Health Center. Дата публикации: 2017-02-14.

Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist

Номер патента: WO1993018783A1. Автор: Rene De Waal Malefyt,Jan De Vries. Владелец: Schering Corporation. Дата публикации: 1993-09-30.

Use of modulators of a novel form of muscle selective calcineurin interacting protein (mcip-1-38) as a treatment for cardiovascular diseases

Номер патента: WO2006034184A3. Автор: David Hood,Erik Bush. Владелец: Myogen Inc. Дата публикации: 2006-10-05.

Uses of FAHD1

Номер патента: US20170312343A1. Автор: Christian Kramer,Haymo Pircher,Pidder Jansen-Duerr,Eva Albertini,Elisabeth Mayr,Andrea Taferner,Susanne von Grafenstein,Klaus R. Liedl,Thomas Diener,Christina Metzger. Владелец: UNIVERSITAET INNSBRUCK. Дата публикации: 2017-11-02.

Composition and use thereof for the treatment of benign and malign diseases

Номер патента: WO2015000946A1. Автор: Rupert Temper. Владелец: Cellquantum Ag. Дата публикации: 2015-01-08.

Dosage and administration regimen for the treatment or prevention of guillan-barré syndrome by the use of the anti-c5 antibody crovalimab

Номер патента: AU2023249891A1. Автор: Kenji SHINOMIYA,Keisuke GOTANDA,Alexandre Antoine Bernard SOSTELLY,Simon Bertrand Marie BUATOIS,Antoine Paul Maxence SOUBRET. Владелец: F Hoffmann La Roche AG. Дата публикации: 2024-08-08.

Use of MP52 or MP121 for treating and preventing diseases of the nervous system

Номер патента: US6531450B2. Автор: Jens Pohl,Gertrud Hotten,Rolf Bechtold,Michael Paulista,Klaus Unsicker. Владелец: Biopharm Gesellschaft zur biotechnologischen Entwicklung von Pharmaka mbH. Дата публикации: 2003-03-11.

A method for the purification of factor xiii by affinity chromatography

Номер патента: AU3122489A. Автор: Werner Stuber,Jürgen Römisch,Hartmut Lobermann. Владелец: Behringwerke AG. Дата публикации: 1989-09-14.

Uses of fahd1

Номер патента: EP3212178A1. Автор: Christian Kramer,Haymo Pircher,Pidder Jansen-Duerr,Eva Albertini,Elisabeth Mayr,Andrea Taferner,Susanne von Grafenstein,Klaus R. Liedl,Thomas Diener,Christina Metzger. Владелец: UNIVERSITAET INNSBRUCK. Дата публикации: 2017-09-06.

Uses of fahd1

Номер патента: WO2016066849A1. Автор: Christian Kramer,Haymo Pircher,Pidder Jansen-Duerr,Eva Albertini,Elisabeth Mayr,Andrea Taferner,Susanne von Grafenstein,Klaus R. Liedl,Thomas Diener,Christina Metzger. Владелец: UNIVERSITÄT INNSBRUCK. Дата публикации: 2016-05-06.

Dosage and administration regimen for the treatment or prevention of guillan-barré syndrome by the use of the anti-c5 antibody crovalimab

Номер патента: AU2023249891A9. Автор: Kenji SHINOMIYA,Keisuke GOTANDA,Alexandre Antoine Bernard SOSTELLY,Simon Bertrand Marie BUATOIS,Antoine Paul Maxence SOUBRET. Владелец: F Hoffmann La Roche AG. Дата публикации: 2024-08-15.

Method for the manufacturing of chitin derivatives through treatment with ultrasounds

Номер патента: WO2020148672A1. Автор: Fabio Di Berardino. Владелец: TEXOL S.R.L.. Дата публикации: 2020-07-23.

Use of lambda interferons in the treatment of obesity-related disorders and related diseases

Номер патента: CA3093480A1. Автор: Evangelos Andreakos,Maria Salagianni. Владелец: BIOMEDICAL RESEARCH FOUNDATION OF ACADEMY OF ATHENS. Дата публикации: 2018-09-20.

Uses of GLI1 in detecting tissue fibrosis

Номер патента: US09970935B2. Автор: Benjamin D. Humphreys,Rafael Kramann,Derek Dirocco. Владелец: Brigham and Womens Hospital Inc. Дата публикации: 2018-05-15.

Cerium oxide nanoparticles for the treatment and prevention of stroke and cardiovascular disease

Номер патента: US09649337B2. Автор: Beverly A. Rzigalinski,Kevin Hockey,Landon M. Klein,Christopher A. Sholar,Justin Himler,Marc J. Billings,Jayce Cook. Владелец: EDWARD VIA VIRGINIA COLLEGE OF OSTEOPATHIC MEDICINE. Дата публикации: 2017-05-16.

Combined use of a sulfated glycosaminoglycan and a hyaluronidase for improving the bioavailability of factor VIII

Номер патента: US09511123B2. Автор: Sabine ZOLLNER,Hubert Metzner. Владелец: CSL Behring GmbH Deutschland. Дата публикации: 2016-12-06.

Use of sulfated glycosaminoglycans for improving the bioavailability of factor VIII

Номер патента: US09393289B2. Автор: Sabine ZOLLNER,Hubert Metzner. Владелец: CSL Behring GmbH Deutschland. Дата публикации: 2016-07-19.

Bicyclic oligopeptides and their use as glucagon receptor antagonists

Номер патента: CA2489189A1. Автор: Klaus Wagner,Juergen Mack,Stefan Peters,Till Maurer,Ruediger Streicher,Olivier Potterat. Владелец: Individual. Дата публикации: 2004-01-22.

Use of actinomycetales for the treatment of diabetes type ii

Номер патента: CA2639129C. Автор: John Lawson Stanford,Graham Mcintyre,Oscar Adelmo Bottasso,Cynthia Stanford. Владелец: Bioeos Ltd. Дата публикации: 2017-03-28.

Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers

Номер патента: US5576306A. Автор: Jennifer B. Dressman,Christos Reppas,Stephen W. Tobey,Cynthia W. Sowle. Владелец: Dow Chemical Co. Дата публикации: 1996-11-19.

Use of polysulphated alginate in cellular matrices

Номер патента: EP1711595A2. Автор: August Verbruggen,Eric Veys. Владелец: Universiteit Gent. Дата публикации: 2006-10-18.

Use of an acylated octasaccharide as antithrombotic agent

Номер патента: EP2427198A1. Автор: Pierre Mourier,Christian Viskov. Владелец: SANOFI SA. Дата публикации: 2012-03-14.

Use of an acylated octasaccharide as antithrombotic agent

Номер патента: WO2010128448A1. Автор: Pierre Mourier,Christian Viskov. Владелец: SANOFI-AVENTIS. Дата публикации: 2010-11-11.

New therapeutic use of chondroitin sulphate

Номер патента: WO2005014012A1. Автор: Francisco Javier Vila Pahi,Josep Verges Milano,Montserrat Pérez López. Владелец: BIOIBERICA, S.A.. Дата публикации: 2005-02-17.

Abhd5 and partial hdac4 fragments and variants as a therapeutic approach for the treatment of cardiovascular diseases

Номер патента: US20160108376A1. Автор: Hugo Katus,Oliver Müller,Lorenz Lehmann,Johannes Backs,Zegeye JEBESSA. Владелец: UNIVERSITAET HEIDELBERG. Дата публикации: 2016-04-21.

ABHD5 and partial HDAC4 fragments and variants as a therapeutic approach for the treatment of cardiovascular diseases

Номер патента: US11312943B2. Автор: Hugo Katus,Oliver Müller,Lorenz Lehmann,Johannes Backs,Zegeye JEBESSA. Владелец: UNIVERSITAET HEIDELBERG. Дата публикации: 2022-04-26.

ABHD5 and partial HDAC4 fragments and variants as a therapeutic approach for the treatment of cardiovascular diseases

Номер патента: US9914912B2. Автор: Hugo Katus,Oliver Müller,Lorenz Lehmann,Johannes Backs,Zegeye JEBESSA. Владелец: UNIVERSITAET HEIDELBERG. Дата публикации: 2018-03-13.

Abhd5 and partial hdac4 fragments and variants as therapeutic approach for the treatment of cardiovascular diseases

Номер патента: WO2014125110A1. Автор: Hugo Katus,Oliver Müller,Lorenz Lehmann,Johannes Backs,Zegeye JEBESSA. Владелец: RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG. Дата публикации: 2014-08-21.

Abhd5 and partial hdac4 fragments and variants as therapeutic approach for the treatment of cardiovascular diseases

Номер патента: EP2956162A1. Автор: Hugo Katus,Oliver Müller,Lorenz Lehmann,Johannes Backs,Zegeye JEBESSA. Владелец: UNIVERSITAET HEIDELBERG. Дата публикации: 2015-12-23.

Composition for the prevention or treatment of obesity or lipid related metabolic deseases

Номер патента: WO2011118953A2. Автор: Soon-Hoe Kim,Seul-Ki Lee,Sang-jin Lee,Tae-Ho Lee,Mi-Won Son,Sang-Zin Choi,Yong-Sung Sohn,Nam-Joon Baek,Jin-Seok Jeong. Владелец: Dong-A Pharm.Co., Ltd.. Дата публикации: 2011-09-29.

New therapeutic use of chondroitin sulphate

Номер патента: EP1660102A1. Автор: Francisco Javier Vila Pahi,Josep Verges Milano,Montserrat Pérez López. Владелец: Bioiberica SA. Дата публикации: 2006-05-31.

New therapeutic use of chondroitin sulphate

Номер патента: US20060247204A1. Автор: Josep Verges Milano,Francisco Vila Pahi,Montserrat Pérez López. Владелец: Bioiberica SA. Дата публикации: 2006-11-02.

Therapeutic Target Molecules For The Development of Novel Medicaments for Degenerative Diseases

Номер патента: US20090222938A1. Автор: Rosemarie Daig,Thomas Rohrmeier. Владелец: Neuroprofile GmbH. Дата публикации: 2009-09-03.

Artificial Pulmonary Surfactant Compositions and Use of the Same

Номер патента: US20080194458A1. Автор: Yoshihiro Nakamura,Sannamu Lee,Ko Yukikate. Владелец: Fukuoka University. Дата публикации: 2008-08-14.

Composition for the prevention or treatment of obesity or lipid related metabolic deseases

Номер патента: WO2011118953A3. Автор: Soon-Hoe Kim,Seul-Ki Lee,Sang-jin Lee,Tae-Ho Lee,Mi-Won Son,Sang-Zin Choi,Yong-Sung Sohn,Nam-Joon Baek,Jin-Seok Jeong. Владелец: Dong-A Pharm.Co., Ltd.. Дата публикации: 2012-01-12.

Uses of galectin-2

Номер патента: EP1727557A1. Автор: Andreas Sturm,Axel Dignass,Stefan Rosewicz. Владелец: Charite Universitaetsmedizin Berlin. Дата публикации: 2006-12-06.

Composition and method for the generation of chlorine dioxide from the oxidative consumption of biomolecules

Номер патента: US20170319877A1. Автор: James L. Ratcliff,Martin C. Grootveld,Christopher J.L. Silwood. Владелец: Micropure Inc. Дата публикации: 2017-11-09.

Use of lambda interferons in the treatment of obesity-related disorders and related diseases

Номер патента: US20200157167A1. Автор: Evangelos Andreakos,Maria Salagianni. Владелец: Individual. Дата публикации: 2020-05-21.

Treatment and prevention of cancer using her3 antigen-binding molecules

Номер патента: WO2024208881A1. Автор: Dipti THAKKAR,Piers INGRAM,Konrad PASZKIEWICZ,Namita Gandhi,Jerome BOYD-KIRKUP,Weiyi TOY,Khang LUU,Kevin Fongching CHAU. Владелец: CLEGG, Richard Ian. Дата публикации: 2024-10-10.

Use of lambda interferons in the treatment of obesity-related disorders and related diseases

Номер патента: US12121564B2. Автор: Evangelos Andreakos,Maria Salagianni. Владелец: BIOMEDICAL RESEARCH FOUNDATION OF ACADEMY OF ATHENS. Дата публикации: 2024-10-22.

Use of amino acid sequences from Mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom

Номер патента: US09829490B2. Автор: Massimo Amicosante,Vittorio Colizzi,Francesca Mariani,Cesare Saltini. Владелец: Cellestis Ltd. Дата публикации: 2017-11-28.

Vaccine for treatment and/or prevention of physical disorder, associated with renin-activated angiotensin system and application of peptide for its production

Номер патента: RU2534883C2. Автор: Вальтер ШМИДТ,Гюнтер ШТАФЛЕР,Петра ЛЮРС,Андреас МАИРХОФЕР,Франк МАТТНЕР,Андреа ДОЛИШКА. Владелец: Аффирис Аг. Дата публикации: 2014-12-10.

Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions

Номер патента: CA2373375C. Автор: Claudio De Simone. Владелец: VSL Pharmaceuticals Inc USA. Дата публикации: 2014-01-14.

Methods of Identifying Improved NMDA Receptor Antagonists

Номер патента: US20100272648A1. Автор: Dennis C. Liotta,Raymond J. Dingledine,Stephen F. Traynelis. Владелец: Individual. Дата публикации: 2010-10-28.

Agents, and methods employing them, for the prevention or reduction of tissue adhesion at a wound site

Номер патента: US20010056079A1. Автор: Hans-Arne Hansson,Gunilla Johansson-Ruden,Olle Larm. Владелец: AstraZeneca AB. Дата публикации: 2001-12-27.

Use of metal astringents for the treatment and prevention of hairy heel warts

Номер патента: NZ584054A. Автор: Joseph P Morelli,Jeffrey R Fernandes,Edward L Verkaar. Владелец: Ecolab Inc. Дата публикации: 2011-09-30.

Treatment and prevention of cancer using her3 antigen-binding molecules

Номер патента: WO2023017151A9. Автор: Jerome Douglas BOYD-KIRKUP,Dipti THAKKAR,Piers INGRAM,Konrad PASZKIEWICZ,Shreya KAR. Владелец: CLEGG, Richard Ian. Дата публикации: 2024-06-06.

A combination of plasma immunoglobulin and antigen-specific immunoglobulin for the modification of the immune system and the treatment or prevention of autoimmune diseases

Номер патента: EP3990016A1. Автор: Reginald M. Gorczynski,Geoffrey William Hoffmann. Владелец: NETWORK IMMUNOLOGY Inc. Дата публикации: 2022-05-04.

New therapeutic use of chondroitin sulphate

Номер патента: NZ545375A. Автор: Pahi Francisco Javier Vila,Milano Josep Verges,Lopez Montserrat Perez. Владелец: Bioiberica. Дата публикации: 2008-11-28.

The use of a human monoclonal anti-hcv antibody as a medicament for the therapeutic treatment and prevention of hcv infections

Номер патента: WO2010035292A8. Автор: Roberto Burioni,Massimo Clementi. Владелец: NATIMAB THERAPEUTICS S.r.l.. Дата публикации: 2010-07-01.

Discovery and use of immunogenic peptides for the treatment and prevention of cancers

Номер патента: WO2022066828A1. Автор: Preethi Gunaratne,Brandon Mistretta,Sakuni Rankothgedera,Micah Castillo,Isabelle Bedrosian. Владелец: UNIVERSITY OF HOUSTON SYSTEM. Дата публикации: 2022-03-31.

Design and therapeutic use of adpase enhanced apyrases

Номер патента: WO2005085468A1. Автор: Soon Seog Jeong,Ridong Chen,Timothy Mitsky. Владелец: APT THERAPEUTICS, INC.. Дата публикации: 2005-09-15.

Method of treating heart failure

Номер патента: US20210275642A1. Автор: David Schwartzman,Sanjeev G. Shroff,Guy Salama,Charles McTiernan. Владелец: University of Pittsburgh. Дата публикации: 2021-09-09.

Method of treating heart failure

Номер патента: US20170182128A1. Автор: David Schwartzman,Sanjeev G. Shroff,Guy Salama,Charles McTiernan. Владелец: University of Pittsburgh. Дата публикации: 2017-06-29.

Compositions for the treatment of ebv associated diseases or conditions

Номер патента: AU2022228701A1. Автор: Christoph Hess,Bojana MÜLLER-DUROVIC,Glenn BANTUG. Владелец: UNIVERSITAET BASEL. Дата публикации: 2023-09-14.

Use of extracellular vesicles for the treatment of cancer

Номер патента: WO2024186630A1. Автор: Michael Chopp,Zhenggang Zhang,Dilip K. MOONKA,Louie SEMAAN. Владелец: HENRY FORD HEALTH SYSTEM. Дата публикации: 2024-09-12.

Composition and method for the oxidative consumption of salivary biomolecules

Номер патента: EP2533750A1. Автор: James L. Ratcliff,Martin C. Grootveld,Christopher J. L. Silwood. Владелец: Micropure Inc. Дата публикации: 2012-12-19.

PEPTIDES WITH ANTI-MICROBIAL ACTIVITY, MEDICINAL COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF ANIMALS, COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF PLANTS, APPLICATION OF THE SPECIFIED PEPTIDES AND USE OF EXTRACT EISRIBENIS FRENCHEN

Номер патента: RU2013150203A. Автор: Карлус Энрики ЭНРИКИ,ДИ АРАУЖУ Жанаина ФЕРНАНДЕС,ДИ КАСТРУ Алинне ПЕРЕЙРА,Лукас КАРВАЛЬЮ,ФРАНКУ Отавью ЛУИС,СИЛЬВА Адриане КУРОКАВА,КРЮГЕР Рикарду ЭНРИКИ. Владелец: Унан Бразильенсе Ди Эдукасан Э Культура-Убек. Дата публикации: 2015-05-20.

A method for preparing purified extract for the prevention and treatment of stroke and ischemia from ginkgo biloba leaves extract and the composition containing the same

Номер патента: KR100623164B1. Автор: 류종훈,한용남. Владелец: 재단법인서울대학교산학협력재단. Дата публикации: 2006-09-19.

New compositions and methods for the treatment of acne vulgaris

Номер патента: EP3942030A1. Автор: Oleg ALEXEYEV. Владелец: Vakona AB. Дата публикации: 2022-01-26.

New compositions and methods for the treatment of acne vulgaris

Номер патента: CA3133047A1. Автор: Oleg ALEXEYEV. Владелец: Vakona AB. Дата публикации: 2020-09-24.

Compositions and their use to treat heart failure with preserved injection fraction (hfpef)

Номер патента: CA2900526C. Автор: Julio A. Chirinos. Владелец: University of Pennsylvania Penn. Дата публикации: 2021-05-04.

Extracts of celery seed for the prevention and treatment of pain, inflammation and gastrointestinal irritation

Номер патента: US20030206980A1. Автор: Craig Davis,Desley Butters,Ross McGeary,Michael Powanda,Kim Rainsford,Michael Whitehouse. Владелец: Individual. Дата публикации: 2003-11-06.

Conjugate vaccines for the prevention of dental caries

Номер патента: WO1999052548A9. Автор: Andrew Lees,Daniel J Smith,Martin A Taubman. Владелец: Martin A Taubman. Дата публикации: 2001-06-07.

Use of the protein UK114 or of fragments thereof for the treatment and prevention of the endotoxic shock.

Номер патента: ZA200307901B. Автор: Alberto Bartorelli,Alberto Panerai,Pierferdinando Nicoletti. Владелец: Zetesis SpA. Дата публикации: 2004-10-11.

Use of the protein uk114 or of fragments thereof for the treatment and prevention of the endotoxic shock

Номер патента: PL367764A1. Автор: Alberto Bartorelli,Alberto Panerai,Pierferdinando Nicoletti. Владелец: Zetesis S.P.A.. Дата публикации: 2005-03-07.

Dosage and administration regimen for the treatment or prevention of guillan-barré syndrome by the use of the anti-c5 antibody crovalimab

Номер патента: IL313962A. Автор: Kenji SHINOMIYA,Keisuke GOTANDA,Alexandre Antoine Bernard SOSTELLY,Simon Bertrand Marie BUATOIS,Antoine Paul Maxence SOUBRET. Владелец: Antoine Paul Maxence SOUBRET. Дата публикации: 2024-08-01.

Use of the protein uk114 or of fragments thereof for the treatment and prevention of the endotoxic shock

Номер патента: HRP20030815A2. Автор: Bartorelli Alberto,Nicoletti Pierferdinando,Panerai Alberto. Владелец: Zetesis S.P.A.. Дата публикации: 2005-08-31.

Compositions and uses of antimicrobial materials with tissue-compatible properties

Номер патента: US12016898B2. Автор: Michael P. Bevilacqua,Diego Benitez,Jarrod A. Hanson. Владелец: Amicrobe Inc. Дата публикации: 2024-06-25.

Compositions and uses of antimicrobial materials with tissue-compatible properties

Номер патента: US09446090B2. Автор: Michael P. Bevilacqua,Diego Benitez,Jarrod A. Hanson. Владелец: Amicrobe Inc. Дата публикации: 2016-09-20.

USE OF MICROORGANISMS FOR REDUCING THE LEVEL OF TRIMETHYLAMINE IN A HUMAN BODY CAVITY, IN PARTICULAR FOR THE TREATMENT OF TRIMETHYLAMINURIA OR OF BACTERIAL VAGINOSIS AND THE PREVENTION OF CARDIOVASCULAR DISEASES

Номер патента: US20160074440A1. Автор: BRUGERE Jean-François,BORREL Guillaume,"OTOOLE Paul William",MALPUECH-BRUGERE Corinne,ALRIC Monique. Владелец: . Дата публикации: 2016-03-17.

Serotonin agonist in combination with a tachykinin receptor antagonist in the treatment or prevention of migraine

Номер патента: US5744482A. Автор: Marlene L. Cohen,Kirk W. Johnson,Lee A. Phebus. Владелец: Eli Lilly and Co. Дата публикации: 1998-04-28.

Use of preparations of polyscias filicifolia plant or its fragments for treatment of elementoses and their consequences

Номер патента: RU2760674C1. Автор: Аркадий Михайлович Котин,Максим Олегович Емельянов,Олег Аркадьевич Котин. Владелец: Общество с ограниченной ответственностью "Биофармокс". Дата публикации: 2021-11-29.

Steroid Nitrons for the treatment and prevention of stroke or ischemia of the head mogh, Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis

Номер патента: RU2015154103A. Автор: КОНТЕЛЬЕС Хосе Луис МАРКО,ГОНСАЛЕС Альберто АЛЬКАСАР. Владелец: Фундасион Пара Ла Инвестигасион Биомедика Дель Оспиталь Университарио Рамон И Кахаль. Дата публикации: 2017-06-27.

Hdl for the treatment of stroke and other ischemic conditions

Номер патента: CA2457840C. Автор: Alphonse Hubsch,Markus G. Lang. Владелец: CSL Behring AG. Дата публикации: 2011-10-11.

Use of vista agonists and antagonists to suppress or enhance humoral immunity

Номер патента: CA2951885C. Автор: LI Wang,Kathy A. Green,Randolph J. Noelle,William R. Green. Владелец: Individual. Дата публикации: 2023-07-04.

NOVEL USE OF RICE, RICE BRAN OR RICE HULL EXTRACT AS AN HISTAMINE RECEPTOR ANTAGONIST

Номер патента: US20130171280A1. Автор: Lee Chang-Ho,Han Jin-Kyu,Kim In-ho,KIM Dong-Soo,Cho Suengmok,Han Daeseok,Baek Nam-In,Jin Young-Ho,Sung Jae-Young. Владелец: KOREA FOOD RESEARCH INSTITUTE. Дата публикации: 2013-07-04.

NOVEL USE OF RICE, RICE BRAN OR RICE HULL EXTRACT AS AN HISTAMINE RECEPTOR ANTAGONIST

Номер патента: US20150320823A1. Автор: Lee Chang-Ho,Han Jin-Kyu,Kim In-ho,KIM Dong-Soo,Cho Suengmok,Han Daeseok,Baek Nam-In,Jin Young-Ho,Sung Jae-Young. Владелец: KOREA FOOD RESEARCH INSTITUTE. Дата публикации: 2015-11-12.

Use of combination of antibody to pd-1 and vegfr inhibitor in production of drug for treatment of malignant neoplasms

Номер патента: RU2762746C2. Автор: Ляньшань Чжан,Гоцин ЦАО,Син СУНЬ,Чанюн ЯН,Юн ГО. Владелец: Цзянсу Хэнжуй Медицин Ко., Лтд.. Дата публикации: 2021-12-22.

Composition for treatment and / or prevention of diseases of oral cavity, method for its preparation and use

Номер патента: RU2747983C1. Автор: Светлана Константиновна Матело,Александр Владимирович Гроссер,Татьяна Владимировна Купец. Владелец: Светлана Константиновна Матело. Дата публикации: 2021-05-18.

Gremlin-1 antagonist for the prevention and treatment of cancer

Номер патента: WO2019243801A1. Автор: Gareth Charles Glyndwr DAVIES,Simon LEEDHAM,Andrew Zannettino,Kimberley CLARK,Duncan Hewett,Vasilios PANAGOPOULOS. Владелец: UCB Biopharma SRL. Дата публикации: 2019-12-26.

Novel use of rice, rice bran or rice hull extract as an histamine receptor antagonist

Номер патента: KR101444098B1. Автор: 김동수,이창호,한진규,김인호,한대석,백남인,진영호,조승목,성재영. Владелец: 한국식품연구원. Дата публикации: 2014-09-29.

Novel use of rice rice bran or rice hull extract as an histamine receptor antagonist

Номер патента: KR20130050882A. Автор: 김동수,이창호,한진규,김인호,한대석,백남인,진영호,조승목,성재영. Владелец: 한국식품연구원. Дата публикации: 2013-05-16.

Use of polysaccharide from fruit of Lycium barbarum to produce a medicament, nutritional supplement or food for the prevention against and for therapy of diseases, preferably nephropathy and disorders of organs in retroperitoneal cavity

Номер патента: DE102007044066A1. Автор: . Владелец: Schrezenmeir, Jürgen, Prof. Dr.. Дата публикации: 2009-05-14.

A vaccine for the treatment of type 1 diabetes in children, the use of a cell sorter and a method for proliferation of Treg cells producing a vaccine for the treatment of type 1 diabetes

Номер патента: PL399447A1. Автор: Piotr Trzonkowski,Małgorzata Myśliwiec,Natalia Marek-Trzonkowska. Владелец: Gdanski Uniwersytet Medyczny. Дата публикации: 2013-12-09.

Method for treatment and prevention of biofilm formation during breast augmentation procedures

Номер патента: EP3615144A1. Автор: Jack Fisher,Albert Rodewald,R. Stephen Porter. Владелец: Integrated Healing Technologies LLC. Дата публикации: 2020-03-04.

Use of metal astringents for the treatment and prevention of hairy heel warts

Номер патента: ZA201002068B. Автор: Petra Vogt,Edward Verkaar,Joseph P Morelli,Jeffrey R Fernandes. Владелец: Ecolab Inc. Дата публикации: 2010-12-29.

Use of wild garlic for the therapy or prevention of heart rhythm disturbances.

Номер патента: GR3019554T3. Автор: Georgios Pandalis,Bettina Rietz,Ruthard Jacob. Владелец: Georgios Pandalis. Дата публикации: 1996-07-31.

Use of metal astringents for the treatment and prevention of hairy heel warts

Номер патента: EP2207557A4. Автор: Petra Vogt,Joseph P Morelli,Jeffrey R Fernandes,Edward L C Verkaar. Владелец: Ecolab Inc. Дата публикации: 2012-01-18.

Use of mage a3-protein d fusion antigen in immunotherapy combined with surgery, chemotherapy or radiotherapy for the treatment of cancer

Номер патента: WO2008084040A8. Автор: Vincent Brichard,Jamila Louahed,Catherine Marie Ghislai Gerard,Frederic Francois Euge Lehmann. Владелец: Frederic Francois Euge Lehmann. Дата публикации: 2008-08-28.

Use of MAGE A3-protein D fusion antigen in immunotherapy combined with surgery, chemotherapy or radiotherapy for the treatment of cancer

Номер патента: AU2008204526A1. Автор: Catherine Marie Ghislaine Gerard,Vincent Brichard,Jamila Louahed,Frederic Francois Eugene Lehmann. Владелец: GLAXOSMITHKLINE BIOLOGICALS SA. Дата публикации: 2008-07-17.

Use of mage a3-protein d fusion antigen in immunotherapy combined with surgery, chemotherapy or radiotherapy for the treatment of cancer

Номер патента: WO2008084040A1. Автор: Catherine Marie Ghislaine Gerard,Vincent Brichard,Jamila Louahed,Frederic Francois Eugene Lehmann. Владелец: GLAXOSMITHKLINE BIOLOGICALS SA. Дата публикации: 2008-07-17.

Method of treatment and prevention of radiation cystitis

Номер патента: RU2730450C1. Автор: Наталия Дмитриевна Олтаржевская,Мария Анатольевна Коровина,Михаил Иосифович Школьник,Татьяна Сергеевна Хлыстова,Луиза Ибрагимовна Корытова,Олег Витальевич Корытов,Артур Рамильевич Ахтемзянов,Валентина Петровна Сокуренко. Владелец: Федеральное государственное бюджетное учреждение "Российский научный центр радиологии и хирургических технологий имени академика А.М. Гранова" Министерства здравоохранения Российской Федерации (ФГБУ "РНЦРХТ им. ак. А.М. Гранова" Минздрава России). Дата публикации: 2020-08-24.

The use for the treatment and prevention of atherosclerosis of the protein-peptide complex (hereinafter BOD) obtained from embryonic nervous tissue or from the rapidly frozen embryonic brain of agricultural ungulates, affecting the return transport of cholesterol from the vascular wall and the monocyte activation profile in patients with severe atherosclerosis of the great vessels or with a predisposition to cardiovascular disease and a method for the prevention and treatment of patients with arteriosclerosis of the arterial vessels and with the disease evanesia caused by atherosclerosis of the main and peripheral vessels of the brain, heart, vessels of the lower extremities and aorta (two options)

Номер патента: RU2014141792A. Автор: Анна Борисовна Назаренко. Владелец: ДИАМОНДЗЛИТЕ ЛИМИТЕД Тридент Чамберс. Дата публикации: 2016-05-10.

Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes

Номер патента: CA2517274C. Автор: Robert J. Binder,Pramod K. Srivastava. Владелец: University of Connecticut Health Center. Дата публикации: 2012-09-18.

Process for obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ros scavengers, photo-protectors, biosensors, biofilters and bioreactors

Номер патента: CA2393816C. Автор: Marc Purcell. Владелец: Purgenesis Technologies Inc. Дата публикации: 2013-12-24.

Novel uses of il-4 and/or il-10, and antibodies against the same

Номер патента: MY111402A. Автор: DE WAAL MALEFYT RENE,Rennick Donna,COFFMAN Robert,Powrie Fiona,E De Vries Jan. Владелец: Schering Corp. Дата публикации: 2000-04-29.

Novel uses of il-4 and/or il-10, and antibodies against the same

Номер патента: CA2142861C. Автор: Rene De Waal Malefyt,Robert Coffman,Fiona Powrie,Donna Rennick,Jan E. De Vries. Владелец: Schering Corp. Дата публикации: 2000-08-15.

Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same

Номер патента: CA2829095C. Автор: David A. Bryce,Adam R. Dorfman,Mikhail Merzliakov,Mark G. Mortenson,Maxwell A. Grace,D. Kyle Pierce. Владелец: Clene Nanomedicine Inc. Дата публикации: 2019-08-27.

Use of Il-18Bp Isoforms for the Treatment and/or Prevention of Neurological Inflammatory Diseases

Номер патента: US20080233085A1. Автор: Yolande Chvatchko,Yves Sagot,Anne Corbaz. Владелец: Laboratoires Serono SA. Дата публикации: 2008-09-25.

Anti-poly-n-acetyl glucosamine (pnag) monoclonal antibody and uses thereof for the prevention or treatment of pnag expressing bacterial infection

Номер патента: CA2882889A1. Автор: MENG Li,Astrid REY,Lei Tang,Cathy CANTALLOUBE,Daniel VLOCK. Владелец: SANOFI SA. Дата публикации: 2014-02-27.

THE COMPOUNDS FOR THE TREATMENT AND PREVENTION OF THE ADHESION, THE PHARMACEUTICAL COMPOSITIONS RELATED TO THE COMPOUND AND THE METHODS FOR THE PREVENTION AND TREATMENT OF ADHERENCES

Номер патента: CR20130600A. Автор: Mikhail Gennadievich Shurygin,Irina Aleksandrovna Shurygina. Владелец: Pharmasyntez. Дата публикации: 2014-04-29.

Use of an anti-g-csf or anti-g -csfr antibody or a soluble g- csfr for the treatment or prophylaxis of arthritis

Номер патента: CA2496485A1. Автор: Donald Metcalf,Ian Keith Campbell,Kathryn Elizabeth Lawlor,Ian Peter Wicks,Andrew Warwick Roberts. Владелец: Individual. Дата публикации: 2004-03-04.

Conjugate vaccines for the prevention of dental caries

Номер патента: CA2325338C. Автор: Daniel J. Smith,Andrew Lees,Martin A. Taubman. Владелец: Individual. Дата публикации: 2015-06-23.

The use of cytokine able to bind il-18bp and of inhibiting the activity of a second cytokine

Номер патента: CA2500577C. Автор: Soo-Hyun Kim,Charles A. Dinarello,Philip Bufler. Владелец: ARES TRADING SA. Дата публикации: 2013-12-17.

Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy

Номер патента: WO2014100857A9. Автор: Graham Vesey,Ross Arthur DAVEY,Christopher John WEIR. Владелец: Northern Sydney Local Health District. Дата публикации: 2015-07-09.

Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids thereof for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom

Номер патента: EP4283303A2. Автор: Massimo Amicosante,Vittorio Colizzi,Francesca Mariani,Cesare Saltini. Владелец: Qiagen Australia Holding Pty Ltd. Дата публикации: 2023-11-29.

Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids thereof for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom

Номер патента: EP4283303A3. Автор: Massimo Amicosante,Vittorio Colizzi,Francesca Mariani,Cesare Saltini. Владелец: Qiagen Australia Holding Pty Ltd. Дата публикации: 2024-01-24.

Dosage and administration regimen for the treatment or prevention of guillan-barré syndrome by the use of the anti-c5 antibody crovalimab

Номер патента: WO2023194271A1. Автор: Kenji SHINOMIYA,Keisuke GOTANDA,Alexandre Antoine Bernard SOSTELLY,Simon Bertrand Marie BUATOIS,Antoine Paul Maxence SOUBRET. Владелец: Chugai Pharmaceutical Co., Ltd.. Дата публикации: 2023-10-12.

Dosage and administration regimen for the treatment or prevention of guillan-barré syndrome by the use of the anti-c5 antibody crovalimab

Номер патента: WO2023194273A1. Автор: Kenji SHINOMIYA,Keisuke GOTANDA,Alexandre Antoine Bernard SOSTELLY,Simon Bertrand Marie BUATOIS,Antoine Paul Maxence SOUBRET. Владелец: Chugai Pharmaceutical Co., Ltd.. Дата публикации: 2023-10-12.

The use of cytokine able to bind il-18bp and of inhibiting the activity of a second cytokine

Номер патента: WO2004032837A3. Автор: Soo-Hyun Kim,Philip Bufler,Charles A Dinarello. Владелец: Charles A Dinarello. Дата публикации: 2006-04-13.

The use of cytokine able to bind il-18bp and of inhibiting the activity of a second cytokine

Номер патента: EP1572291A2. Автор: Soo-Hyun Kim,Charles A. Dinarello,Philip Bufler. Владелец: ARES TRADING SA. Дата публикации: 2005-09-14.

Use of bacteriophages

Номер патента: WO2014195871A1. Автор: Andrzej Gorski,Renata JAKUBOWSKA-ZAHORSKA,Maciej PRZYBYLSKI,Jan BORYSOWSKI. Владелец: Instytut Immunologii I Terapii Doświadczalnej Im Ludwika Hirszfelda Pan We Wrocławiu. Дата публикации: 2014-12-11.

Compositions and methods useful for the prevention of malaria and dengue virus transmission

Номер патента: US11992015B2. Автор: George Dimopoulos,Sarah M. Short,Jose L. Ramirez. Владелец: JOHNS HOPKINS UNIVERSITY. Дата публикации: 2024-05-28.

Method for the manufacturing of chitin derivatives through treatment with ultrasounds

Номер патента: CA3126219A1. Автор: Fabio Di Berardino. Владелец: Texol Srl. Дата публикации: 2020-07-23.

Method for the manufacturing of chitin derivatives through treatment with ultrasounds

Номер патента: AU2020209255A1. Автор: Fabio Di Berardino. Владелец: Texol Srl. Дата публикации: 2021-08-12.

Method for the manufacturing of chitin derivatives through treatment with ultrasounds

Номер патента: EP3911684A1. Автор: Fabio Di Berardino. Владелец: Texol Srl. Дата публикации: 2021-11-24.

Method for the manufacturing of chitin derivatives through treatment with ultrasounds

Номер патента: US20220098330A1. Автор: Fabio Di Berardino. Владелец: Texol Srl. Дата публикации: 2022-03-31.

Dosage and administration regimen for the treatment or prevention of guillan-barré syndrome by the use of the anti-c5 antibody crovalimab

Номер патента: AU2023248634A1. Автор: Kenji SHINOMIYA,Keisuke GOTANDA,Alexandre Antoine Bernard SOSTELLY,Simon Bertrand Marie BUATOIS,Antoine Paul Maxence SOUBRET. Владелец: F Hoffmann La Roche AG. Дата публикации: 2024-05-16.

Use of bacteriophages

Номер патента: EP3003333A1. Автор: Beata Weber-Dabrowska,Andrzej Gorski,Renata JAKUBOWSKA-ZAHORSKA,Maciej PRZYBYLSKI,Jan BORYSOWSKI. Владелец: Instytut Immunologii I Terapii Doświadczalnej Im Ludwika Hirszfelda Pan We Wrocławiu. Дата публикации: 2016-04-13.

Use of bacteriophages

Номер патента: US20160122725A1. Автор: Beata Weber-Dabrowska,Andrzej Gorski,Renata JAKUBOWSKA-ZAHORSKA,Maciej PRZYBYLSKI,Jan BORYSOWSKI. Владелец: Instytut Immunologii I Terapii Doświadczalnej Im Ludwika Hirszfelda Pan We Wrocławiu. Дата публикации: 2016-05-05.

CERIUM OXIDE NANOPARTICLES FOR THE TREATMENT AND PREVENTION OF STROKE AND CARDIOVASCULAR DISEASE

Номер патента: US20140030335A1. Автор: Rzigalinski Beverly A.,Hockey Kevin,Klein Landon M.,Sholar Christopher A.,Himler Justin,Billings Marc J.,Cook Jayce. Владелец: EDWARD Via COLLEGE OF OSTEOPATHIC MEDICINE. Дата публикации: 2014-01-30.

CERIUM OXIDE NANOPARTICLES FOR THE TREATMENT AND PREVENTION OF STROKE AND CARDIOVASCULAR DISEASE

Номер патента: US20160206652A9. Автор: Rzigalinski Beverly A.,Hockey Kevin,Klein Landon M.,Sholar Christopher A.,Himler Justin,Billings Marc J.,Cook Jayce. Владелец: EDWARD Via COLLEGE OF OSTEOPATHIC MEDICINE. Дата публикации: 2016-07-21.

Uses of anti-insulin-like growth factor I receptor antibodies

Номер патента: NZ563207A. Автор: Vahe Bedian,Huifen Faye Wang,Bruce David Cohen,Mihail Obrocea,Jesus Gomez-Navarro,John Daniel Cusmano,Deborah Jean Guyot,Kelly Lynn Page. Владелец: Pfizer Prod Inc. Дата публикации: 2010-02-26.

Use of a fusion protein between a cytokine and an antibody targeting the ed-b fibronectin domain for the treatment of atherosclerosis

Номер патента: WO2008052679A3. Автор: Andreas Menrad,Hans Dietrich Menssen,Kristof Graf. Владелец: Kristof Graf. Дата публикации: 2008-09-25.

Pharmaceutical compositions and dietary soybean food products for the prevention of osteoporosis

Номер патента: US5424331A. Автор: Mark Shlyankevich. Владелец: Bio Virus Research Inc. Дата публикации: 1995-06-13.

Use of rhodococcus for preventing post-weaning multisystemic wasting syndrome

Номер патента: CA2475190C. Автор: John Lawson Stanford,Graham Mcintyre,Cynthia Ann Stanford,Oscar Adelmo Bottasso. Владелец: UCL Biomedica PLC. Дата публикации: 2012-11-20.

Use of amino acid sequences from Mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom

Номер патента: AU2011281147A1. Автор: Massimo Amicosante,Vittorio Colizzi,Francesca Mariani,Cesare Saltini. Владелец: 4ROMAPEPTIDI Srl. Дата публикации: 2013-02-07.

Thixotropic topical fluoride-phosphate gel compositions useful for the prevention of dental caries

Номер патента: US4267167A. Автор: Roy D. Archibald,Stewart Weitzman. Владелец: Cooper Care Inc. Дата публикации: 1981-05-12.

Use of expanded lymphocytes in the preparation of a medicament for the treatment of cancer

Номер патента: NZ539843A. Автор: Ola Winqvist,Magnus Thorn. Владелец: Sentoclone AB. Дата публикации: 2008-05-30.

The use of an l3 and/or l5 source as a vaccine or as a diagnostic for a parasitic disease

Номер патента: TN2012000217A1. Автор: Álvarez Manuel Soto,García Laura Ramírez,- Bedate Carlos Alonso. Владелец: Laboratorios Leti S L. Дата публикации: 2013-12-12.

Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament for inhibiting inflammatory effects

Номер патента: NZ550619A. Автор: Peter Petzelbauer. Владелец: Fibrex Medical Res & Dev Gmbh. Дата публикации: 2008-06-30.

E-SELECTIN FOR THE TREATMENT OR PREVENTION OF STROKE

Номер патента: DE60129552T2. Автор: John M. Kensington HALLENBECK,Hidetaka 35Shinanomachi Shinjuku-ku TAKEDA,Maria Bethesda SPATZ. Владелец: US Department of Health and Human Services. Дата публикации: 2008-04-17.

Use of toll-like receptor 4 antagonists for the treatment or prevention of osteoarthritic conditions

Номер патента: WO2009059143A2. Автор: Vedrana Stojanovic-Susulic,Linda Wu,Mark Ware,Simon Blake. Владелец: Centocor, Inc.. Дата публикации: 2009-05-07.

Use of a fragment of rasgap peptide in the treatment or prevention of metastasis

Номер патента: EP2391378A1. Автор: Christian Widmann. Владелец: UNIVERSITÉ DE LAUSANNE. Дата публикации: 2011-12-07.

Use of amino acid sequences from Mycobacterium tuberculosis or corresponding nucleic acids thereof for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom

Номер патента: AU2023258370A1. Автор: Saltini Cesare,Mariani Francesca,Amicosante Massimo,Colizzi Vittorio. Владелец: Qiagen Australia Holding Pty Ltd. Дата публикации: 2023-11-23.

New use of probiotics

Номер патента: WO2021176387A1. Автор: Antonio La Marca. Владелец: Antonio La Marca. Дата публикации: 2021-09-10.

Discovery and use of immunogenic peptides for the treatment and prevention of cancers

Номер патента: US20230338485A1. Автор: Preethi Gunaratne,Brandon Mistretta,Sakuni Rankothgedera,Micah Castillo,Isabelle Bedrosian. Владелец: University of Texas System. Дата публикации: 2023-10-26.

Use of the endoglycosidase endos for treating immunoglobulin g mediated diseases

Номер патента: US20100135981A1. Автор: Mattias Collin,Arne Olsen,Rikard Holmdahl,Kutty Selva Nandakumar,Lars Björck,Oonagh Shannon. Владелец: HANSA MEDICAL AB. Дата публикации: 2010-06-03.

Use of the foamy virus bet protein for inactivating apobec

Номер патента: WO2005117947A1. Автор: Martin LÖCHELT,Carsten MÜNK. Владелец: Deutsches Krebsforschungszentrum - Stiftung Des Öffentlichen Rechts -. Дата публикации: 2005-12-15.

Use of anti-aging glycopeptides for treatment of dry eye disease, retinal degenerative diseases, or occular inflammation

Номер патента: US20230338464A1. Автор: Lachlan Grant YOUNG. Владелец: Individual. Дата публикации: 2023-10-26.

Extracts of celery seed for the prevention and treatment of pain, inflammation and gastrointestinal irritation

Номер патента: US6576274B2. Автор: Michael Wellesley Whitehouse,Ross Peter Mcgeary,Desley Ethel Butters,Craig Kendall Charles Davis,Michael Christopher Powanda,Kim Drummond Rainsford. Владелец: International Celery Development Alliance Pty Ltd. Дата публикации: 2003-06-10.

Zonulin antagonists for the treatment of multisystem inflammatory syndrome in children (mis-c) and adults (mis-a)

Номер патента: EP4326304A1. Автор: Alessio Fasano,Lael YONKER,David Walt,Moshe Arditi. Владелец: Ebris Srl. Дата публикации: 2024-02-28.

The use of beta-hydroxybutyrates for the treatment or prevention of aneurysms and dissections

Номер патента: EP4366720A1. Автор: Young-Min Han,Ming-Hui Zou. Владелец: Georgia State University Research Foundation Inc. Дата публикации: 2024-05-15.

Use of tsg-6 for treating bone diseases

Номер патента: WO2007101988A3. Автор: Anthony Day,Caroline Milner,Afsie Sabokbar. Владелец: Afsie Sabokbar. Дата публикации: 2007-11-01.

Design and therapeutic use of adpase enhanced apyrases

Номер патента: US7390485B2. Автор: Timothy A. Mitsky,Ridong Chen,Soon S. Jeong. Владелец: APT Therapeutics Inc. Дата публикации: 2008-06-24.

Design and therapeutic use of adpase enhanced apyrases

Номер патента: US20050215505A1. Автор: Ridong Chen,Timothy Mitsky,Soon Jeong. Владелец: APT Therapeutics Inc. Дата публикации: 2005-09-29.

Method and system for treating or preventing type ii diabetes and/or reducing inflammation and body weight/waist circumference

Номер патента: US20220071262A1. Автор: Patrick Angelo, JR.. Владелец: Individual. Дата публикации: 2022-03-10.

Method and system for treating or preventing type ii diabetes and/or reducing inflammation and body weight/waist circumference

Номер патента: US20200008459A1. Автор: Patrick Angelo, JR.. Владелец: Individual. Дата публикации: 2020-01-09.

Method and system for treating or preventing type II diabetes and/or reducing inflammation and body weight/waist circumference

Номер патента: US11185101B2. Автор: Patrick Angelo, JR.. Владелец: Individual. Дата публикации: 2021-11-30.

Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations

Номер патента: AU2023205920A1. Автор: Pascal Druzgala,Peter Gerard Milner. Владелец: Xyra LLC. Дата публикации: 2024-07-11.

Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations

Номер патента: US11759640B2. Автор: Pascal Druzgala,Peter Gerard Milner. Владелец: Xyra LLC. Дата публикации: 2023-09-19.

Methods for Reducing the Risk of Strokes by Pharmacotherapy to Reduce the Number and Duration of Atrial Fibrillations

Номер патента: US20240238596A1. Автор: Pascal Druzgala,Peter Gerard Milner. Владелец: Xyra LLC. Дата публикации: 2024-07-18.

Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations

Номер патента: US11839768B2. Автор: Pascal Druzgala,Peter Gerard Milner. Владелец: Xyra LLC. Дата публикации: 2023-12-12.

Methods for Reducing the Risk of Strokes by Pharmacotherapy to Reduce the Number and Duration of Atrial Fibrillations

Номер патента: US20230218907A1. Автор: Pascal Druzgala,Peter Gerard Milner. Владелец: Xyra LLC. Дата публикации: 2023-07-13.

Methods for Reducing the Risk of Strokes by Pharmacotherapy to Reduce the Number and Duration of Atrial Fibrillations

Номер патента: US20230233863A1. Автор: Pascal Druzgala,Peter Gerard Milner. Владелец: Xyra LLC. Дата публикации: 2023-07-27.

Methods for Reducing the Risk of Strokes by Pharmacotherapy to Reduce the Number and Duration of Atrial Fibrillations

Номер патента: US20230355990A1. Автор: Pascal Druzgala,Peter Gerard Milner. Владелец: Xyra LLC. Дата публикации: 2023-11-09.

Methods for Reducing the Risk of Strokes by Pharmacotherapy to Reduce the Number and Duration of Atrial Fibrillations

Номер патента: US20240033531A1. Автор: Pascal Druzgala,Peter Gerard Milner. Владелец: Xyra LLC. Дата публикации: 2024-02-01.

Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations

Номер патента: US11975202B2. Автор: Pascal Druzgala,Peter Gerard Milner. Владелец: Xyra LLC. Дата публикации: 2024-05-07.

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

Номер патента: US20120004206A1. Автор: Bryan K. Sorensen,James T. Link,Marina A. Pliushchev,Dariusz Wodka. Владелец: Link James T. Дата публикации: 2012-01-05.

Novel mch receptor antagonists

Номер патента: US20070135485A1. Автор: John Morin,James Gillig,Michael Kinnick,Antonio Navarro Martinez. Владелец: Eli Lilly and Co. Дата публикации: 2007-06-14.

Use of conkunitzin-s1 for the modulation of glucose-induced insulin secretion

Номер патента: WO2010015421A1. Автор: Stefan Becker,Heinrich Terlau,Rocio Finol-Urdaneta,Walter Raasch. Владелец: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin. Дата публикации: 2010-02-11.

Use of conkunitzin-s1 for the modulation of glucose-induced insulin secretion

Номер патента: US20110224135A1. Автор: Stefan Becker,Heinrich Terlau,Rocio Finol-Urdaneta,Walter Raasch. Владелец: Univesitat zu Lubeck. Дата публикации: 2011-09-15.

Use of conkunitzin-s1 for the modulation of glucose-induced insulin secretion

Номер патента: EP2367848A1. Автор: Stefan Becker,Heinrich Terlau,Rocio Finol-Urdaneta,Walter Raasch. Владелец: Max Planck Gesellschaft zur Foerderung der Wissenschaften eV. Дата публикации: 2011-09-28.

Kinase inhibitors for the treatment of diabetes and obesity

Номер патента: WO2006047759A2. Автор: Stephen Owens,Jane Lamerdin,Marnie L. Macdonald,John K. Westwick. Владелец: Odyssey Thera, Inc.. Дата публикации: 2006-05-04.

Kinase inhibitors for the treatment of diabetes and obesity

Номер патента: WO2006047759A3. Автор: Stephen Owens,Jane Lamerdin,John K Westwick,Marnie L Macdonald. Владелец: Odyssey Thera Inc. Дата публикации: 2007-10-25.

Kinase inhibitors for the treatment of diabetes and obesity

Номер патента: EP1812078A2. Автор: Stephen Owens,Jane Lamerdin,Marnie L. Macdonald,John K. Westwick. Владелец: Odyssey Pharmaceuticals Inc. Дата публикации: 2007-08-01.

Use of conkunitzin-s1 for the modulation of glucose-induced insulin secretion

Номер патента: US20130244933A1. Автор: Stefan Becker,Heinrich Terlau,Rocio Finol-Urdaneta,Walter Raasch. Владелец: Max Planck Gesellschaft zur Foerderung der Wissenschaften eV. Дата публикации: 2013-09-19.

N-acylaminobenzene derivatives, processes for their preparation, medicaments containing them, such compounds for the treatment and prevention of diseases, and the use of such compounds for the manufacture of drugs and the prevention of diseases.

Номер патента: NO329387B1. Автор: Synese Jolidon,Rosa Maria Rodriguez Sarmiento,Andrew William Thomas,Rene Wyler. Владелец: Hoffmann La Roche. Дата публикации: 2010-10-11.

Substituted 2-methyl-2-phenoxy-n-propyl-propionamides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity

Номер патента: US20080287505A1. Автор: John F. Mcelroy,Robert J. Chorvat. Владелец: Jenrin Discovery LLC. Дата публикации: 2008-11-20.

Uses of EPH receptor antagonists and agonists for the treatment of vascular disorders

Номер патента: DK1135153T3. Автор: Michel Aguet. Владелец: Genentech Inc. Дата публикации: 2005-08-15.

USE OF EPH RECEPTOR ANTAGONISTS AND AGONISTS FOR THE TREATMENT OF VASCULAR DISEASES

Номер патента: DE69925024D1. Автор: Michel Aguet. Владелец: Genentech Inc. Дата публикации: 2005-06-02.

Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1

Номер патента: CA2513349A1. Автор: Gary Mark Coppola,Paivi Jaana Kukkola,Robert Edson Damon,James Lawrence Stanton. Владелец: Individual. Дата публикации: 2004-08-05.

Methods involving the use of capg as a diagnostic marker and methods for the identification of capg modulators for the treatment and prevention of osteoporosis and related disease states

Номер патента: EP1368487A4. Автор: C Patrick Mcatee. Владелец: Bristol Myers Squibb Co. Дата публикации: 2004-10-13.

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

Номер патента: CA2594098C. Автор: Qi Shuai,Martin Winn,HONG Yong,Bryan K. Sorensen,Jurgen Dinges,James T. Link,Jyoti R. Patel,Jeffrey J. Rohde,Vince S. Yeh. Владелец: AbbVie Inc. Дата публикации: 2014-04-01.

Substituted adamantyl-containing acetamides as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 and pharmaceutical compositions comprising the same

Номер патента: IL184328A. Автор: . Владелец: Abbott Lab. Дата публикации: 2013-01-31.

Imidazole derivatives as glutamate receptor antagonists

Номер патента: CA2527315C. Автор: Bernd Buettelmann,Sabine Kolczewski,Eric Vieira,Georg Jaeschke,Simona Maria Ceccarelli,Richard Hugh Phillip Porter. Владелец: F Hoffmann La Roche AG. Дата публикации: 2010-08-10.

Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

Номер патента: NZ555966A. Автор: Qi Shuai,Martin Winn,HONG Yong,Jurgen Dinges,Jeffrey J Rohde,James T Link,Jyoti R Patel,Bryan K Sorensen,Vince S Yeh. Владелец: Abbott Lab. Дата публикации: 2011-03-31.

Alpha v integrin receptor antagonists

Номер патента: WO2002022615A1. Автор: Mark E. Duggan,Wasyl Halczenko,John H. Hutchinson,Byron H. Arison,Xiaojun Fang,Donghui Cui,Thomayant Prueksaritanont,Raju Subramanian. Владелец: Merck & Co., Inc.. Дата публикации: 2002-03-21.

Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their use

Номер патента: EP2552209A1. Автор: Michael K. Wong,Joseph A. Kozlowski,XING Dai,William J. Greenlee,Andrew W. Stamford,Michael W. Miller,Brian J. Lavey,Wensheng Yu,Guowei Zhou,Duane E. Demong. Владелец: Merck Sharp and Dohme LLC. Дата публикации: 2013-02-06.

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

Номер патента: US20120004206A1. Автор: Bryan K. Sorensen,James T. Link,Marina A. Pliushchev,Dariusz Wodka. Владелец: Individual. Дата публикации: 2012-01-05.

Glucagon receptor antagonists, compositions, and methods for their use

Номер патента: EP2291358A1. Автор: Andrew Stamford,William J. Greenlee,Michael W. Miller,Duane Eugene DeMong. Владелец: Schering Corp. Дата публикации: 2011-03-09.

A 2-METHYLPROPIONIC ACID DERIVATIVE, A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, USE OF A 2-METHYLPROPIONIC ACID DERIVATIVE AND A PARALLY PROCEDURE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF DISEASES

Номер патента: AR015761A1. Автор: . Владелец: Kissei Pharmaceutical. Дата публикации: 2001-05-16.

Thiazole derivatives as npy receptor antagonists

Номер патента: CA2475299A1. Автор: Patrizio Mattei,Matthias Heinrich Nettekoven,Werner Neidhart,Sven Taylor,Philippe Pflieger. Владелец: Individual. Дата публикации: 2003-09-04.

MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF HEART FAILURE AND DISORDERS RELATED THERETO

Номер патента: US20200385395A1. Автор: SHIN Young-Jun,Tran Thuy-Anh,Ullman Brett,DO Quyen-Quyen Thuy,Kramer Bryan Aubrey. Владелец: . Дата публикации: 2020-12-10.

Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders

Номер патента: CA2443724C. Автор: Andrew Mott,Gary Johansson,Annika Jensen,Ulf Bremberg,Patrizia Caldirola,Lori Sutin,Jan Tejbrant. Владелец: Biovitrum Ab. Дата публикации: 2009-11-03.

The use of compounds such as pyridoxal derivatives for the treatment of diabetes or diseases associated with the metabolic syndrome

Номер патента: WO2009005469A3. Автор: Olov Sterner,David Erlinge,Albert S Salehi,Stefan Amisten,Sandra Meidute-Abaravecien,Johan Wingstrand. Владелец: Sandra Meidute-Abaravecien. Дата публикации: 2009-02-26.

1-monoglyceride of c12 fatty acid for the treatment or prevention of infectious plant diseases

Номер патента: WO2024165554A1. Автор: Maria BLASCO BIGATÁ. Владелец: Mbp 4 Life, S.L.. Дата публикации: 2024-08-15.

Composition for the treatment or prevention of an energy imbalance in ruminants

Номер патента: CA2199398C. Автор: Richard S. Patton,Neil A. Mckeown. Владелец: Don J Pestell Ltd. Дата публикации: 2000-12-05.

Methods and Compositions for the Treatment and Prevention of Citrus Greening Disease

Номер патента: US20100074972A1. Автор: Russell L. Rouseff,Lukasz L. Stelinski. Владелец: University of Florida Research Foundation Inc. Дата публикации: 2010-03-25.

Agricultural composition for the treatment and prevention of bacterial diseases and disorders

Номер патента: EP4169380A1. Автор: Marco Aurelio Takita,Marcos Antonio Machado,Lígia Segatto Muranaka,Simone Cristina Picchi,Alessandra Alves DE SOUZA DELLA COLETTA,Helvecio DELLA COLETTA FILHO. Владелец: Instituto Agronomico De Campinas Iac. Дата публикации: 2023-04-26.

Composition for the treatment and prevention of the esca disease

Номер патента: US20240260585A1. Автор: Mario Guerrieri,Roberto Ercolani. Владелец: Escafix Srl. Дата публикации: 2024-08-08.

Composition for the treatment and prevention of the esca disease

Номер патента: EP4384015A1. Автор: Mario Guerrieri,Roberto Ercolani. Владелец: Escafix Srl. Дата публикации: 2024-06-19.

A set of sheets for protection of a surface of an induction-cooking device and the use of sheets

Номер патента: WO2005039366A1. Автор: Willy Kjeldsen. Владелец: Willy Kjeldsen. Дата публикации: 2005-05-06.

Use of germ flour of certain fruits for the manufacture of food products useful for the treatment of phytate deficiency states

Номер патента: US20020136817A1. Автор: Antonia Costa Bauza,Feliciano Grases Freixedas. Владелец: INDUSTRIAS AGRICOLAS DE MALLORCA SA. Дата публикации: 2002-09-26.

The bacterial strain Paenibacillus mucilaginosus, a method of stimulating the growth and protection of plants from diseases and the use of the bacterial strain Paenibacillus mucilaginosus as a fertilizer and biological control agent (anti-pathogenic agent) in the prevention and / or treatment of plant diseases

Номер патента: RU2015148020A. Автор: Сергей Аркадьевич Пластинин,Алексей Вячеславович Здорнов,Вадим Альбертович Никульшин. Владелец: Общество с ограниченной ответственностью "Промышленные Инновации". Дата публикации: 2017-05-16.

Pharmaceutical composition for the treatment and prevention of a rhinovirus infection

Номер патента: CA2778540C. Автор: Rudolf Valenta,Nikos Papadopoulos,Dieter Blaas,Katarzyna Niespodziana,Verena Niederberger-Leppin,Johanna Edlmayr,Theresia Popow-Kraupp. Владелец: Viravaxx AG. Дата публикации: 2019-05-07.

Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation

Номер патента: US20020198188A1. Автор: John Clifford,Minghua Sun,Eugene Kelleher,Jose Halperin,Ying-Duo Gao,Adel Moussa,Carlo Brugnara,Rudolf Fluckiger,Richard Lombardy,Emile Bellott,Reem Haidar,Yesh Sachdeva,Heather Taft. Владелец: Childrens Medical Center Corp. Дата публикации: 2002-12-26.

Msbi sequences as an early marker for the future development of cancer and diseases of the cns and as a target for the treatment and prevention of these diseases

Номер патента: US20200002723A1. Автор: Harald Zur Hausen,Ethel-Michele De Villiers-Zur Hausen,Karin Gunst,Corinna Whitley,Iranzu Lamberto-Pérez. Владелец: Deutsches Krebsforschungszentrum DKFZ. Дата публикации: 2020-01-02.

Compounds, pharmaceutical compositions containing them and their medical use for the treatment or prevention of vascular diseases

Номер патента: WO2024005556A1. Автор: Sung Hoon Jung,Sang Won Kang,Kyung Joo LEE,Dong Hoon Kang,Doo Jae Lee,Hiteshkumar Bhanubhai JALANI. Владелец: Vasthera Co., Ltd.. Дата публикации: 2024-01-04.

System and method for the detection and prevention of battery exhaustion attacks

Номер патента: US20150161389A1. Автор: Richard L. Gregg. Владелец: PRISM TECHNOLOGIES LLC. Дата публикации: 2015-06-11.

Rnai-based therapies targeting claudin-1 for the treatment and prevention of fibrotic diseases

Номер патента: WO2024126765A1. Автор: Thomas Baumert,Catherine Schuster,Laurent MAILLY,Emilie CROUCHET,Antonio SAVIANO. Владелец: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE. Дата публикации: 2024-06-20.

Bioremediation systems for wastewater treatment and methods for the use thereof

Номер патента: EP4178921A1. Автор: Tahereh Karimi,Truong Huu NGUYEN,Marcio Luis Busi DA SILVA. Владелец: Cemvita Factory Inc. Дата публикации: 2023-05-17.

Bioremediation systems for wastewater treatment and methods for the use thereof

Номер патента: US20230234867A1. Автор: Tahereh Karimi,Truong Huu NGUYEN,Marcio Luis Busi DA SILVA. Владелец: Individual. Дата публикации: 2023-07-27.

Process for the preparation of an acesulfame with sulphuric acid processing

Номер патента: US20210122720A1. Автор: Hans Wolfgang EBERTZ. Владелец: Chemadvice GmbH. Дата публикации: 2021-04-29.

Crimping pliers, die half unit and method for the assembly

Номер патента: US12057672B2. Автор: Thomas Glockseisen,Roman Zinser. Владелец: Wezag GmbH and Co KG. Дата публикации: 2024-08-06.

Triazolopyrimidine derivatives which are angiotensin II receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present

Номер патента: US5387747A. Автор: Timur Gungor,Nicole Bru-Magniez,Jean-Marie Teulon. Владелец: UPSA SAS. Дата публикации: 1995-02-07.

Creation and use of multiple gradients in electrophoresis in gel slabs and in capillaries

Номер патента: AU1768697A. Автор: Pier Giorgio Righetti,Cecilia Gelfi. Владелец: Individual. Дата публикации: 1997-09-02.

Sigma-1 receptor ligands and therapeutic uses thereof

Номер патента: US20230076057A1. Автор: Jean-Jacques Bourguignon,Martine Schmitt,Tangui Maurice,Jacques Bricard. Владелец: Ecole Pratique des Hautes Etudes SAS. Дата публикации: 2023-03-09.

Use of naphtha in carbo-metallic oil conversion

Номер патента: CA1168613A. Автор: George D. Myers, (Deceased). Владелец: Ashland Oil Inc. Дата публикации: 1984-06-05.

Methods using non-genic sequences for the detection, modification and treatment of any disease or improvement of functions of a cell

Номер патента: US20050164252A1. Автор: Wah Hin Yeung. Владелец: Individual. Дата публикации: 2005-07-28.

Use of a tungsten/heavy metal alloy

Номер патента: CA2365366A1. Автор: Robert Grill,Norbert Dreer,Joachim Resch. Владелец: Plansee Se. Дата публикации: 2002-06-19.

Bioremediation systems for wastewater treatment and methods for the use thereof

Номер патента: CA3183750A1. Автор: Tahereh Karimi,Truong Huu NGUYEN,Marcio Luis Busi DA SILVA. Владелец: Cemvita Factory Inc. Дата публикации: 2022-01-13.

Peptidic compounds and derivatives thereof for the treatment of human diseases through inhibition of signaling via growth factors

Номер патента: EP1647556B1. Автор: Bernd Hentsch,Helmut Ponta,Veronique Orian-Rousseau,Alexandra Matzke,Peter A. Herrlich,Jan Adam. Владелец: Karlsruher Institut fuer Technologie KIT. Дата публикации: 2010-05-19.

Optical sensors for boron detection based on the use of 2,3,6,7,10,11-hexahydroxytriphenylene or its derivatives

Номер патента: WO2014123436A8. Автор: José Paulo Sequeira FARINHA,Carlos Miguel Calisto BALEIZÃO,Sérgio Paulo do Carmo ALVES. Владелец: INSTITUTO SUPERIOR TÉCNICO. Дата публикации: 2014-10-16.

Bioremediation systems for wastewater treatment and methods for the use thereof

Номер патента: ZA202213850B. Автор: Tahereh Karimi,Truong Huu NGUYEN,Silva Marcio Luis Busi Da. Владелец: Cemvita Factory Inc. Дата публикации: 2023-09-27.

The use of an oil-based composition for reducing ammonia volatilization in urea-based fertilizer application

Номер патента: CA3126751A1. Автор: Stuart Ward,Andres Felipe Rangel Becerra,Anke Kwast,Ana Gajic. Владелец: Yara Uk Ltd. Дата публикации: 2020-09-24.

For the flat or roller lifter of stroke piston combustion engine

Номер патента: CN106884694A. Автор: 诺伯特·盖耶,马可·容克尔. Владелец: Schaeffler Technologies AG and Co KG. Дата публикации: 2017-06-23.

Multiple genes relevant for the characterization, diagnosis, and manipulation of stroke

Номер патента: US20030219807A1. Автор: Peter Engels,Stefan Zwilling,Hermann LÜBBERT. Владелец: Biofrontera Pharmaceuticals GmbH. Дата публикации: 2003-11-27.

Use of 4-bora-3a,4a-diaza-s-indacenes for security purposes

Номер патента: CA3010667C. Автор: Cosimo Prete. Владелец: Crime Science Technology SAS. Дата публикации: 2023-12-12.

Process for the production of electrically conducting elements and elements produced thereby

Номер патента: WO2008040420A1. Автор: Frank Dirks,Mathijs Ten Haaft,Paul Rothfusz. Владелец: Scheuten S.A.R.L. Дата публикации: 2008-04-10.

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

Номер патента: US20120004202A1. Автор: KLEY Joerg,ROTH Gerald Juergen,LEHMANN-LINTZ Thorsten,Park John Edward,Heckel Armin,CHAUDHARY Nveed. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2012-01-05.

Pyrimidine-based bicycles as antiviral agents for the treatment and prevention of HIV infection

Номер патента: OA21003A. Автор: Mikhail Gennadievich Shurygin,Vladimir Nikolaevich Ivanov,Denis Nikolaevich KAZYULKIN,Ekaterina Vladimirovna MANASOVA,Alexander Vitalievich Kurkin. Владелец: Pharmasyntez, Joint Stock Company. Дата публикации: 2023-08-24.

Therapeutic compositions for the treatment and prevention of gastrointestinal cancer

Номер патента: NZ713046A. Автор: PAUL Kerry,CATCHPOLE Owen,Lazarova Lazarova Darina. Владелец: Manuka Health New Zealand Ltd. Дата публикации: 2017-04-28.

PHENYLALANINE DERIVATIVES AND THEIR USE AS NON-PEPTIDE GLP-1 RECEPTOR MODULATORS

Номер патента: US20120004198A1. Автор: Wang Yong,Liao Jiayu,Hong Yufeng,von Geldern Thomas W.,Zhang Kanyin E.. Владелец: ARGUSINA INC.. Дата публикации: 2012-01-05.

METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF VASCULAR INFLAMMATORY DISORDERS OR ENDOTHELIAL CELL DISORDERS

Номер патента: US20120003227A1. Автор: SUKHATME VIKAS P.,CHAN CHUNKONG BARDEN. Владелец: . Дата публикации: 2012-01-05.

BIOMARKER FOR THE PREDICTION OF FIRST ADVERSE EVENTS

Номер патента: US20120003751A1. Автор: Struck Joachim,Bergmann Andreas,Melander Olle,Newton-Cheh Christopher,Wang Thomas J.. Владелец: B.R.A.H.M.S. GMBH. Дата публикации: 2012-01-05.

11-Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds

Номер патента: US20120004209A1. Автор: Ebdrup Soren,Andersen Henrik Sune. Владелец: HIGH POINT PHARMACEUTICALS, LLC. Дата публикации: 2012-01-05.

G PROTEIN-COUPLED RECEPTOR ANTAGONIST AND ITS USE FOR PREVENTING AND TREATING ALZHEIMER'S DISEASE

Номер патента: US20120004254A1. Автор: Pei Gang,Ni Yanxiang,Zhao Xiaohui. Владелец: Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. Дата публикации: 2012-01-05.

METHODS FOR IDENTIFYING AND COMPOUNDS USEFUL FOR THE DIAGNOSIS AND TREATMENT OF DISEASES INVOLVING INFLAMMATION

Номер патента: US20120004160A1. Автор: Dickson Marion Catherine,Janssen Richard Antonius Jozef,De Groot Anton,Lekkerkerker Annemarie Nicolette,Meldrum Eric Charles,Thompson Nicola,Ray Keith Paul,Boyce Susan Heather. Владелец: . Дата публикации: 2012-01-05.

Enterovirus Vaccines for Preventing or Treating Type 1 Diabetes (I)

Номер патента: US20120003238A1. Автор: Hyoty Heikki,Knip Mikael,Laitinen Olli,Tolonen Outi,Pulkki Minna,Oikarinen Sami,Honkanen Hanna-Riikka,Lecouturier Valerie,Almond Jeffrey. Владелец: . Дата публикации: 2012-01-05.

Enterovirus Vaccines for Preventing and Treating Type 1 Diabetes (II)

Номер патента: US20120003239A1. Автор: . Владелец: . Дата публикации: 2012-01-05.

Systems and Methods for the Collection, Retention, and Redistribution of Rainwater and Methods of Construction of the Same

Номер патента: US20120000546A1. Автор: . Владелец: . Дата публикации: 2012-01-05.

COMPOUNDS FOR THE MODULATION OF BETA-CATENIN EXPRESSION

Номер патента: US20120004288A1. Автор: . Владелец: . Дата публикации: 2012-01-05.

Use of a thrombolytic agent and an NR2B subtype selective NMDA receptor antagonizing compound in combination for the treatment of stroke and traumatic brain injury

Номер патента: NZ524168A. Автор: Frank Samuel Menniti,Bertrand Leo Chenard,Mario David Saltarelli. Владелец: Pfizer Prod Inc. Дата публикации: 2004-04-30.

Device for use of electrostatic field energy

Номер патента: RU2439864C1. Автор: Евгений Иванович Старченко,Александр Иванович Гавлицкий,Ирина Викторовна Черунова,Алла Владимировна Меркулова. Владелец: Государственное образовательное учреждение высшего профессионального образования "Южно-Российский государственный университет экономики и сервиса" (ГОУ ВПО "ЮРГУЭС"). Дата публикации: 2012-01-10.

Method for early postoperative prevention of acute gastroduodenal ulcers in patients suffering colorectal cancer

Номер патента: RU2403904C1. Автор: Виктор Васильевич Дуйко,Владимир Владимирович Кутуков,Василий Викторович Дуйко,Юрий Вирабович Оганесян. Владелец: Государственное учреждение здравоохранения областной онкологический диспансер. Дата публикации: 2010-11-20.

Compounds for Use as Ferments for the Production of Alcohol from Farinaceous Matter.

Номер патента: GB189810809A. Автор: Henry Gribble Turner. Владелец: Individual. Дата публикации: 1899-05-06.

"The Use of a PAR-1 Antagonist in Combination with a P2Y12 ADP Receptor Antagonist for Inhibition of Thrombosis"

Номер патента: US20120184504A1. Автор: Strony John T.,Chintala Madhu. Владелец: . Дата публикации: 2012-07-19.

A system in which advertisement is displayed, a method for monitoring the use of advertising in a system, system and method for providing information in real time classifications for the users, system and method for collecting information on display guides of program guidelines were exhibited and method to collect information in which program non-guiding applications were used

Номер патента: BRPI9909238B1. Автор: . Владелец: . Дата публикации: 2017-07-04.

Use of the protein UK114 or of fragments thereof for the treatment and prevention of the endotoxic shock

Номер патента: AU2002338299A1. Автор: Alberto Bartorelli,Alberto Panerai,Pierferdinando Nicoletti. Владелец: Zetesis SpA. Дата публикации: 2002-10-28.

Methods involving the use of capG as a diagnostic marker and methods for the identification of capG modulators for the treatment and prevention of osteoporosis and related disease states

Номер патента: AU2002306744A1. Автор: C. Patrick Mcatee. Владелец: Bristol Myers Squibb Co. Дата публикации: 2002-10-03.

The use of the pharmaceutical composition based on the magnesium salt of aminoethanesulfonic acid with hepatoprotective activity for the prevention and treatment of hepatitis

Номер патента: RU2017144206A. Автор: Михаил Александрович МОРОЗОВ,София Яковлевна Скачилова,Екатерина Валерьевна Блинова. Владелец: Федеральное государственное бюджетное образовательное учреждение высшего образования "Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва". Дата публикации: 2019-06-18.

Combination therapy of angiotensin converting enzyme inhibitor and side-effect-reduced amount of aldosterone antagonist for treatment of cardiovascular disease

Номер патента: AU2003202461A1. Автор: Todd E. Maclaughlan,Alfonso T. Perez. Владелец: GD Searle LLC. Дата публикации: 2003-06-12.

Use of racemic reboxetine for the treatment of chronic fatigue syndrome, fibromyalgia or another somatoform disorder, migraine headaches and peripheral neuropathy

Номер патента: NZ550213A. Автор: Saeeduddin Ahmed,Robert Mcarthur,Lars Birgerson,Pasquale Cetera,Robert C Marshall,Erik H F Wong,Duncan P Taylor. Владелец: Pharmacia & Upjohn Co Llc. Дата публикации: 2008-02-29.

Condensed benzene derivatives with 5-HT4 receptor antagonistic activity, procedure for the preparation thereof, compositions which contain them, and applications

Номер патента: ES2065238A1. Автор: Gordon Smith Baxter,Francis David King,Alberto Julio Kaumann,Kay Alison Wardle,Keith Raymond Gaster,Shirley Katheri Mulholland,Paul Adrian Rahman,Gareth Wyman,Johan Sanger,Anthony Kennett. Владелец: SmithKline Beecham Ltd. Дата публикации: 1995-02-01.

Use of thymohexin as therapeutic agent

Номер патента: TN2011000576A1. Автор: V Lebedev V,Boujbel L,B Bonicek B,Matha V. Владелец: Les Laboratoires Medis S A. Дата публикации: 2013-05-24.

Бесплатный поиск патентной информации. Построение патентных ландшафтов и отчетов.

Главная
Проекты и услуги
Контакты

© 2021-2022 - All Rights Reserved - разработано Ecoruspace.me.